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Tobacco smoking is the leading avoidable cause of death and disability in 
the world.  The UK is unique in that it offers a dedicated smoking cessation 
service providing behavioural support to all smokers, freely available 
through the National Health Service and with pharmacotherapy available at 
prescription cost.  The service has been proven effective and cost-effective, 
yet only a small minority of smokers are currently using these services. 
7KH UHVHDUFK LQ WKLV WKHVLV H[DPLQHV VPRNHUV¶ XVH RI VXSSRUW DQG KRZ
more smokers might be identified and encouraged to use it. 
 
The first study investigated whether proactive identification of smokers in a 
primary care setting and referral into such services is a potential means by 
which awareness and use of services may be increased.  As such a study is 
reliant on the identification of smokers from primary care records and the 
accuracy of this data, a precursor to this study investigated the 
completeness and accuracy of smoking status recording in primary care 
medical records.  General practices in this study had a smoking status 
recorded for between 42.4 and 100% of patients, and comparison of 
medical records with responses to self-completion questionnaires revealed 
that this recording is likely to be inaccurate in approximately 20% of cases.  
Even so, approximately 40% of smokers who responded to the 
questionnaire were interested in speaking to a smoking cessation advisor 
when asked, indicating that there is potential to intervene with smokers 
identified in this way in primary care and that there is a need which is 
currently not being met. 
 
In the trial, all smokers in 12 intervention practices were proactively 
identified and offered referral into evidence based support, and compared 
WR  µXVXDO FDUH¶ FRQWURO SUDFWLFHV a significantly greater proportion of 
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these smokers reported using local smoking cessation services (16.6% and 
8.9% respectively).  Validated 7-day point prevalence from smoking at 6 
months was higher in the intervention than the control groups, although 
this difference was not statistically significant (3.5% and 2.5% 
respectively).  Post-hoc analysis in the sub-group of smokers who had 
initially reported that they wanted to speak to a smoking cessation advisor 
did, however, reveal a significant difference between intervention and 
control groups (4.0% and 2.2% respectively).  A proactive approach to 
enrolling smokers in smoking cessation services is, therefore, effective if 
you can identify smokers who want support for their quit attempt.  
 
Use of an NHS support service traditionally involves some degree of pre-
planning.  Anecdotal evidence from the proactive trial indicated that many 
smokers did not pre-plan their quit attempts and as recent evidence from 
elsewhere has indicated that a large proportion of smokers make an 
attempt to quit smoking without any pre-planning, this may in part explain 
the relatively low proportion of smokers accessing services.  The next 
study therefore was a questionnaire survey designed to investigate the 
occurrence, determinants and use of support in planned and unplanned 
quit attempts.  The study findings revealed that over one third of quit 
attempts were made without pre-planning, and over half of these 
unplanned attempts were made without the use of any support and 
unplanned quit attempts appeared to be more likely to be successful, in 
line with previous findings.  However, the use of evidence-based support is 
known to increase the likelihood of a quit attempt being successful and 
thus for each successful unplanned and unsupported quitter there are likely 
to be many more who are unsuccessful.   
iv 
 
There has been no detailed exploration of how unplanned quitters engage 
in quit attempts, why they may or may not choose to use support and their 
attitudes to the support currently available.   Gaining a greater insight into 
these factors may result in the identification of better ways to support 
those who make unplanned quit attempts.  The final study therefore 
involved qualitative research with a group of unplanned quit attempters 
and revealed that sPRNHUV¶ UHSRUWV RI µXQSODQQHG¶ TXLW DWWHPSWV PD\
indeed involve elements of planning and delay, and often this delay is in 
order to gain access to cessation support.  The majority of smokers and 
ex-smokers interviewed were receptive to the idea of support being 
immediately available whether or not their last quit attempt had involved 
support.  Engaging smokers in using support at an appropriate time, 
without the need to delay their quit attempt in order to achieve this, may 
be a potential means of increasinJVPRNHUV¶XSWDNHRIHIIHFWLYHFHVVDWLRQ
support and subsequently improving quit rates.  It is therefore important to 
investigate ways in which smoking cessation support can be made available 
to potential quitters within a much shorter timescale. 
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CHAPTER 1: INTRODUCTION 
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1.1 The health and economic costs of smoking                                                     
 
The UK suffers a huge burden of premature mortality and morbidity as a 
direct result of tobacco use.  The burden of cigarette smoking is not limited 
to the UK, but is a worldwide epidemic.  Tobacco smoking is predicted to 
become the leading single cause of death worldwide by the 2020s1, 
becoming responsible for more than 1 in every 8 deaths2. 
 
1.1.1 Economic costs  
Smoking related illness in England has been recently estimated to cost the 
National Health Service £2.7 billion3  In addition, there are also economic 
costs arising from smoking related disease.  In England and Wales, it is 
estimated that some 34 million work days are lost through smoking related 
illness per year4.  In Scotland alone, lost productivity as a result of smoking 
(for example, working time lost for smoking breaks) costs employers 
approximately £450 million, with a cost of £40 million arising from smoking 
related absence from work5.  Environmental tobacco smoke (ETS) also 
costs the NHS; at least 1000 deaths per year in adult non-smokers can be 
attributed to passive ETS, costing approximately £12.8 million per year, 
and around £410 million per year is spent treating childhood illness 
resulting from ETS4.  The costs attributable to ETS may have decreased 
following the introduction of smoke free legislation in 2007, however, 
although this has not yet been assessed. 
 
The financial cost to the smoker is also noteworthy.  In 2007, the total 
household expenditure on tobacco was £16.6 billion6.  A 20 a day smoker 
will spend around £1800 per year on cigarettes.  The proportion of income 
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spent on cigarettes is much higher in those on low incomes.  Those 
households with the lowest 10% income spent 2.61% of the weekly 
household expenditure on cigarettes in 2006, compared to 0.35% in 
households with the highest 10% income7.  
 
1.1.2 Health costs of smoking 
 
There is another significant cost to the smoker, that of their health.  On 
average, a cigarette smoker will die some 10 years earlier than non-
smokers8.  Approximately half of all smokers will eventually die as a result 
of their habit9 10, although it has been reported that  this figure may be as 
high as two thirds8.  These deaths are usually as a result of one of the 
three major diseases caused by smoking: lung cancer, chronic obstructive 
pulmonary disease (COPD) and coronary heart disease. 
 
Over 1 million GP consultations in 1997/8 were attributable to cigarette 
smoking11.  In 2007, the proportion of deaths attributable to smoking in 
England was estimated at 18% in adults over 35 years of age, with the 
number of hospital admissions attributable to smoking being an estimated 
445,1006.   
  
1.1.2.1 Cancer 
Cancer is a major public health problem in most developed countries and 
the UK is no exception, with at least 1 in 3 people being diagnosed with 
some form of cancer in their lifetime12.  Cancer is the major cause of death 
in men and women in the UK, accounting for around 25% of all deaths12.  
In the year 2000 this amounted to just over 150,000 deaths, of which 
around a third (over 43,000) were smoking-attributed13. 
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Lung cancer 
Lung cancer is currently the most common cancer in the world; about 90% 
of cases are caused by tobacco smoking12 and is generally between four 
and six times higher in men than women12.  One of the first to examine the 
relationship between tobacco smoking and lung cancer were Doll and Hill, 
who set up a cohort study of British doctors starting in 1951.  After 40 
years of follow up of the cohort, Doll and colleagues reported that lung 
cancer was 15 times more likely in current than never smokers in their 
study population14.  In a study of a population of over one million men and 
women aged over 35 years, the risk of lung cancer was reportedly elevated 
20-fold in smokers compared with non-smokers9.  
 
The risk of individual smokers developing lung cancer is influenced by both 
the amount smoked and the duration of smoking.  Smoking more than 40 
cigarettes per day doubles the risk of lung cancer compared to smoking 20 
or less a day, and individuals who start smoking before the age of 15 are 
four times more likely to develop lung cancer than those who started after 
the age of 2510.  Stopping smoking can dramatically reduce the risk of 
developing lung cancer; it has been suggested that stopping smoking even 
at 50 or 60 years of age avoids most of the subsequent risk of developing 
lung cancer, and stopping smoking before the age of 30 avoids more than 
90% of the risk attributed to tobacco consumption15.  Passive smoking may 
contribute to approximately 25% of lung cancer cases in non-smokers, and 
the risk is increased for non-smokers living with smokers12.   
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There are several other cancers in which tobacco smoking has been 
implicated to some extent, including cancer of the oesophagus, bladder, 
pancreas, kidney, lip, mouth, pharynx, and larynx. 
 
Oesophagus 
Cancer of the oesophagus is the seventh most common cancer in men and 
thirteenth in females with over 6000 new cases diagnosed in England and 
Wales in 199712.  There is an apparent strong association with tobacco 
smoking, although an interaction with alcohol consumption has also been 
suggested.  Smokers have approximately a 7.5 times greater risk of 
developing oesophageal cancer than lifetime non-smokers9 14. 
 
Bladder 
Bladder cancer is the fourth most common cancer in males and ninth most 
common cancer in females in England and Wales, with over 12,000 cases 
diagnosed in 1997 and tobacco smoking being one of the main risk 
factors12.  Smokers have a 2-3 times increased risk of developing cancer of 
the bladder and other urinary organs than lifelong non-smokers9 14. 
 
Pancreas 
Pancreatic cancer is the tenth most common cancer in males and eleventh 
most common in females in England and Wales, with around 5700 new 
cases diagnosed in 199712.  Pancreatic cancer is rapidly fatal, and the only 
consistent risk factor identified is tobacco smoking.  Smokers have 
approximately twice the risk of developing pancreatic cancer than lifetime 
non-smokers9 14, with little difference between males and females. 
 
Kidney 
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Cancers of the kidney are the eighth most common cancer in males and 
fourteenth most common cancer in females in England and Wales, with 
nearly 5000 cases diagnosed in 199712.  Tobacco smoking is one of a 
number of factors implicated in the development of these particular 
cancers.  Smokers are around twice as likely to develop kidney cancers 
that lifetime non-smokers9. 
 
Lip, mouth and pharynx 
Cancer of these three sites combined are the eleventh most common 
cancer in males and sixteenth in females, with around 3800 new cases 
diagnosed each year12.  Tobacco smoking is a major risk factor for 
developing oral cancer. 
 
Larynx 
Cancer of the larynx is the fourteenth most common cancer in males in 
England and Wales, with 1500 new cases diagnosed in males in 1997 and 
only a small numbers of cases diagnosed in women12.  Along with alcohol, 
and possibly in a multiplicative effect, tobacco smoking is a major risk 
factor for laryngeal cancer, particularly in glottal cancers12. 
 
1.1.2.2 Respiratory disease 
Cigarette smoking alters the structure and function of the central and 
peripheral airways, alveoli, capillaries and immune system of the lung10.  
Current smokers generally have a lower FEV1 and accelerated decline in 
FEV1 compared to former and never smokers, and these are the two most 
useful findings for identifying smokers who are likely to develop severe 
pulmonary impairment10.  It has been suggested that moderate to heavy 
smoking men have an average decline in FEV1 of 15ml/year more than 
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non-smokers16.  The decline in lung function in smokers is related to 
duration of smoking and number of pack years17.  A large scale randomised 
clinical trial investigated the effect of smoking cessation on the decline in 
FEV1 in smokers aged 35 to 60 years with mild obstructive pulmonary 
disease and reported that there was a significant reduction in the decline in 
FEV1 in those patients who quit smoking
18.  Pulmonary function improves 
by approximately 5% within several months of quitting smoking17.     
 
Cigarette smoking is the principal risk factor for developing chronic 
obstructive pulmonary disease (COPD)10 19 20, with current smokers being 
nearly 10 times as likely to suffer COPD as lifetime non-smokers9. 
However,  Doll and colleagues reported chronic obstructive lung disease 
was nearly 13 times more likely in current than never smokers in their 
study of male British doctors14.  In the year 2000, there were nearly 
30,000 deaths from COPD, of which 73% were attributable to smoking13.  
An estimated 10-15% of all smokers develop clinically significant airflow 
obstruction10.  The age of the smoker at commencement of smoking, total 
pack-years smoked and current smoking status are all predictive of COPD 
mortailty20.  Passive smoking has little effect on lung function, and has a 
limited clinical relevance for developing COPD20.   
 
1.1.2.3 Cardiovascular disease 
Smoking causes more deaths from ischaemic heart disease (IHD) than any 
other disease, and this is the most common cause of death in economically 
developed countries9.  In the UK each year, smoking currently causes 
nearly 18,000 deaths from coronary heart disease (CHD) and over 10,000 
from aortic aneurysm and stroke21.  Smokers have a two- to four-fold 
increased risk of CHD and sudden death than non-smokers10 and 
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approximately 50% or more of non-fatal myocardial infarctions have been 
attributed to cigarette smoking22 23.  In a study looking at the decline in 
risk of a major coronary event  following smoking cessation, McElduff and 
colleagues reported that whilst the risk of suffering a major coronary event 
was 3.5 times higher than in never smokers (95% CI 3.0-4.0), this fell to 
1.5 (95% CI 1.1-1.9) for men who had quit for between 1 and 3 years.  
Likewise for women, the risk of suffering a major coronary event was 4.8 
times higher than in never smokers (95% CI 4.0-5.9), this fell to 1.6 (95% 
CI 1.0-2.5) for those who had quit for between 1 and 3 years.  In both 
males and females who had quit smoking for 4-6 years or more, the risk 
had decreased to a similar level to that of never smokers24.  
 
Exposure to cigarette smoke has been shown to be associated with 
atherosclerosis, with current smoking being associated with a 50% increase 
in the progression of atherosclerosis25.  There is a direct relationship 
between disease severity and total pack years of tobacco, but there is no 
association between current vs. past smoking.  This suggests that some of 
the adverse atherosclerotic effects of smoking may be cumulative and 
irreversible25.  Smoking has also been implicated in stroke, with up to one 
quarter of all strokes being directly attributable to cigarette smoking and 
an approximate three-fold increase independent increase in risk26.  The risk 
of stroke is dependent on the number of cigarettes smoked, and declines 
considerably and rapidly after cessation26.   
 
1.1.2.4 Smoking and reproductive health 
Smoking has an effect on all aspects of reproductive health, from male and 
female fertility to the health of the developing foetus.  It is reported that 
women who smoke take longer to conceive, and a dose-response exists for 
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>20 cigarettes per day27.  In males, cotinine concentrations consistent with 
heavy smoking have been shown to exert a detrimental effect on sperm 
motility and sperm membrane function28.   
 
1.1.2.5 Smoking and pregnancy 
Smoking during pregnancy is an important problem.  Smoking related 
causes of preterm birth may include spontaneous preterm labour, 
premature rupture of the membranes and antepartal bleedings29.  It has 
been reported that smokers compared to non-smokers have adjusted ORs 
of preterm birth of 1.9 (95% CI 1.0-3.6) and 2.6 (95% CI 1.1-1.6) for 
moderate and heavy smokers respectively, and very preterm birth of 1.4 
(95% CI 0.8-2.4) and 2.9 (95% CI 1.5-5.7) for moderate and heavy 
smokers respectively29.  A study by Larsen and colleagues reported the 
gestational age of babies born to mothers who smoked 11-20 cigarettes 
per day was significantly lower than non-smoking mothers, and the median 
birth weight was also significantly reduced in those babies born to mothers 
who smoked compared to non-smokers30.  A study by Cliver and colleagues 
found that an overall reduction in birth weight of 130g was seen in those 
babies born to mothers who smoked during the first trimester, and an 
average adjusted reduction in birth weight of 189g for babies born to 
mothers who continued to smoke throughout the pregnancy31.  It is 
suggested that cigarette smoking modifies the placental blood flow, 
diminishing the capacity for gas and nutrient exchange between the 
mother and foetus30.   
 
1.1.2.6 Cigarette smoking and inequalities in health 
Inequalities in health are apparent whether measured in terms of mortality, 
life expectancy or health status32 and are endemic throughout the world33.  
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Smoking is one of the main contributors  to health inequalities in industrial 
countries34 and a recent analysis of causes of death in England and Wales 
by the ONS argued that smoking played a key role in the relationship 
between deprivation and mortality35.  Amongst men, smoking is 
responsible for over half of the excess risk of premature death between the 
highest and lowest socio-economic groups36. 
 
1.1.2.7 Conclusions 
Smoking clearly has wide-reaching economic and health costs to both 
smokers and society as a whole.  Finding ways of reducing smoking 
prevalence remains, therefore, a key area for research. 
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1.2 Trends in smoking 
 
The key source for monitoring changes in the prevalence of cigarette 
smoking in the adult population in Great Britain is the General Household 
Survey (GHS), a multi-purpose continuous survey carried out by the Office 
for National Statistics (ONS).  Questions about smoking behaviour were 
first asked of respondents aged over 16 biennially from 1974, and annually 
from 2000 onwards.  Also, since 1995 (with the exception of 1998) an 
annual survey has been carried out by the ONS for the Department of 
Health to specifically explore views on smoking behaviour. 
 
In 1974, the first year smoking was included in the GHS, the prevalence of 
cigarette smoking was 51 percent of men and 41 percent of women.  
Cigarette smoking prevalence decreased sharply in the late 1970s/early 
1980s, from 45 percent in 1974 to 35 percent in 1982.  After this point, the 
rate of decline slowed, with falls of 1 percent per 2 years until 1990, with 
little change in subsequent years.  Overall the GHS reports a gradual 
decrease in cigarette smoking between 1998 and 2007, from 28 percent to 
21 percent, although there have been some fluctuations in figures for men 
and women separately37.   
 
1.2.1 Smoking uptake 
The majority of regular adult smokers take up smoking in adolescence38.  
The initiation of smoking behaviour is more common in teenagers from 
smoking-favourable backgrounds, such as those with parents, siblings or 
peers who smoke, from deprived neighbourhoods, and in those who may 
consider themselves as under-achievers at school, have low self esteem, 
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impaired psychological wellbeing and are overweight39.  About two thirds of 
respondents to the 2007 GHS who were either current or previous regular 
smokers started before the age of 1837. 
 
Although this age group are likely to experience constraints on their 
smoking behaviour, such as financial and legal limitations and not being 
able to smoke at home or school, indicators of nicotine intake are apparent 
from an early age.  A longitudinal study of adolescent school girls showed 
that levels of cotinine (a major metabolite of nicotine) indicated significant 
intake of nicotine even in occasional smokers.  In daily 11-14 year old 
smokers, cotinine levels of half the average adult concentration were seen 
initially, and when levels were measured in the same subjects two years 
later, this had increased to two-thirds.  There were also signs of nicotine 
dependence apparent in these young smokers: they reported a calming 
effect of smoking, with withdrawal symptoms evident when they attempted 
to quit40.   
 
1.2.2 Cigarette smoking and age 
Since the early 1990s, the GHS has indicated that highest prevalence of 
cigarette smoking amongst men and women is in the 20-24 age group 
(31% in 2007), and the lowest prevalence in those aged 60 and over, 
standing at just 12 percent in 200737.   
 
1.2.3 Cigarette smoking and gender 
Cigarette smoking has been consistently higher in men than women in the 
years that the GHS has been carried out, and in 2007 (the last date for 
which GHS data has been published), this stood at 22 percent of men and 
20 percent of women37.  However, the difference in prevalence of smoking 
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between men and women has been decreasing for many years. It has been 
suggested that there may be gender differences in smoking cessation 
rates, with men being more successful at quitting that women41 42.  A study 
by Jarvis43 reported differences in cessation rates are apparent with age.  
Up to the age of 40, cessation rates were significantly higher in women 
than men but this trend was reversed in those aged 50-65 where rates 
were higher in men.   
 
1.2.4 Cigarette smoking and socio-economic classification 
Data from the General Household Survey has shown consistent differences 
in smoking prevalence relative to socio-economic group, with a 
considerably higher prevalence amongst those in manual groups than in 
non-manual groups.  A sharp decline in smoking prevalence in the 1970s 
and 1980s was more apparent in the non-manual groups, which widened 
the gap between them and manual groups further and this gap has 
changed little in subsequent years37.  Current smoking prevalence rates 
(2007) stand at 30% in the routine and manual occupations compared to 
16 percent in the managerial and professional occupations44.  These data, 
however, should be treated with caution as they may be affected by 
changes to socio-economic groupings introduced in 2001.  Other studies 
have similarly found socioeconomic differences in smoking, for example, a 
prospective cohort study by Jefferis and colleagues45 followed a group of 
individuals from birth to age 41, and collected brief smoking information 
aged 23, 33 and 41. At each point in time, cohort members from manual 
and unskilled manual backgrounds were more likely to be smokers than 
those from non-manual and professional backgrounds.   
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Cessation rates in the lower socio-economic groups are also reportedly 
lower32.  Jefferis45 and colleagues, in the study described above, reported 
that annual cessation rates were higher in men from a professional±
managerial background than in those from unskilled manual backgrounds 
(4.0 percent and 2.9 percent respectively).  As low socio-economic status 
has also been identified as a risk factor for uptake of smoking in children, it 
is likely that differences in smoking prevalence in these groups will 
continue to be evident, if not increasing in the foreseeable future without 
successful interventions.  
 
1.2.5 Cigarette smoking and pregnancy 
According to a UK survey published by The Information Centre for health 
and social care, 33% of all UK mothers in 2005 smoked at some point in 
the 12 months before, or during their pregnancy and 17% of all UK 
mothers continued to smoke throughout their pregnancy46.   
 
1.2.6 Cigarette smoking and mental illness 
Current smoking, particularly heavy smoking, are associated with a 
number of mental disorders47.  A study in the United States using data 
from the National Comorbidity Survey found smoking rates of 41% in those 
who had an incidence of mental illness in the last month, compared to 
22.5% in those who had no mental illness48.  When compared to those 
without mental illness, those with any history of mental illness were 
significantly more likely to be lifetime smokers (OR 2.1, 95% CI 1.9-2.4) or 
current smokers (OR 1.9, 95% CI 1.7-2.2).  The effect was stronger when 
there was an occurrence of mental illness in the last month (OR 2.7, 95% 
CI 2.3-3.1 for current smokers, OR 2.7, 95% CI 2.4-3.2 for lifetime 
smokers)48.  The ONS have reported that those with a significant level of 
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neurotic symptoms were more likely to smoke than those without (44% 
compared to 27%), those with probable psychosis had significantly higher 
rates of heavy smoking than those without psychosis (35% compared to 
9%) and those with depressive episodes, phobias or obsessive compulsive 
disorder were twice as likely to smoke as those with no neurotic disorder47.  
Additionally, there is a progressive increase in rates of heavy smoking with 
comorbid neurotic disorders-from 7% in those with no disorders to 15% for 
one disorder and 23% for 2 or more disorders47. 
 
1.3 Smoking and nicotine addiction 
Whilst smoking has traditionally been regarded as a social habit by many, 
it has been proposed that it would be reasonable to conclude that nicotine, 
delivered through tobacco use should be regarded as an addictive drug11, 
resulting in a dependence on tobacco. 
 
1.3.1 Symptoms of nicotine dependence 
Dependence has been defined as a cluster of three or more of the following 
cognitive, behavioural and/or psychological symptoms (Table 1) occurring 
at any time within the same 12 month period49. 
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Table 1: Symptoms of substance dependence (adapted from49) 
 
Criteria for substance dependence Potential application to 
nicotine dependence 
A markedly diminished effect with continued use of 
the same amount of the substance (tolerance).  
Greater amounts are needed to achieve the desired 
effect 
An absence of nausea and 
dizziness with continued smoking 
Blood or tissue concentrations of the substance 
decline, producing unpleasant symptoms 
(withdrawal).  The individual is likely to take the 
substance to avoid or relieve the symptoms 
Cessation of nicotine use may 
result in symptoms of nicotine 
withdrawal syndrome 
Use of the substance in larger quantities, or over a 
longer period of time than originally planned. 
Smokers may consuming their 
nicotine supplies faster than 
intended  
Many unsuccessful attempts to stop or reduce 
usage 
35% of smokers try to stop each 
year, less than 5% are 
successful unaided 
A great deal of time spent obtaining, using or 
recovering from the effects of the substance 
For example, chain smoking 
Use of the substance interferes with important 
social, occupational or recreational activities 
Smokers may avoid activities 
which occur in a smoking 
restricted environment 
Continued use of the substance despite recognition 
of psychological or physical problems arising from 
its use 
An individual may continue to 
smoke despite having a tobacco-
induced general medical 
condition such as COPD 
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1.3.2 Symptoms of nicotine withdrawal 
The key feature of substance withdrawal is the development of a 
substance-specific change in behaviour as a consequence of cessation or 
reduction in heavy, prolonged substance use49.  The cessation of or 
reduction in smoking and nicotine intake may lead to a well known 
FRQGLWLRQ NQRZQDV WKH µQLFRWLQHZLWKGUDZDO V\QGURPH¶  7KHUH DUHPDQ\
signs and symptoms which have been proposed as being part of the 
nicotine withdrawal syndrome; the American Psychiatric Association have 
proposed the following diagnostic criteria, although the diagnostic criteria 
for withdrawal do not cover all potential symptoms (Table 2). 
 
Table 2: Symptoms of substance and nicotine withdrawal (adapted from49) 
Criteria for substance withdrawal Diagnostic criteria for nicotine withdrawal 
The development of a substance-
specific syndrome following the 
cessation or reduction of heavy or 
prolonged substance use 
Abrupt cessation or reduction of nicotine use 
following at least several weeks of use is 
followed within 24 hours by four or more of the 
following: 
1. dysphoric or depressed mood 
2. insomnia 
3. irritability, frustration or anger 
4. anxiety 
5. difficulty concentrating 
6. decreased heart rate 
7. increased appetite or weight gain 
The substance-specific syndrome 
causes clinically significant distress or 
impairment in social, occupational or 
other important areas of functioning 
The symptoms above cause clinically 
significant distress or impairment in social, 
occupational or other important areas of 
functioning 
The symptoms are not attributable to 
a general medical condition or best 
accounted for by an alternative 
mental disorder 
The symptoms above are not attributable to a 
general medical condition or best accounted for 
by an alternative mental disorder 
 
 
18 
 
1.3.3 A theory of motivation 
Numerous theories of addiction have been proposed over the years to 
attempt to explain the phenomenon, however whilst capturing important 
aspects of addiction they fail to encompass all features.  West has 
proposed a synthetic theory that attempts to draw together factors 
proposed in these existing theories50.  West offers a starting definition of 
DGGLFWLRQDVµLPSDLUHGFRQWURORYHUDUHZDUG-seeking behaviour from which 
KDUPHQVXHV¶  ,W LVSUHVHQW LQ YDU\LQJGHJUHHVDQGPD\EHDVVHVVHGE\
the severity of urges or cravings, the intensity or frequency of harm-
causing behaviour and a failure of repeated attempts to limit or cease the 
behaviour.  West proposes that, given these factors, any theory of 
addiction should be based upon a theory of motivation as addictions are 
activities that are given an unhealthy priority because of disorders in the 
motivational system.  In a susceptible individual, drug-taking behaviours 
such as tobacco use become out of control because they have an increased 
motivation to seek out and engage in the drug taking activity and an 
artificial drive is created for a number of possible reasons: abstinence is 
unpleasant, the drug taking behaviour is rewarding or motivation to resist 
engagement in the activity is diminished51.   
 
West suggests that there are five underlying themes to his theory of 
motivation, the first of which is the structure of the motivational system 
itself.  It is proposed that there are five levels of operation which are 
encompassed by the acronym PRIME:  plans, responses, impulses, 
motivations and evaluations.  PRIME theory proposes that higher elements 
feed into and influence each other, i.e. plans (highest level) influence 
evaluations which subsequently influence motives which act through 
impulses or inhibitory forces to directly influence responses (lowest level), 
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i.e. behaviour50.  The hierarchical nature of the motivational system offers 
an advantage to impulses over desires and desires over evaluations in the 
control of behaviour.  The second theme is the focus on the moment and 
this states that actions can only be influenced by forces operating at that 
point in time, and PRIME theory focuses on the dynamic nature of 
motivation and behaviour.  The third theme, neural plasticity, concerns the 
way in which the motivational system changes in response to experience 
with the potential for the formation of causal connections between patterns 
of activity in the motivational system becoming more habitual.  Identity 
and self-awareness, and the role these have in self-control compose the 
penultimate theme of the motivational system.  According to PRIME theory, 
self-control consists of the operation of evaluations and motives arising 
from self-awareness and is based on a desire or evaluation of oneself.  
Identity is the one factor which provides some stability to the motivational 
system.  The final unifying theme is the unstable mind and concerns the 
DSSOLFDWLRQ RI µFKDRV WKHRU\¶ WR WKH PRWLYDWLRQDO V\VWHP ZKLFK VXJJHVWV
that motivation is inherently unstable and is controlled by constant 
balancing input and explains how the smallest influence can send the 
system in a different direction if it occurs at a critical time51.   
 
The PRIME theory is largely untested although West has used some data 
from a national survey of smokers to test aspects of the PRIME model in 
relation to smoking and nicotine dependence.  
 
1.4 Interventions to reduce smoking  
Smoking cessation interventions can have far reaching benefits to both 
smokers and society as a whole. In addition to improving the health status 
of smokers, cessation interventions also reduce healthcare costs and 
improve attendance and productivity in the workplace52.  Cessation 
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interventions may be seen as falling along a public health-clinical 
continuum.   Public health interventions tend to be briefer and can reach 
more smokers53 and include, for example, quit-lines, mass media 
campaigns and No Smoking Day.  Public health interventions may achieve 
lower quit rates but they have a larger reach into the population, thus 
having the potential for a higher impact.  Similarly, less intensive clinical 
interventions, such as brief advice by a GP, achieve modest smoking 
cessation rates but reach a larger number of smokers than more intensive 
interventions. More intensive clinical interventions, such as intensive 
counselling, are generally delivered by trained professionals. Intensive 
interventions tend to achieve higher quit rates but reach a relatively small 
and selected number of smokers.  All types of clinical cessation 
interventions have, however, been found to be highly cost-effective 
medical interventions54.   
 
Clinical interventions for smoking cessation can also be referred to as 
tobacco dependence treatment. The definition of tobacco dependence 
treatment includes (singly or in combination) behavioural and 
pharmacological interventions such as brief counselling, intensive support, 
and administration of pharmaceuticals55. Evidence from randomised studies 
has shown that the use of intensive support and medications increases the 
success rate of quit attempts by up to four fold56.  On an individual level, 
however, the likelihood of a quit attempt being successful is dependent on 
a number of factors which fall into one of three categories.  These are: the 
personal and socio-economic characteristics of the smoker; smoking 
history and the level of dependence; and the nature of the treatment 
received57.  Recent advances in pharmacotherapy have meant that there 
are now more options available to smokers than ever before. What follows 
is a summary of commonly used cessation interventions in England. 
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1.4.1 Pharmacotherapy 
1.4.1.1 Nicotine replacement therapy 
Nicotine replacement therapy (NRT) products are licensed as an aid to 
smoking cessation to relieve withdrawal symptoms58  (Recently some have 
been licensed for the purposes of temporary abstinence or cutting down to 
stop).  NRT was launched as the first licensed pharmacological treatment 
for smoking cessation in the form of nicotine gum in 198158 but was not 
made available on NHS prescriptions until 2001. There are currently six 
types of NRT products licensed for use in the UK59 60 (Table 3). Efforts have 
been made to increase the accessibility of NRT.  In 1999, the 2mg chewing 
gum was made available on a general sale category (GSL), and the 
Medicines Commission subsequently made the 4mg gum, patches and 
lozenges58 and inhalator61 available on GSL.  NRT can be offered to any 
regular cigarette smoker (more than 10 cigarettes per day55) who wants to 
quit.  If possible, smokers should also be offered behavioural support for 
the quit attempt, and given the option of referral to smoking cessation 
services when available59.  NRT aims to replace the nicotine from cigarettes 
and is thought to stimulate the nicotinic receptors in the ventral tegmental 
area of the brain to release dopamine in the nucleus accumbens60.  This 
leads to a reduction in symptoms of nicotine withdrawal experienced by 
smokers attempting to quit.  NRT products currently available alleviate but 
do not eliminate all withdrawal symptoms, most likely because no form 
allows the rapid systemic arterial delivery experienced when cigarette 
smoke is inhaled11 60.   
2
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Product Dose   Precautions 
Transdermal 
patch 
5mg, 10mg, 15mg/16 
hours 
7mg, 14mg, 21mg/24 
hours 
1 patch every 16 or 24 
hours 
Enters the body though 
the Skin 
Stomach ulcers, CV disease, diabetes, 
liver & kidney disease, 
pregnant/breast feeding, 
psoriasis/chronic dermatitis 
Chewing 
gum 
2mg, 4mg Up to15 pieces per 24 
hours 
Enters the body though 
the lining of the mouth 
Stomach ulcers, CV disease, diabetes, 
liver & kidney disease, 
pregnant/breast feeding 
Sublingual 
tablet 
2mg Up to 2 microtabs per 
hour, maximum of 40 per 
24 hours 
Enters the body though 
the lining of the mouth 
Stomach ulcers, CV disease, diabetes, 
liver & kidney disease, 
pregnant/breast feeding 
Lozenge 1mg, 2mg, 4mg 1 lozenge every 1-2 
hours, maximum of 30 
per 24 hours 
Enters the body though 
the lining of the mouth 
Stomach ulcers, CV disease, diabetes, 
liver & kidney disease, 
pregnant/breast feeding 
Inhalation 
cartridge 
10mg Up to 12 cartridges per 24 
hours 
Enters the body though 
the lining of the mouth 
Stomach ulcers, CV disease, diabetes 
liver & kidney disease, 
pregnant/breast feeding 
Nasal spray 0.5mg per puff Up to 2 sprays in each 
nostril per hour, 
maximum of 64 sprays 
per 24 hours 
Enters the bloodstream 
through the lining of the 
nose 
Stomach ulcers, CV disease, diabetes 
liver & kidney disease, 
pregnant/breast feeding 
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It is recommended that initial prescriptions of NRT should cover a period of 
up to 2 weeks after the target quit date, with additional prescriptions only 
subsequently given to individuals who are still abstinent at this point59.  
There is growing evidence that smoking cessation is more effective with 
combination treatment: for example, using the patch and gum together will 
provide the smoker with a steady supply of nicotine during the day but an 
option to increase intake in response to cravings or stressful situations58.  
Research has shown that combining these 2 products has been shown to 
be more effective in reducing nicotine withdrawal symptoms than either 
treatment alone62.  Recent guidelines published by the National Institute of 
Health and Clinical Excellence recommend that a combination of nicotine 
patches and another form of NRT (although not in combination with 
bupropion or varenicline) should be offered to people who are highly 
dependent on nicotine or have previously found use of a single form of NRT 
ineffective59.  
 
A recent Cochrane review of 132 studies reported that the pooled odds 
ratio (OR) of abstinence for any form of NRT compared to control was 1.58 
(95% CI: 1.50 to 1.66).  When looking at different forms of NRT, this value 
ranged from 1.43 with nicotine gum to 2.02 with the nasal spray (95% CI: 
1.33 to 1.53 and 1.49 to 3.73 respectively)63.  There was no evidence to 
suggest that there was a significant difference in effectiveness between the 
different forms of NRT. 
 
Currently no form of NRT uses the same pulmonary route of absorption 
resulting from smoking a cigarette.  It is not, therefore, possible to achieve 
the same high arterial concentrations of nicotine in as short a time.  
Several neurochemical pathways mediate nicotine withdrawal, a result of 
the many actions nicotine has within the central nervous system.  A 
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number of non-nicotine medications have been investigated for smoking 
cessation, acting at various points in these pathways.   
 
1.4.1.2 Non-nicotine pharmacotherapies for smoking cessation 
The relationship between smoking behaviour and a depressed mood 
suggested that there may be a role for antidepressant drugs in smoking 
cessation.  Results of clinical trials of antidepressant therapy for smoking 
cessation suggest that this group of drugs are more effective than placebo, 
especially using bupropion and nortriptyline64  
   
Bupropion sustained release (SR) (Zyban®, GSK) is an aminoketone 
antidepressant licensed for use in the UK for smoking cessation65.  In the 
US, bupropion is also used as an anti-depressant.  The exact mechanism 
by which bupropion aids smoking cessation is not fully understood, but is 
hypothesised to inhibit the reuptake of dopamine in the mesolimbic 
dopamine system (the so-called reward centre of the brain)66. 
 
Bupropion is a prescription only drug.  Recent guidance states that 
bupropion should not be offered to pregnant or breastfeeding women or 
those under the age of 18, but may be offered to those with unstable 
cardiovascular disorders, subject to clinical judgement59.  The 
recommended dosage is one 150mg tablet per day for the first 6 days, 
followed by 2 tablets per day for the next 6-8 weeks.  A quit date should be 
set for 7-14 days after starting the course to allow the drug to achieve its 
optimal effect59.  Hughes and Colleagues67 reviewed 31 trials which have 
been conducted comparing bupropion alone to placebo and concluded that 
bupropion produced a pooled OR of 1.94 (95% CI 1.72 to 2.19).  Like NRT, 
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bupropion should be prescribed alongside advice or counselling to assist 
the smoker in their quit attempt. 
 
Nortriptyline is believed to reduce withdrawal symptoms thorough its 
noradrenergic mechanism68.  It is generally considered to be a second-line 
treatment for tobacco dependence as it tends to have more side effects 
than bupropion and has been less well-researched as a cessation aid69.  A 
recent Cochrane review reported that from six studies which have been 
carried out comparing nortriptyline to placebo, a significant benefit of this 
therapy has been suggested (OR 2.34, 95% CI: 1.61 to 3.41)67. 
 
Other antidepressants which have been used, but not proven effective, for 
smoking cessation include imipramine, doxepin, venlafaxine, fluoxetine and 
moclobemide65. 
 
Varenicline is a highly selective Įǃ nicotine acetylcholine receptors 
(nAChR) partial agonist developed specifically for smoking cessation70.  
Nicotine dependence begins with nicotine binding to nicotinic nAChRs in the 
central nervous system71,WKDVEHHQVXJJHVWHGWKDWĮǃSDUWLDODJRQLVWV
may be more effective as a smoking cessation aid than therapies which are 
currently available.  Through its agonistic actions, varenicline theoretically 
could reduce cigarette craving and nicotine withdrawal whilst 
simultaneously blocking the binding of, and subsequent reinforcing effects 
of nicotine through an antagonistic action66 72.  Recent guidance states that 
varenicline should not be offered to pregnant or breastfeeding women or 
those under the age of 18, but may be offered to those with unstable 
cardiovascular disorders, subject to clinical judgement59.  
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Varenicline is a relatively new potential treatment for smoking cessation 
and studies into its efficacy are limited.  A recent Cochrane review 
identified seven trials which compared varenicline to placebo and reported 
a pooled risk ratio of 2.33 for continuous abstinence at 6 months (95% CI 
1.95 to 2.80).   Three trials also included a comparison with bupropion, for 
which a pooled risk ratio of 1.52 was reported for continuous abstinence at 
12 months (95% CI 1.22 to 1.88)73. 
 
&ORQLGLQH LV DQ Į-noradrenergic agonist which suppresses sympathetic 
activity.  It has been used to reduce withdrawal symptoms associated with 
alcohol and opiate misuse and increased smoking cessation in 8 out of 9 
trials in both its low dose and patch formation65.  Mecamylamine is a 
nicotinic agonist which blocks the effects of nicotine but does not 
precipitate withdrawal symptoms65. 
 
1.4.2 Behavioural support  
1.4.2.1 Brief interventions 
Brief advice against smoking has been defined by the Cochrane Tobacco 
$GGLFWLRQ *URXS DV ³YHUEDO LQVWUXFWLRQV WR VWRS VPRNLQJ ZLWK RU ZLWKRXW
added information about the harPIXO HIIHFWV RI VPRNLQJ´74.  Recent 
guidelines75 have made several recommendations for the provision of brief 
advice including, but not limited to: every smoker should be advised to quit 
unless there are exceptional circumstances; smokers should be asked how 
interested they are in stopping and GPs and nurses in primary and 
community care should offer cessation advise to all smokers and Figure 1 
(page 30) illustrates the recommended procedure for the delivery of brief 
advice.  Brief advice achieves modest cessation rates, but is one of the 
most cost effective interventions in medicine at a discounted cost to society 
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of £212 per life year gained76.  The general practitioner has good 
opportunities to intervene with smoking patients, largely due to the level of 
trust and respect that patients generally hold for their doctor.  The level of 
involvement of the GP in smoking management has been summarised in 
different ways, but in the UK is frequently VXPPDULVHG E\ WKH ILYH ³$´V
ask (ascertain smoking status), assess (interest in stopping), advise 
(against smoking), assist (a quit attempt if the smoker is interested in 
stopping) and arrange (referral to specialised support services if 
appropriate)77.   
 
Recent smoking cessation guidelines recommend that health professionals 
should provide brief advice (as described below) to smokers during routine 
consultations whether or not they are seeking help to stop75 78 and that GPs 
offer a prescription of NRT for interested smokers during routine 
consultations regardless of whether the smoker wishes to be referred to 
intensive specialist support75.  As levels of nicotine dependence increase 
systematically with deprivation79, and more deprived smokers tend to be 
harder to reach with healthcare interventions, this group of smokers in 
particular may benefit from this approach.   However, other research has 
been published indicating that smoking cessation advice should be 
delivered periodically and not necessarily at every consultation80, with one 
study reporting that not all primary care physicians agree that advice 
should be given at every consultation81 and another that offering smoking 
cessation advice to asymptomatic smokers actually represented a strong 
negative reinforcement to quitting82.  Many GPs are concerned about 
maintaining good doctor-patient relationships and are keen to avoid 
negative responses from patients about their smoking behaviour.  For this 
reason, many GPs restrict most discussions about smoking to situations 
where patients present with smoking related illnesses83.  It has been 
28 
 
suggested that GPs should be offered the opportunity to undertake 
smoking cessation training in order to increase the involvement of general 
practices.  It may give the GP confidence in the efficacy of brief 
intervention and improve their skills in smoking cessation techniques, both 
of which should help the GP realise their potential to decrease smoking 
prevalence84. 
 
Thirty nine trials involving over 31,000 smokers were included in a recent 
Cochrane review of physician advice for smoking cessation85.  The pooled 
effect of a minimal intervention equated to an increase in cessation rates of 
approximately 2.5% when comparing those who had received advice and 
those who had not.   
 
1.4.2.2 Telephone counselling 
Telephone counselling is becoming more popular as a method of helping 
people to stop smoking.  Telephone provision of support and problem 
solving assistance appears to be an efficacious intervention for cigarette 
smoking 86.  Advantages of telephone counselling include the potential to 
provide individual counselling to a large number of people relatively 
cheaply, convenient access, and the centralised nature of services87.   
Telephone counselling may be used in combination with self-help 
interventions and pharmacotherapy as a substitute to face-to-face contact, 
or as a supplement to face to face counselling.   Telephone helplines may 
be reactive (a dedicated phone line is established and its availability is 
advertised to a target population) or proactive (calls are initiated by 
intervention staff)53.  Proactive telephone counselling has been shown to 
help smokers interested in quitting, with evidence of a dose-response 
relationship existing between number of calls and success88.  Less evidence 
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exists for the efficacy of reactive services due to the lack of randomised 
trials in this area. 
 
1.4.2.3 Internet support 
The use of the internet as an intervention tool has many potential benefits, 
such as relatively low cost per user, widespread availability, convenience 
and anonymity for the user and an extended reach compared to traditional 
smoking cessation support.  The internet is a promising avenue for the 
provision of smoking cessation support, either as an adjunct to 
pharmacotherapy or as a stand-alone programme89 90.  It has been shown 
that tailored web based programmes have significant advantages over a 
non-tailored programme91, although limited research has been conducted 
to date looking at the effects from intervention studies. 
 
1.4.2.4 Self help 
The primary aim of self-help interventions is to reach a greater proportion 
of the smoking population than would be possible through more intensive 
interventions such as face-to-face or telephone counselling.  Self help 
materials include, but are not limited to written materials, audio or 
videotape and internet sources.  Self help materials may also be of benefit 
to those who would like advice or support to quit smoking but do not wish 
to attend treatment sessions for any reason.  A recent Cochrane review 
pooled the results of 11 studies which compared self help materials sent by 
post to no information at all and reported an odds ratio of 1.24 (95% CI 
1.07 to 1.45)58.  The review reported a non-significant effect for self help 
materials being given with face to face contact, as an adjunct to face to 
face advice from a healthcare provider or in addition to NRT. 
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YES 
YES 
ACCEPT 
DECLINE 
ACCEPT 
 
Figure 1: Recommended procedure for the delivery of brief advice for 
smoking cessation (adapted from75)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Give brief advice on 
how to stop.  Give 
helpline number.  
Record advice given in 
clinical records 
Prescribe 
appropriate 
treatment.  Record 
in clinical records.  
Arrange a follow up 
for support 
Offer 
pharmacotherapy in 
line with NICE 
guidelines 
Refer using local 
arrangements.  
Record in clinical 
records 
Offer referral to an 
intensive support 
programme (for 
example NHS Stop 
Smoking Services) 
Explain what intensive 
support programmes 
offer (for example 
NHS Stop Smoking 
Services) 
Ask if the patient is 
interested in stopping 
Ask if the patient 
is still smoking 
Accept answer non-
judgementally.  Leave 
offer of help open.  
Record in clinical 
records.  Review once a 
year 
 
Give positive feedback 
and record in clinical 
records 
NO 
NO 
DECLINE 
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1.4.2.3 Intensive support 
 
Intensive support by a smoking cessation specialist is the most effective 
non-pharmacological intervention available for those smokers with a strong 
desire to quit74 and is often delivered in combination with NRT, bupropion 
or varenicline.  Combining intensive behavioural support with 
pharmacotherapy has been shown to have an effect size of up to 19% on 
abstinence for six months or longer56.  A smoking cessation specialist is 
trained and paid to deliver skilled advice to smokers who need more 
support to quit than is offered from brief advice55.  Intensive behavioural 
support usually involves assessment of the patient¶s smoking history, 
motivation to quit, identification of potential relapse situations and 
development of strategies to overcome these situations.  Stop smoking 
services (SSS) are typically based on the premise that smokers are in the 
preparation phase of the stages of change model (see section 1.7) and the 
first meeting typically involves an introduction, smoking cessation 
medication is made available and a quit date set for some point in the 
following week depending on which medication is being used92.  Expired 
carbon monoxide levels should be measured at this point, and in each 
subsequent meeting.  It is advised that specialist services should include 
weekly meetings over approximately 6 weeks, covering at least 4 weeks 
after the quit date93.   
 
Intensive counselling sessions may be conducted on a one-to-one basis or 
in a group setting. Arguments exist for the benefits of each, but ultimately 
it may come down to the individual requirements of the smoker.  Individual 
counselling is more expensive than group, but some smokers may not be 
comfortable in a group situation, for example those with psychiatric 
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problems.  Findings from the Cochrane Library report that individual 
counselling results in an OR of 1.56 (95% CI 1.32 to 1.84) compared to 
minimal contact94. Group counselling is more cost effective, but may also 
have other benefits to participants.  A group situation may allow smokers 
the opportunity to share experiences and problems with other smokers 
trying to quit, thus increasing potential quit rates.  When comparing group 
therapy to various self-help materials, an OR of 1.97 (95% CI 1.57 to 
2.48) was reported in a recent Cochrane review95.  The same review also 
reports no significant difference between group and individual therapy (OR 
0.86, 95% CI 0.66 to 1.12).   A recent study compared the outcomes of 
users accessing pharmacy one-to-one and group based smoking cessation 
treatments and found that group users were nearly twice as likely to be 
CO-validated abstinent compared to those who had used the pharmacy 
based service.  One study conducted in the US and Canada offered a more 
intensive intervention than other studies, with groups meeting 12 times 
over a 10 week period combined with aggressive use of NRT.  The study 
resulted in one of the highest validated quit dates reported, with 
approximately 35% of those in the intervention groups being abstinent at 
one year compared to 10% of those receiving usual care18. 
 
Table 4 summarises some commonly employed smoking cessation 
interventions, their target population and the estimated effect size. 
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Table 4: Incremental effects of smoking cessation interventions on 
abstinence for six months or longer.  Adapted from West et al56.   
 
Intervention Target population Effect 
sizea 
95% 
confidence 
interval 
Brief opportunistic advice 
from a physician to stop 
Smokers attending GP 
surgeries or outpatient 
clinics 
2% 1% to 3% 
Face to face intensive 
behavioural support from a 
specialistb 
Moderate to heavy 
smokers seeking help with 
stopping 
7% 3% to 10% 
Proactive telephone 
counsellingb 
Smokers wanting help 
with stopping but not 
receiving face to face 
support 
2% 1% to 4% 
Written self-help materials Smokers seeking help and 
not receiving other 
support 
1% 0% to 2% 
Nicotine gum Moderate to heavy 
smokers receiving limited 
behavioural supportc 
5% 4% to 6% 
Nicotine gum Moderate to heavy 
smokers receiving 
intensive behavioural 
support 
8% 6% to 10% 
Nicotine transdermal patch Moderate to heavy 
smokers receiving limited 
behavioural support 
5% 4% to 7% 
Nicotine transdermal patch Moderate to heavy 
smokers receiving 
intensive behavioural 
support 
6% 5% to 8% 
Nicotine nasal spray Moderate to heavy 
smokers receiving 
intensive behavioural 
support 
12% 7% to 17% 
Nicotine inhalator Moderate to heavy 
smokers receiving 
intensive behavioural 
support 
8% 4% to 12% 
Nicotine sublingual tablet Moderate to heavy 
smokers receiving 
intensive behavioural 
support 
8% 1% to 14% 
Bupropion (300mg/day 
sustained release) 
Moderate to heavy 
smokers receiving 
intensive behavioural 
support 
9% 5% to 14% 
Intensive behavioural 
support plus NRT or 
bupropiond 
Moderate to heavy 
smokers seeking help 
IURPDVPRNHUV¶FOLQLF 
13-19% - 
aDifference in >6 month abstinence rate between intervention and 
control/placebo in the studies reported; data from Cochrane meta-analyses 
unless otherwise stated. 
bEfficacy figures based on a subset of studies from the general population 
with biochemical verification 
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c7KH WHUP ³OLPLWHG EHKDYLRXUDO VXSSRUW´ UHIHUV WR EULHI VHVVLRQV UHTXLUHG
primarily for collecting data.  Following the Cochrane definition, ³LQWHQVLYH´
behavioural support was defined as an initial session of more than 30 
minutes, or an initial session of less than 30 minutes plus more than 2 
subsequent visits. 
dExpected effect combining effects of medication with effects of behavioural 
support. 
 
 
1.5 Government initiatives regarding smoking cessation 
In 1997, an Independent Inquiry into Inequalities in Health Report was 
commissioned by the Minister of Public Health to address health 
inequalities, including smoking, and to identify priority areas for future 
policy development32.  A number of government policies have been 
implemented to encourage smokers to quit smoking, with considerable 
emphasis on those in lower socio-economic groups, pregnant women and 
young people33.  These policies either aim to act as a disincentive to 
smoking (such as increasing tobacco sales tax and restricting smoking in 
public places), or to provide incentives to give up smoking (through health 
promotion campaigns and interventions in the NHS)34.   
 
In 1998, the government published a strategy to reduce smoking in 
England called Smoking Kills: a White Paper on Tobacco96.  The paper 
aimed to reduce smoking in all adult smokers, particularly amongst 
children and young people, pregnant women and disadvantaged adults.  A 
number of policies therein were designed to encourage smokers to quit 
smoking and placed considerable emphasis on those in lower socio-
economic groups96.   
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Targets were established nationwide to reduce the prevalence of smoking 
in England, with the specific aim of reducing adult smoking across social 
classes to 24% or less by 201096 and a target to reduce adult smoking 
prevalence in routine and manual groups to 26% or less by 201097. It was 
recognised that significant health gains were likely to be achieved by 
reducing the proportion of current smokers and if more of these smokers 
are drawn from disadvantaged groups then this could make a significant 
contribution to reducing inequalities in health.    
 
1.5.1 Stop Smoking Services 
As part of the White Paper in the same year, the government announced 
funding for NHS SSS offering intensive cessation support and medications 
as detailed above initially for a period of a year but with funding for a 
further two years, providing the first year was successful.  The new 
services were initially set up in 26 areas known as Health Action Zones 
(HAZs)93.  These were areas with high levels of deprivation and a high 
smoking prevalence98.  From the second year, the services were expanded 
to cover the whole of England and funding has been provided every year 
since then.    Current government guidelines state that stop smoking 
services should be able to treat at least 5% of the local smoking 
population, with an expected success (four week quit rate) range of 35% to 
70%99. 
 
Intensive services are designed to be as accessible as possible to clients.  
Access to services may be either on referral from a GP or other health 
professional or from the smokers themselves and sessions most commonly 
take place in the primary care setting.  A broad range of approaches are, 
however, being employed to maximise the likelihood of SSS reaching 
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target populations, particularly those who are more disadvantaged.  These 
include basing smoking cessation advisors and advertising services in 
primary care venues in deprived areas, basing advisors in easily-accessible 
city centre venues and training pharmacists and others as advisors, 
utilising community venues such as community centres and libraries and 
training people from deprived neighbourhoods to provide smoking 
cessation advice100.  In certain instances, advisors may see clients in their 
own homes when circumstances deem this appropriate101.  The impact of 
these different strategies has not been measured although some 
evaluations are ongoing. 
 
A number of barriers to reaching and supporting more disadvantaged 
smokers in their quit attempts still exist however.  Health services in the 
UK are traditionally more accessible in the more affluent areas-a 
SKHQRPHQRQ NQRZQ DV WKH µLQYHUVH FDUH ODZ¶102, and those living in 
disadvantaged communities may be less willing to seek help from statutory 
health services103.  Developing appropriate strategies to identify, contact, 
support and keep smokers in treatment is therefore of key importance for 
the NHS SSS, particularly in disadvantaged communities where smoking 
prevalence and tobacco addiction are often higher79. 
 
1.5.2 Current performance of Stop Smoking Services 
Between April 2007 and March 2008, over 680,000 people set a quit date 
through NHS stop smoking services, with over 350,00 people being 
successfully quit (by self report) at 4-week follow up104.  The total 
expenditure on NHS SSS in England for the same period was almost £61 
million (excluding pharmacotherapy prescriptions) with a cost per quitter of 
£173104. 
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The English SSS have been reported to be one of the most cost effective 
health interventions available in medicine today56 59 76. Godfrey et al report 
a cost-effectiveness of £684 per life year gained, reducing to £438 per life 
year gained when adjusted for future health care costs52. 
   
Recent statistics on NHS SSS reported that a lower number of smokers in 
Spearhead PCTs (areas with the worst health and deprivation in England) 
set a quit date with SSS than non-Spearhead PCTs and had slightly lower 
quit rates (49 percent and 54 percent respectively)104. These figures 
indicate that SSS may not be reaching as many smokers in deprived areas, 
and disadvantaged smokers may benefit from approaches to increase the 
reach of, and their access to, these services as previously discussed. 
 
1.5.3 The UK Quality and Outcomes Framework 
 
The Quality and Outcomes Framework (QOF) is the annual reward and 
incentive programme detailing GP practice achievement results. QOF is a 
voluntary process for all surgeries in England and was introduced as part of 
the GP contract in 2004105.  Its introduction means that up to a quarter of 
*3¶V LQFRPH LV GHSHQGHQW XSRQ SUDFWLFH SHUIRUPDQFH which is measured 
against 146 indicators. Two specific targets were established for smoking 
cessation management106: determining smoking status for all patients aged 
15-75 years and recording the delivery of brief smoking cessation advice 
for patients with CHD, hypertension, asthma, diabetes, COPD and 
stroke/TIA. 
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GPs can now earn a proportion of the new quality payments by complying 
with these targets. This provides a direct incentive for GPs to routinely ask 
about smoking status and also provide cessation advice to specific groups 
of patients. As yet, the QOF does not include any specific incentive for GPs 
to then refer smokers on to specialist services, although some do this as 
part of routine clinical practice.   
 
1.6 Efforts to increase the accessibility of Stop Smoking Services / 
programmes 
 
Recent research in England suggests that, at the national level, less than 
10% of smokers who make a quit attempt do so with the support of NHS 
SSS44.  As discussed earlier, disadvantaged smokers in particular are not 
accessing services as much as other smokers.  Improving access and 
increasing reach is therefore essential but it is equally important that 
services are appropriately meeting the needs of the clients it attracts.  The 
evidence-base for smoking cessation interventions depends upon the 
assumption that treatments that have been proven to be effective in 
research trials will work for all or the majority of smokers 56 107.  However, 
not all smokers are alike and some may respond better to interventions 
that appeal to their individual circumstances.  A recent systematic review 
108 conducted as part of a review for the National Institute for Health and 
Clinical Excellence (NICE) identified a number of studies which have looked 
at methods by which the acceptability of, access to and reach of SSS may 
be improved, particularly for disadvantaged smokers. 
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1.6.1 Qualitative research with disadvantaged smokers 
Two qualitative studies have been undertaken with smokers to identify 
these types of barriers and explore how they can be overcome. 
 
A study by Roddy et al109 conducted focus groups with 39 socio-
economically deprived smokers in Nottingham, UK, to explore how they 
viewed SSS and to identify specific barriers and motivations to improve 
access to cessation services. It was concluded that this group of smokers 
displayed a fear of being judged, fear of failure and demonstrated a lack of 
correct knowledge about cessation services and the medication available.  
Many smokers were unaware of the smoking cessation services available to 
them, but believed that a personal invitation to, and information about, 
these services would make them more likely to use them and it was 
recommended that services be promoted in a personalised, non-
judgemental and flexible manner. 
 
Wiltshire and colleagues110 conducted interviews with 100 disadvantaged 
smokers to investigate their perceptions of smoking and past experiences 
of attempts to quit. The authors concluded that smokers lack the 
motivation to access cessation services unless they feel they will not only 
get help with their nicotine addiction, but also help dealing with the wider 
life circumstances linked to their smoking habits. 
 
1.6.2 Location of Stop Smoking Services 
 
As discussed earlier, SSS are designed with the aim of being as accessible 
as possible for clients and basing services in community locations outside 
of the general practice is one means of doing so.  Studies in both the UK 
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and the US have investigated the use of pharmacy, dental and works-
based settings for smoking cessation services with potentially promising 
results.   
 
The pharmacy setting is a promising means to reach a wide variety of 
smokers as it provides access to trained health professionals without the 
need to book an appointment. A recent systematic review by Blenkinsopp 
and colleagues111 including 2 randomised controlled trials and 3 non-
randomised experimental studies in the UK, demonstrated the importance 
of training pharmacists in smoking cessation counselling. Both RCTs 
recruited participants from customers asking for smoking cessation advice 
or NRT in the UK during a 12 month period but only one of the trials 
showed a statistically significant effect of pharmacist counselling.  In 
addition, a recent study by Bauld and colleagues112 investigated a number 
of components of stop smoking services in Glasgow, including pharmacy-
based treatments, and provided evidence that pharmacy-based 
interventions may be a valuable means of reaching and improving smoking 
cessation rates in disadvantaged smokers. The study examined pharmacy 
services that provided behavioural support and NRT and reported 4 week 
CO-validated cessation rates of 20% (28% including self reported cases).  
7KHVWXG\VXJJHVWVWKDWEDVLQJVHUYLFHVLQSKDUPDFLHVRQWKH³KLJKVWUHHW´
is effective in reaching smokers and improving their access to services.  In 
the US, a pilot study by Doescher and colleagues113 reported that 
pharmacist-delivered treatment is feasible, although participation in the 
study was low and there was a significant drop out rate.  
 
Dental healthcare providers may see patients on a regular basis and thus 
have a unique opportunity to identify smokers and provide smoking 
cessation advice.  A recent review in the UK114 focused on a variety of 
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study types examining smoking cessation in dentistry and barriers to 
providing smoking cessation advice in this environment. The review 
concluded that behavioural and pharmacological interventions are effective, 
although the magnitude of the effect is unclear. The review also included 
studies which investigated barriers to implementing smoking cessation 
support in the dental setting. It reported a large number of barriers 
including a lack of training for dental professionals and a need for cultural 
and policy changes to facilitate the provision of cessation support. The 
authors suggested that further research is needed in this area, and should 
include qualitative or mixed methods designs to explore the issue further 
and studies that evaluate the impact of changing these barriers on the 
provision of smoking cessation support.  More research as to the benefit of 
using the dental setting as a means of supporting smoking cessation has 
been conducted in the US.  A systematic review of 6 RCTs115 reported a 
statistically significant increase in the odds of tobacco abstinence at 12 
months when results of all 6 studies were pooled (OR 1.44, 95% CI 1.16-
1.78), a 3% difference in cessation rates was reported between 
intervention and control groups. Three of these studies were conducted in a 
dental office setting and three involved oral health professionals providing 
interventions within high schools or community college settings. Five 
studies targeted smokeless tobacco users and only 1 targeted cigarette 
smokers and so there was insufficient evidence to draw any conclusions as 
to the effectiveness of the intervention in cigarette smokers.  
 
A further review in the US116 reviewed 7 RCTs in dental settings utilizing a 
range of interventions including self-help materials, NRT provision and 
behavioural support. Duration of follow-up varied between trials, but all 
showed a positive effect for interventions in the dental setting on quit 
attempts or cessation.  The reviewers conclude that cessation interventions 
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in the dental setting are effective, include a proactive case finding element, 
and should be part of routine care. 
 
The possibility of basing SSS in the workplace has been investigated by 
one cohort study in the US117.  Barbeau and colleagues investigated the 
feasibility of a smoking cessation intervention with a specific manual group 
(unionised apprentice iron workers). This was a multi-faceted intervention 
involving 139 smokers and resulted in a 7-day point prevalence smoking 
abstinence rate of 19.4% and statistically significant positive changes in 
intention and self efficacy to quit within 6 months and 30 days. Participants 
in the intervention were 3 times more likely to quit than those who did not 
participate. Although there was no formal control group in this study and 
cessation outcomes were short, the results suggest that providing a 
smoking cessation programme within the workplace may have the potential 
to reach a number of smokers and increase quit rates in blue collar 
workers. 
 
1.6.3 Method of accessing Stop Smoking Services 
 
Access to SSS in the UK typically requires booking an appointment in 
advance.  However, several initiatives in the UK have attempted to move 
DZD\ IURP WKLV µWUDGLWLRQDO¶ PRGHO RI 1+6 VWRS VPRNLQJ VHUYLFHV ZLWK
positive results.  Fag Ends is a smoking cessation service in Liverpool which 
is community-based, staffed by lay advisors and clients are able to drop in 
to their nearest meeting without pre-booking an appointment.  Smokers 
are also able to return to the service immediately following relapse.  An 
observational study based around this service118 reported CO-validated quit 
rates at 4 weeks between 2001 and 2005 from 34%-45%, rising to 57% 
overall when self-report cases were included.  At 52 weeks, self-reported 
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quit rates ranged from 16%-22% between 2001 and 2004.  The authors 
claim that these rates are higher than existing published evidence although 
limitations of the study design mean these conclusions should be regarded 
as preliminary in nature.  The proSRUWLRQRIµZDONLQ¶FOLHQWV increased from 
19% in 2001 to 41% in 2004, indicating that the service may be reaching 
more smokers.  A qualitative study (face to face interviews)119 aimed to 
explore the main characteristics of the service and factors which 
contributed to its effectiveness.  The main findings were that using lay 
advisors rather than health professionals can be successful and that the 
nature of a drop-in service was valued by clients.  This service is now being 
independently evaluated.  
 
A qualitative study (face to face interviews)120 UHSRUWHGRQµ6PRNH\-RH¶D
group-based NHS smoking cessation intervention in a low income area of 
6FRWODQG  7KLV VHUYLFH HQFRXUDJHV µGURS LQ¶ FOLHQWV DW DQ\ VWDJH RI WKH
quitting process. 11 interviewees who had used the service at least 3 times 
in 6 months were selected and suggested that flexible services available to 
smokers at all stages of quitting are beneficial and valuable and 
interventions should be shaped to the local community and culture.  The 
service reported 52 week quit rates of 16% but this was not a robust 
evaluation.  
 
1.6.4 Incentive schemes 
 
Incentive schemes are intended to motivate smokers to either make a quit 
attempt or engage with some sort of smoking cessation support, and are 
usually used alongside other interventions such as GP advice or quitlines.  
In recent years, a number of Primary Care Trusts have offered a variety of 
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incentives for smokers, particularly pregnant, deprived and adolescent 
smokers to quit and remain abstinent, although the success of these 
schemes have not been formally assessed. 
 
Cahill and Perera carried out a Cochrane review of 17 studies of smoking 
cessation interventions offering a material or financial incentive.121.  Twelve 
studies were based in the US, three in the UK, one in Australia and one in 
the US and Canada.  The authors reported that none of the studies 
demonstrated significantly higher quit rates for the intervention group than 
for the control group beyond six-month abstinence and there was no 
evidence of one type of incentive bein more beneficial than another. 
 
1.6.5 Proactive Identification and Recruitment 
 
The introduction of the QOF discussed previously has the potential to have 
LQFUHDVHGWKHUHFRUGLQJRIVPRNLQJVWDWXVLQSDWLHQW¶VSULPDU\FDUHPHGLFDO
record, and thus improved the value of this resource in identifying 
smokers.  Coleman and colleagues122 examined the impact of QOF on the 
identification of smokers in primary care and the delivery of brief advice, as 
well as smoking cessation medication prescribing patterns. Using The 
Health Improvement Network (THIN) database which includes patient 
records from a large number of primary care practices in England, they 
were able to track changes between 1990 and 2005. They found that 
recording of smoking status and recording of advice delivery increased 
around the time of the 2004 contract but did not find any change in 
prescribing patterns over and above existing trends. This would suggest 
that the new GP contract has improved the recording of smoking status 
and the recording of advice to stop smoking but the lack of concurrent 
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increase in prescribing of smoking cessation medication suggests that 
opportunities to support successful cessation are possibly being missed.  
 
Most smoking cessation services rely on smokers to contact them but some 
settings provide an ideal environment for services themselves to 
proactively identify smokers and then target them for intervention.  
Primary care in particular has been identified as an important source of 
referrals to stop smoking services and it is suggested that all local GPs are 
aware of the need to refer smokers who are motivated to quit to the local 
stop smoking service99.  Proactive recruitment approaches have the 
capacity to reach a much larger number of smokers than reactive 
alternatives, although the vast majority of research on this approach has 
been conducted in the US. 
 
Two studies have described how smokers in two US states123 124 were 
identified by primary care staff as part of a routine appointment. In both 
studies, smokers were provided with brief advice to quit and asked whether 
they would consent to their details being either faxed to the State 
telephone quit line who then contacted the smoker at home and provided 
follow-up telephone support124 or given a brochure advertising the quit line 
number so that the client could contact the quit line for support 
themselves123. Fax referral resulted in greater uptake (59% successfully 
contacted from fax referral compared with 19% of those receiving the 
brochure who then contacted the quit line) although the cost of the two 
approaches was not compared. Both studies reported that the intervention 
was well-received by primary care staff and patients and resulted in an 
increased number of referrals from primary care to the state quit line. Both 
articles argued that this proactive approach was more cost-effective than 
relying on costly media campaigns to trigger reactive calls to the quit lines.   
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Milch and colleagues125 conducted a trial examining how two different 
screening tools could affect the proactive identification of smokers and the 
delivery of cessation advice to patients attending a primary care practice in 
the USA. Smokers were identified by filling in a short questionnaire when 
attending the practice for an un-related appointment. They were then 
UDQGRPLVHGLQWRRQHRIWKUHHJURXSVFRQWUROPLQLPDODµYLWDOVLJQVWDPS¶
QRWH RQ WKHLU ILOHV WKDW LGHQWLILHG WKHLU VPRNLQJ VWDWXV RU µHQKDQFHG¶
(completion of a 6 part smoking questionnaire attached to their files). 
Smoking status was documented more often (86%, 91% and 49% 
(p<0.001)) and cessation advice was delivered more often (38%, 47% and 
30% p<0.014) in the minimal and enhanced groups compared with the 
control group. Self-reported quit rates were higher at 9 months for the 
enhanced group (12% compared with 4% for minimal and 2% for control 
p<0.001). The study demonstrates how a short questionnaire that 
assesses readiness to quit and documents whether cessation advice was 
given can improve rates of advice giving and smoking cessation.  
 
Prochaska and colleagues126 conducted a randomized controlled trial of two 
forms of smoking cessation support with just over 4,000 smokers who had 
been identified by a random digit dialling procedure in the US, involving 
µFROG FDOOLQJ¶ DOO KRXVHKROGV LQ WKUHH parts of Rhode Island to identify 
smokers. A large number of calls (32,456) were made and 4296 eligible 
smokers were eventually identified, of which 80% agreed to participate in 
WKH VWXG\ 7KHVH VPRNHUV ZHUH WKHQ UDQGRPLVHG WR DQ µH[SHUW V\VWHP¶
intervention (who received intervention materials by post tailored to their 
µVWDJH RI FKDQJH¶ DW EDVHOLQH DQGPRQWKVDQGDQ µDVVHVVPHQWRQO\¶
intervention, the control group. The study found higher quit rates in the 
intervention group at each stage of follow-up (culminating in 25.6% point 
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prevalence and 12% prolonged abstinence at 24 months which were 30% 
and 56% greater than in the control group). The authors concluded that 
proactively identifying smokers in this way was effective both in 
encouraging them to participate in the study and in achieving cessation.  
 
Tillgren and colleagues127 carried out an observational study in Sweden to 
examine the impact of direct mail as a method to recruit smoking mothers 
LQWRDµ4XLWDQGZLQ¶FRQWHVW'LUHFWPDLOUHVXOWHGLQWKHPRVWSDUWLFLSDWion 
(compared with local newspapers and personal communication) and higher 
quit rates, but very small numbers overall were abstinent although this 
appears to be a potentially useful way of targeting smokers.  
 
The only research in the UK which has taken a proactive approach to 
offering smoking cessation was a cohort study128 which followed up 120 
smokers recruited opportunistically by GPs following a discussion on 
smoking initiated by the GP, although the majority of the consultations 
concerned other matters, and were given a prescription for NRT as an 
incentive to quit. The smokers were followed up 3 months later when 
around a fifth had stopped smoking with over twice as many having cut 
down their cigarette consumption. Although no details were provided on 
how GPs recruited smokers into the trial, and self-report was used for 
outcomes, the findings suggest that proactive targeting of patients by GPs 
in a deprived area for prescriptions of NRT and cessation advice may be 
effective.  
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1.7 The process of quitting smoking  
 
The prevailing model of smoking cessation assumes that smokers have the 
best outcomes when quit attempts involve advance planning.  This 
assumption is probably typically based around theories of behaviour 
change such as the Stages of Change concept, i.e. where the smoker is in 
terms of readiness to attempt to quit smoking129 130.  There are five key 
stages of change: 
 
x Precontemplation ± there is no intention to change behaviour in the 
near future 
x Contemplation ± people are aware that a problem exists and are 
seriously considering making a change, although they have not 
committed to taking action 
x Preparation ± individuals are intending to take action in the next 
month 
x Action ± individuals modify their behaviour to overcome their 
problem 
x Maintenance ± people work to prevent relapse and consolidate gains 
accomplished in the action phase131 132. 
 
It is suggested that the smoker moves through the 5 stages gradually and 
sequentially, although relapse to an earlier stage can occur133.  Typically, 
NHS stop smoking services and health professionals advise individuals in 
the preparation stage to plan ahead and set a quit date, subsequently 
moving into the action stage.  The model has been criticised for numerous 
reasons including a lack of qualitative distinctness of categories134 135, the 
fact that that the approach assumes that individuals make stable plans136 
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and that the Stages of Change algorithm systematically underestimates 
motivation to quit smoking relative to other measures137 138 and it has been 
suggested that a discrete 5-stage model does not fit reality well139.  
Additionally, it has been suggested that far from being productive to advise 
smokers to plan a quit date in advance it may in some cases be counter-
productive by pushing the decision to quit further into the future, an action 
which may be dangerous for ambivalent potential quitters140.   
 
Recent evidence from Canada140, the US141 and the UK142 indicates that a 
substantial proportion of quit attempts are made spontaneously and are, 
therefore, not compatible with the Stages of Change concept.  It has also 
been reported that unplanned quit attempts may be up to three times 
more likely to be successful for six months or more than planned ones142.  
West and Sohal142 suggest an alternative model to the stages of change 
approach which provides many of the underlying principles for traditional 
NHS SSS ZKLFKLVEDVHGRQ³FDWDVWURSKHWKHRU\´143.  This model proposes 
that beliefs, past experiences and the current situation create varying 
levels of motivational tension which can lead to an attempt to quit smoking 
with small triggers.   
 
The impact of these findings on helping people to stop smoking and the 
design of the NHS SSS has not yet been evaluated. 
 
1.8 Summary 
There is consistent evidence that smoking has huge economic and health 
costs and even though prevalence is decreasing, over one in five of the 
population still smoke, and a higher proportion in more deprived groups, so 
further research is needed to find new ways of tackling smoking and 
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encouraging cessation.  Evidence suggests that primary care provides an 
ideal opportunity for the identification of smokers and, independently, that 
a proactive approach to smokers may be an effective way of increasing 
access to smoking cessation services.  To date, however, limited research 
has been conducted in the UK as to the effectiveness of a proactive 
approach to identify smokers and no research has attempted to combine 
these two approaches. In addition, little attention has been paid to how 
smokers stop and the implications of the finding that a large proportion 
quit spontaneously, without prior planning.  
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1.9 Aims and Objectives 
The overall aim of this thesis is to investigate novel approaches to 
providing smoking cessation support, initially focused on a proactive 
approach through primary care and then on the nature of unplanned quit 
attempts and how these may be supported. 
 
Specifically, the objectives are: 
x To establish the feasibility of identifying and reaching smokers in 
primary care by evaluating the completeness and accuracy of 
smoking status recording in primary care medical records, and the 
demand by these smokers for support to quit smoking (chapter 3). 
x To test the effectiveness of a proactive approach to identifying 
smokers and offering smoking cessation support in primary care 
using a cluster randomised controlled trial (chapter 4) 
x To determine the prevalence and characteristics of smokers who 
make unplanned quit attempts, and the type of support they 
currently use (chapter 5) 
x To explore the factors surrounding the use of support in unplanned 
quit attempts (chapter 6) 
 
The remaining part of the thesis is divided into individual chapters 
addressing the above four objectives. However, the following chapter, 
Chapter 2, details the methodology used in the subsequent two chapters 
(Chapter3 & 4) 
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CHAPTER 2: TRIAL DESIGN AND METHODOLOGY 
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Chapter 2 describes the methods used to collect data presented in both 
chapters 3 and 4.  Chapter 3 describes the completeness and accuracy of 
smoking status recorded in primary care, the data for which was collected 
as part of a cluster randomised trial  discussed in chapter 4, investigating 
whether a systematic, proactive and personalised identification and 
invitation system can encourage smokers to use smoking cessation 
services to stop smoking.   
 
2.1 Study design 
To recruit practices, all 90 practices with list sizes of up to 10,000 patients 
in three Nottingham Primary Care Trust areas were written to requesting 
their participation in the study.  Of those who agreed to participate (n=27), 
24 practices were randomly selected (based on the power calculation for 
this study, see below) and allocated to either intervention or control groups 
by simple cluster randomisation.  The use of cluster randomisation is 
common in general practice research144 and although the use of this study 
design results in a loss of power due to variability between clusters145, it 
avoids contamination of control groups through contact with those in 
treatment groups146. 
 
2.2 Sample size determination 
With 12 practices in each treatment group, and expecting to recruit 500 
smokers per practice and assuming an intra-cluster correlation coefficient 
of not more than 0.007147, the study was designed to have 80% power to 
detect a change from a quit rate of 2.5% in the control group to 4% in the 
intervention group (an odds ratio of 1.625).   
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2.3 Identification of smokers from general practice records.  
In both groups, practice records were used to identify all patients aged 18 
years or over who were either recorded as smokers, or had no smoking 
status recorded.  These patients were sent a short self-completion 
questionnaire (Appendix I) from the participating practice, with a covering 
letter (Appendix II) explaining that the practice was using the 
questionnaire to update medical records and for a research study aimed at 
helping smokers to quit in collaboration with the University of Nottingham. 
In accordance with the approval for the study given by the Nottingham 
Ethics Committee, respondents were asked to provide written consent for 
the information provided on the questionnaire to be seen by the research 
team. 
 
The contents of the letters and questionnaires to patients in the 
intervention and control practices were identical to try to ensure that the 
initial contact with, and response from, participants was comparable 
between the two groups.    The questionnaire elicited details of smoking 
status, which may have been missing or out of date on patient records148, 
by asking respondents whether they had smoked any cigarettes or tobacco 
in the last 12 months, the frequency of smoking (every day, most days or 
occasionally) and number of cigarettes smoked per day (<10, 11-20, 21-
30, 31-40, 41+). The questionnaire also asked current smokers whether 
they would like to speak to a smoking cessation advisor to receive help or 
advice to quit smoking, and if so, to provide telephone contact details so 
that a smoking cessation advisor could contact them.  Respondents were 
given an option to receive postal information if they were not contactable 
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by telephone. All subjects were informed that this contact might happen 
after a short delay, as was the case for those in the control group.   
  
For logistic reasons, and to minimise any seasonal affects, letters to 
patients in each practice were posted over a period of a few days for each 
practice, and in random order of practices over a 6 month period. The date 
of distribution of the initial letter was defined as baseline for each practice, 
with a reminder sent to any non-responders three weeks after baseline.   
Completed questionnaires were returned directly to the practice and, if 
written consent had been given, collected by the research team and 
photocopied with a copy being returned to the practice to enable the 
clinical team to update smoking status on the medical record. 
 
These questionnaires collected at baseline were analysed to assess the 
completeness and accuracy with which smoking status is recorded in 
general practice, the results of which are detailed in Chapter 3. 
 
2.4 Trial study population 
The completed questionnaires were used to identify those who were 
current smokers (smoke every day, most days or occasionally and have 
smoked within the last 7 days) at baseline and these individuals formed the 
study population for the trial.  Completed questionnaires were used, with 
data provided from practice databases, to estimate the prevalence of 
smoking at baseline.   
 
2.5 Estimation of numbers of smokers 
Since smoking status in primary care records is incomplete and can be 
inaccurate148, the number of true current smokers in intervention and 
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control practices at baseline was estimated using the responses to the 
baseline questionnaire, and these estimates used in turn as the 
denominators to estimate the response rates in our study. The number of 
true current smokers in each practice was estimated by calculating the 
proportion of those documented to be smokers in medical records, and of 
those with no recorded smoking status, who confirmed in the baseline 
questionnaire that they were current smokers, and applying these 
proportions to the total number of documented smokers and those with no 
smoking status in each practice.  The estimated number of true current 
VPRNHUV WKHUHIRUHXVHVTXHVWLRQQDLUH UHVSRQVHVDVD µJROGVWDQGDUG¶ IRU
current smoking status and corrects for the fact that smoking status 
recorded in medical records becomes inaccurate with time elapsing after 
this is ascertained as some smokers tend to stop smoking as they age. 
 
2.6 Intervention  
All smokers in the intervention group who indicated that they would like 
help or advice to quit smoking were contacted by the research team, who 
had undertaken the same basic training as that of NHS stop smoking 
advisors and all calls followed a similar format (Appendix III) but in 
summary:  patients were asked if they were still interested in stopping 
smoking and if so, were given brief advice on smoking cessation in 
accordance with evidence-based guidelines56.  They were also given 
information about their local NHS SSS-clinic locations, times and format 
(one to one or group) and the benefits this could offer.  If desired, an 
appointment with the NHS SSS was booked by the research team on their 
behalf, and if not, smokers were given the option of being sent an 
information pack about the local service. The information pack included an 
information leaflet from the service, encouragement to the smoker to use 
57 
 
the service, and contact details for the research team and the local NHS 
SSS for further information or to book an appointment. Smokers who were 
not contactable by telephone were sent the postal information pack 
detailed above.  These contacts were made within 8 weeks of baseline for 
each practice. 
 
Smokers who attended the local NHS SSS will have received an initial 
consultation with a trained advisor and offered the standard range of 
evidence-based smoking cessation interventions offered by services 
throughout England57, including the option of one-to-one or group 
behavioural support lasting an average of 8 weeks, and nicotine 
replacement, bupropion or varenicline therapy, depending on the 
preferences and needs of the smoker.  At the initial consultation, smokers 
are asked to provide their age, sex, ethnicity, postcode and employment 
status.  They are also asked a series of questions about their smoking 
behaviour, including amount smoked, reasons for smoking, number of 
previous quit attempts and motivation to quit.  The SSS advisors routinely 
record whether the smoker sets a quit date while using the local NHS SSS, 
and smoking status at 4 weeks after the quit date.  These data, which are 
routinely collected by the NHS SSS, were provided to the research team in 
an anonymised form, for clients who used the service in the period of the 
study and for the same period of the previous year (June to December) to 
determine whether the intervention had altered the characteristics of 
service attendees.       
 
2.7 Control 
For six months from baseline, smokers in the control practices received no 
further intervention other than that provided by usual care. Previous 
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studies suggest that in most cases, this will have amounted to little or no 
advice or support being given149.  
 
2.8 Follow up 
Seven months after baseline, and at least six months after the research 
team contacted smokers from each intervention practice, a follow up 
questionnaire (Appendix IV) and accompanying letter (Appendix V) was 
sent to all who had reported being current smokers at baseline and who 
gave consent for their information to be used by the research team, 
excluding any who had died during the seven months.  This questionnaire 
repeated baseline questions and also asked about current desire to quit, 
the number of quit attempts made and the number of attempts that had 
lasted more than 24 hours, receipt of smoking cessation advice, and any 
use of any smoking cessation service over the previous six months.  Any 
non-responders were sent a reminder after 3 weeks, and those who did not 
reply at follow up were presumed to be continuing to smoke in accordance 
with the suJJHVWHGµ5XVVHOO6WDQGDUG¶150.  Respondents who indicated that 
they were abstinent at six months were asked when they stopped, and to 
consent to further contact with the research team to validate this.  After 
the follow-up measurements were complete, smokers in the control group 
who indicated that they would like help or advice to stop smoking were 
contacted directly by the local NHS SSS to offer specialist cessation 
support.  
 
2.9 Biochemical validation of smoking status 
The validation of smoking status is important when evaluating the 
effectiveness of a smoking cessation intervention151.  Validation in this 
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study involved respondents providing either a sample of saliva for cotinine 
estimation (a metabolite of nicotine) or, in the case of those reporting use 
of nicotine replacement therapy, exhaled air carbon monoxide (CO) 
measurement LQ OLQH ZLWK WKH µ5XVVHOO VWDQGDUG¶150.  The use of saliva 
cotinine validation was selected as it has a relatively long half life when 
compared to exhaled carbon monoxide and is non-invasive and easily 
collected when compared to serum and urine151.  Those consenting to 
provide samples were given the option of a visit from the research team at 
home or work, or attending Nottingham City Hospital for sample collection. 
Up to six attempts were made to contact these individuals at different 
times of the day.  Individuals providing a saliva sample were asked to chew 
on the cotton wool roll from a Salivette collection device (Sarstedt AG & 
Co, Germany) until it was saturated, then place into the salivette.  Saliva 
cotinine concentrations were measured by enzyme-linked immunosorbent 
assay (ELISA) (Salimetrics, PA, USA). Non smokers were defined as those 
with a salivary cotinine level below 15ng/ml152 or, if using NRT, an exhaled 
carbon monoxide level below 10ppm153. 
 
2.10 Calculation of the Townsend Material Deprivation Index score  
The Townsend Material Deprivation Index was used as an estimate of social 
deprivation154 and is based on the following four 1991 Census variables155: 
1. Unemployment: unemployed residents over 16 years as a 
percentage of all economically active residents aged over 16 
2. Overcrowding: households with one and over person per room as a 
percentage of all households 
3. Non car ownership: households with no car as a percentage of all 
households 
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4. Non home ownership: households not owning their own home as a 
percentage of all households 
 
The percentage produced for unemployment and overcrowding are 
transformed using the natural log function and each of the variables are 
then standardised using Z scores (observed value ± man value divided 
by the standard deviation) using the mean and standard deviation for 
the whole area.  The resulting Z scores are added together to produce 
the Townsend Index score. 
 
Townsend Material Deprivation Index scores have been found to explain 
variations in health measures and adhere closely to the concept of material 
disadvantage156.  Townsend scores were divided into quintiles for the 
purpose of data analysis. 
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CHAPTER 3: ASCERTAINMENT OF SMOKING STATUS IN 
PRIMARY CARE AND SMOKERS REQUIREMENTS FOR 
SUPPORT TO QUIT 
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3.1 INTRODUCTION 
 
Previous research, discussed in Chapter 1, identified the use of primary 
care medical records as being a potential avenue for identifying and 
proactively contacting smokers in the population. This chapter therefore 
focuses on ascertaining whether primary care records concerning smoking 
status are accurate, and also whether smokers are receptive to receiving 
smoking cessation advice if offered.   
 
Well established clinical guidelines in both the US157 and UK56 recommend 
that systematic recording of smoking status and intervention to promote 
cessation in all smokers is highly cost-effective and should be a 
fundamental component of all health care provision.  Previous studies 
indicate, however, that the recording of smoking status in primary care 
medical records is often inaccurate148 158 and that it is probably updated 
infrequently148 158.  This potentially limits the utility of smoking status 
UHFRUGHG LQ SDWLHQWV¶ PHGLFDO UHFRUGV IRU HLWKHU FOLQLFDO SUDFWLFH RU IRU
determining smoking prevalence within practices148 158.  Following the 
introduction of the QOF (discussed in section 1.5.3), the frequency with 
ZKLFK *3V DVFHUWDLQ SDWLHQWV¶ VPRNLQJ VWDWXV has increased122, therefore 
the completeness and accuracy of smoking status data in such records may 
have improved.   
 
This chapter, therefore, aims to establish the completeness and accuracy of 
VPRNLQJ VWDWXV UHFRUGLQJ LQ SDWLHQWV¶ SULPDU\ FDUH PHGLFDO UHFRUGV E\
comparing computerised medical records and responses to a questionnaire 
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asking about smoking behaviour one year after the introduction of the 
QOF.  It will also assess the level of interest in receiving smoking cessation 
support amongst primary care patients in an inner city UK population and 
determine how this varies with their socio-demographic characteristics.   
 
3.2 METHODS 
Smokers were identified and questionnaire data collected as detailed in 
&KDSWHU³7ULDO'HVLJQDQG0HWKRGRORJ\´ 
 
3.2.1 Primary outcomes 
Primary outcomes were the completeness and accuracy of smoking status 
recording in primary care records and interest of smokers in receiving 
smoking cessation support. 
 
3.2.2 Data analysis 
Questionnaire data were entered into SPSS Version 14.  Townsend scores 
EDVHGRQSDWLHQW¶VSRVWFRGHVZHUHFDOFXODWHGas previously described.   
 
The proportion of patients with a smoking status recorded was calculated 
from medical records and the proportions of recorded smokers who were 
misclassified as smokers and of self-reported smokers with no record of 
this in their medical records were calculated by comparing medical records 
with questionnaire responses.  The proportion of smokers wanting to speak 
to an advisor was calculated from questionnaire responses.  These 
variables were calculated at the practice level, and presented as the 
median and range because the distributions of some of these data were 
skewed.  
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The correlation between the proportion of patients at each practice with a 
recorded smoking status and the proportion misclassified as smokers was 
assessed using Spearman rank correlation coefficients, to determine 
whether better apparent recording of smoking status was associated with 
increased misclassification.  The effect of individual characteristics such as 
age, sex and Townsend Index on whether individuals responded to the 
questionnaire, were misclassified as smokers, and whether smokers 
wanted help to quit, was analysed at the individual level using logistic 
regression, and robust standard errors to allow for clustering by practice 
using STATA release 9.0; STATA Corp., College Station, TX.  
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3.3 RESULTS  
3.3.1 Recording of smoking status and response to the 
questionnaire 
Within the 24 participating general practices there were 87,861 patients 
aged 18 or over, of whom 23,044 were recorded as smokers, 52,629 as 
non-smokers and 12,188 had no record of smoking status in their medical 
records. The proportion of patients with smoking status recorded varied 
between practices from 42.4% to 100% (median 90.0%, Figure 2). 
  
 
 
  6
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Figure 2: Cumulative distribution of the percentage of patients in a practice with a smoking status recorded 
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35,232 questionnaires were dispatched WRJHQHUDOSUDFWLFHV¶SDWLHQWVrecorded as 
smokers and also to those with no smoking status recorded. The proportions of 
patients returning the questionnaire and giving signed consent for their 
information to be shared with the research team varied between practices from 
13.9% to 41.1% (median 33.2%). Respondents recorded as smokers in their 
medical records were more likely to respond than those with no smoking status 
recorded [35.5% (8176/23044) and 24.2% (2951/12188) respectively], and 
males and younger patients were less likely to respond to the questionnaire 
(Table 5).  
 
Table 5: Questionnaire response rates and numbers of self-reported smokers 
     
NUMBER 
SENT 
NUMBER (%) 
RETURNED 
NUMBER  OF SELF- 
REPORTED CURRENT 
SMOKERS 
TOTAL 35232 11127 (31.6) 6856 
Practice median 
(range) 
1312  
(432-2985) 
33.2%  
(13.9-41.4%) 
258  
(52-766) 
     
SMOKER 23044 8176 (35.5) 5943 
NO STATUS 12188 2951 (24.2) 913 
     
MALE 20040 5839 (29.1) 3515 
FEMALE 15192 5288 (34.8) 3340 
    
 AGE    
<=30 9965 2161 (21.7) 1344 
31-40 8176 2187 (26.7) 1430 
41-50 6635 2205 (33.2) 1440 
51-60 5007 2052 (41.0) 1305 
61+ 5449 2522 (46.3) 1337 
 
 
The proportion of responding patients who were recorded as smokers on 
SUDFWLFHV¶ FOLQLFDO LQIRUPDWLRQ V\VWHPV EXW who denied tobacco use in the 
previous 12 months varied between 6.3% and 58.1% across practices (median 
20.3%).  Across all practices, there was no correlation between the proportions 
of patients with a smoking status recorded and the proportions of patients who 
were recorded as smokers but denied tobacco use in the previous 12 months 
(Spearmans r = -0.14). The proportion of patients with no record of smoking 
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status who, as defined by questionnaire responses, were self reported current 
smokers varied from 5.7% to 60.2% across practices (median 29.8%).  
 
The proportion of patients misclassified as smokers in their medical record was 
unrelated to gender, but did vary with age.  In those aged 30 or below, 13.1% of 
patients recorded as smokers in their medical record reported not smoking in the 
past year on questionnaires and this increased to 31.7% in those aged over 61. 
 
3.3.2 6PRNHUV¶LQWHUHVWLQVXSSRUWWRVWRp smoking 
Of the 6856 respondents who were current smokers, 2840 (41.4%) indicated 
that they would like to speak to a specialist smoking cessation advisor to help 
them stop smoking (Table 6).  This varied between practices from 30.6% and 
51.8% (median 39.8%). Individuals who were previously recorded as smokers 
tended to be more likely to want to speak to a cessation adviser than those who 
previously had no smoking status recorded (42.7% and 33.4% respectively).  
 
Interest in support did not vary with gender (40.7% and 42.2%, for men and 
women respectively, p=0.20) but did vary with age and economic disadvantage. 
Those aged between 31 and 50 were most likely to want to speak to an advisor 
and the oldest and youngest age groups were least likely to desire this (33.4% 
and 34.1% respectively) and this effect was significant overall (p<0.01).  
6PRNHUV¶ UHSRUWHG GHVLUH WR WDON ZLWK VPRNLQJ FHVVDWLRQ DGYLVRUV LQFUHDVHG
linearly with economic disadvantage (measured by Townsend index) such that 
demand for support was highest (44.6%) from the most disadvantaged and 
lowest (39.1%) from the least socially disadvantaged groups although this was 
not significant (p=0.20) (Table 6). 
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Table 6: Number of current smokers who would like support to quit smoking 
 
  
Number of 
smokers who 
responded 
Number 
who 
wanted 
help to quit 
% 
Adjusted odds 
ratios (95% CI) 
 
P 
value 
Total 6856 2840 41.4   
       
Males 3516 1430 40.7 1 0.20 
Females 3340 1410 42.2 1.07 (.97-1.17)  
      
 AGE      
<=30 1344 447 33.4 1 <0.01 
31-40 1430 674 47.1 1.82 (1.55-2.13)  
41-50 1440 680 47.2 1.83 (1.45-2.31)  
51-60 1305 583 44.7 1.63 (1.34-1.99)  
61+ 1337 456 34.1 1.05 (.89-1.25)  
       
Townsend quintile 1  1373 537 39.1 1 0.20 
Townsend quintile 2 1343 530 39.5 1.00 (.81-1.23)  
Townsend quintile 3 1335 552 41.3 1.09 (.93-1.29)  
Townsend quintile 4 1362 576 42.3 1.12 (.89-1.40)  
Townsend quintile 5 1354 604 44.6 1.26 (1.01-1.56)  
 
*Townsend quintile 1 (least deprived) = <= -1.60 
*Townsend quintile 2 =  -1.60 to -0.49 
*Townsend quintile 3 = -0.49  to 3.03 
*Townsend quintile 4 = 3.03   to 5.09 
*Townsend quintile 5 (most deprived) = 5.09 + 
 
**Townsend data for 84 consenting smokers was unavailable 
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3.4 DISCUSSION 
3.4.1 Main findings 
Practices in this study had a recording of smoking status in the primary care 
medical record for, on average, 90% of registered patients, but this was 
probably not accurate in about 20% of cases.  Additionally, among smokers who 
responded to questionnaires sent from their general practitioners, over 41% 
were interested in talking to a smoking cessation advisor to obtain support with 
stopping smoking and interest was highest amongst the most economically 
deprived smokers. The findings of this study indicate that although the 
ascertainment of smoking status in primary care is apparently high, these data 
are relatively inaccurate and more regular updating of smoking status records 
might increase the numbers of opportunities which health professionals use to 
intervene and promote smoking cessation.   
 
Although 41% of smokers who responded to the questionnaire reported that 
they would like to speak to a smoking cessation advisor, this figure is almost 
certainly an overestimate of the true proportion. If it were conservatively 
presumed that all those who wanted help to quit responded then the true 
denominator would be all current smokers who were sent a questionnaire, which, 
based on the accuracy of smoking status recording found in our study, may be 
estimated to be 20,521, reducing the proportion wanting to speak to an adviser 
to 13.8%.   Nevertheless, between April 2007 and March 2008 over 680,000 
smokers set quit dates using English NHS SSS6 and as this represents less than 
10% of English smokers, our findings suggest that there is considerable interest 
in speaking to cessation advisors, and potentially receiving cessation support 
amongst smokers that is not currently translated into their use of NHS stop 
smoking services.  
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The challenge for the UK NHS is to find ways of engaging smokers who are 
interested in talking to smoking cessation advisors and receiving support with 
stopping smoking and encouraging them to access such support. In particular, 
these results throw into question the reluctance of many GPs to raise the topic of 
smoking due to concern of negative responses from their patients83 and suggests 
that this attitude results in missed opportunities to provide help and advice to 
smokers who would welcome this. The findings here suggest that the most 
economically disadvantaged smokers who suffer from the greatest smoking-
related morbidity33 are also the most interested in receiving support.  It is 
important to ensure that this group is appropriately assisted, possibly by using 
QRYHOPHWKRGVRIµPDUNHWLQJ¶1+6666 to this group. 
 
3.4.2 Strengths and limitations 
To our knowledge, this study is the first to systematically contact large numbers 
of smokers living in a large, relatively-deprived urban area and ascertain their 
interest in engaging with smoking cessation support.  This systematic approach 
ZLWKLQDGHILQHGSRSXODWLRQDOORZVHVWLPDWHVRIVPRNHUV¶GHVLUHIRr support with 
smoking cessation to be made.   
 
The limitations of the study include the fact that participation was relatively low, 
ZKLFKLVOLNHO\WREHSDUWO\DWWULEXWDEOHWRLQDFFXUDFLHVLQDGGUHVVHVRQSUDFWLFHV¶
registers.  In addition, ethical constraints dictated that the research team 
obtained signed consent from questionnaire respondents before their data could 
be used for research purposes.  As not all respondents gave their consent for 
their information to be used in this way, this will have lowered the response rate.   
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The findings reported rely on self reported smoking status, which may be a 
potential limitation of the study.  However, it has been assumed that the 
smoking status reported by questionnaire respondents was reliable, since 
questionnaire data obtained by similar means in previous studies148 158 have been 
found to be accurate159, and informing recipients that their responses would be 
used to update their medical records should, if anything, have improved the 
validity of responses.  In addition, the figures reported here for the accuracy of 
smoking status recording in general practice use only the self-reported 
prevalence of current smokers compared with medical records and did not 
investigate the accuracy of registered non-smokers with self-reported data.  
However, as 90% of adult smokers start smoking before the age of 18160, it is 
unlikely that many recorded non smokers would have taken up smoking since 
this was recorded, therefore having a minimal effect on the results presented 
here.      
 
It is also possible that there may have been selection bias in the practices that 
took part, as only 30% of those approached agreed to take part in the study.  
For example, they may have had a greater interest in smoking cessation than 
others meaning that they may have had a greater likelihood of maintaining up to 
date records on smoking status. 
 
3.4.3 Comparison with previous research 
 
The proportion of primary care patients in these inner city practices whose 
records included a note of smoking status (median 90%) was higher than in 
previous studies (73.4% and 76%)148 158 and this more comprehensive recording 
could be due to the introduction of the 2004 general practice contract (discussed 
in section 1.5.3) which has increased rates of smoking status ascertainment122.  
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However, no data from study practices during the period before the contract was 
introduced was available to compare the findings of this study with and recording 
rates may be higher for other reasons.  Higher rates of smoking status recording 
amongst women and older people have been observed previously148, and are 
SUREDEO\ LQIOXHQFHG E\ WKHVH SDWLHQWV¶ KLJKHU JHQHUDO SUDFWLFH FRQVXOWDWLRQ
rates161.  
 
Nevertheless, across practices, an average of 20% of individuals recorded in 
their medical records as smokers were not currently smoking; whilst this may be 
an overestimate of the true figure for our study population if smokers who had 
successfully quit were more likely to return the questionnaire, it is also possible 
that offering support to stop smoking may have encouraged more current 
smokers to return the questionnaire.  This level of accuracy of recorded smoking 
status is no better than that found in earlier studies.  In the late 1990s, Wilson 
et al148 found that around 18% of patients recorded as smokers in general 
practice medical records reported in postal questionnaires that they were not.  
The rate reported here is very similar, and moreover, we found a large variation 
between practices in the proportion of smokers who were misclassified such that 
in one practice this reached 58.1%.  It was also observed that the proportion 
misclassified as smokers increases ZLWK DJH VXJJHVWLQJ WKDW RQFH SDWLHQWV¶
smoking status has been ascertained, it is not routinely updated, so that the 
accuracy of this information reduces as time passes.  A previous study found 
that although 99% of GPs record smoking status when patients first join their 
practices, only 57% claim to routinely update this information56 and the findings 
reported here may reflect this.  Nevertheless, no correlation was found between 
the level of recording and misclassification suggesting that high ascertainment of 
smoking status among practices in this sample was not necessarily at the 
expense of accuracy, and that both may be achieved.  
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3.4.4 Conclusions  
DDWDRQVPRNLQJVWDWXVUHFRUGHGLQSDWLHQWV¶SULPDU\FDUHPHGLFDOUHFRUGVwere 
found to contain inaccuracies which reduce its utility for either effective health 
planning or research purposes.  A significant minority of smokers are interested 
in talking to smoking cessation advisors about receiving support and help with 
stopping smoking. Currently a very much smaller proportion than this is actually 
trying to stop smoking with the support of NHS stop smoking services.   
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CHAPTER 4: THE EFFECT OF PROACTIVELY IDENTIFYING 
SMOKERS AND OFFERING SMOKING CESSATION SUPPORT 
IN PRIMARY CARE POPULATIONS: A CLUSTER RANDOMISED 
TRIAL 
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4.1 INTRODUCTION 
As previous research has identified the use of primary care medical records as a 
potential avenue for identifying and proactively contacting smokers in the 
population, this chapter tests the effectiveness of such an approach to 
identifying smokers and offering smoking cessation support in primary care 
using a cluster randomised controlled trial. 
The aim was to determine whether proactively identifying all smokers in a 
primary care population, followed by personal contact giving advice and 
information about local cessation services increases abstinence from smoking, 
increases access to and uptake of NHS stop smoking services, changes smoking 
and quitting behaviour and/or changes the characteristics of NHS SSS attendees. 
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4.2 METHODS 
Trial participants, the intervention and follow up procedure are detailed in 
&KDSWHU³7ULDO'HVLJQDQG0HWKRGRORJ\´ 
 
4.2.1 Primary Outcomes 
The primary outcome was 7-day validated point abstinence from smoking at the 
6 month follow-up. Validated point abstinence from smoking at 6 months was 
used rather than sustained abstinence over the 6 months period.  Although 
sustained abstinence would have been a better indicator of likelihood to stay 
VWRSSHGDQGLQOLQHZLWKWKHµ5XVVHOO6WDQGDUG¶150, point abstinence was the only 
feasible outcome in this community-based study.  All non-responders, and those 
who did not provide a validation sample at 6 months, were assumed to be still 
smoking LQDFFRUGDQFHZLWKWKHVXJJHVWHGµ5XVVHOO6WDQGDUG¶150.   
 
4.2.2 Secondary Outcomes 
Secondary outcomes included self-reported abstinence for the past seven days 
at 6 months calculated for all those reported as smokers at baseline as it was 
likely that a proportion of those who reported having quit smoking would be 
unable or unwilling to provide a saliva sample for biochemical validation of 
smoking status.  The proportion of smokers who reported using the local NHS 
SSS or receiving smoking cessation advice, calculated for those who responded 
at 6 months was used to evaluate whether the intervention had increased 
VPRNHUV¶ UHFHLSW RU UHFROOHFWLRQ RI UHFHLSW RI VPRNLQJ FHVVDWLRQ DGYLFH DQG
support. 
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In those who were still smoking at 6 months, the proportion of people who 
reported a desire to quit and had made at least one quit attempt lasting more 
than 24 hours was calculated to see if the intervention had had any effect on 
VPRNHUV¶GHVLUHWRRUHIIRUWVWRWU\DQGTXLW.  In those who were still smoking, a 
lower category of cigarette consumption at follow-up was taken as representing 
UHGXFHGFLJDUHWWHFRQVXPSWLRQ7RZQVHQGVFRUHVEDVHGRQSDWLHQW¶VSRVWFRGHV
were used to adjust for socio-economic status. 
 
4.2.3 Data analysis 
Since smoking status in primary care records is incomplete and can be 
inaccurate162, we estimated the number of true current smokers in intervention 
and control practices at baseline using the responses to the baseline 
questionnaire (the method for this calculation has been previously described in 
section 2.5), and used these estimates in turn as the denominators to estimate 
the response rates in our study.  For each primary and secondary outcome, we 
calculated the percentage of positive responses for each practice and compared 
the means of these percentages between intervention and control practices by 
an independent samples t-test, having first checked the normality of the 
distribution of percentages.   
 
To obtain odds ratios comparing abstinence from smoking, receipt of smoking 
cessation advice and quitting behaviour between intervention and control 
practices and to adjust for apparent baseline differences between practices, we 
used logistic regression in MLWin Version 2.02163.  We used a two-level 
hierarchical model with subjects nested within practices, a random effect of 
practice, intervention fitted at the practice level.  Age, sex, Townsend Score and 
amount smoked per day were included as a priori confounders at the subject 
level. With 12 practices in each treatment group, and expecting to recruit 500 
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smokers per practice and assuming an intra-cluster correlation coefficient of not 
more than 0.007147, the study was designed to have 80% power to detect a 
change from a quit rate of 2.5% in the control group to 4% in the intervention 
group (an odds ratio of 1.625).   
 
Characteristics of service attendees between the period of the study and the 
same months in the previous year were compared by an independent samples t-
test, Mann-Whitney U test for non-normally distributed data, or chi-squared test 
for categorical data to assess whether the intervention influenced the 
characteristics of smokers using smoking cessation services.  A post hoc 
subgroup analysis of validated and self-reported abstinence at 6 month follow-up 
in those who responded to the initial questionnaire that they wanted help or 
advice from a smoking cessation adviser.  
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4.3 RESULTS 
4.3.1 Characteristics of intervention and control practices 
In intervention and control practices, there were 10,402 and 12,642 patients 
respectively aged 18 or over recorded as smokers, and 6523 and 5665 with no 
record of smoking status in their medical records.  We estimate the total number 
of true current smokers in intervention and control practices at baseline to have 
been 10,177 and 11,783 respectively, of whom 3051 (30%) and 3805 (32%) 
respectively (total 6856) participated in our study (Table 7).  The distribution of 
gender and age was similar for participants in intervention and control practices 
(Table 7).  Townsend Scores were slightly higher (implying greater relative 
deprivation), and cigarette consumption also higher, for participants in 
intervention practices. A similar proportion of smokers in intervention and 
control practices requested help with quitting smoking (mean 40.6% (range 30.6 
to 51.8) and 41.6% (range 36.4 to 50.2) respectively).   Of those requesting 
help from intervention practices, 67% received telephone contact from the 
research team.  The remaining 33% were sent postal information, either on their 
request (12%) or because they were un-contactable by telephone (21%). 
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Table 7: Characteristics of the intervention and control practices and participants 
at baseline 
 Intervention Control 
 Individual  
(%) 
Mean per practice 
(range) 
Individual 
(%) 
Mean per practice 
(range) 
     
Estimated 
number of eligible 
individuals 
(smokers aged 18 or 
over) 
 
10,177 
 
848 
(307,1834) 
 
11,783 
 
982 
(312,2070) 
     
Number of 
participants 
3051 (30.0) 254 (52,529) 3805 (32.3) 317 (53,766) 
     
Age 
    
18-39 1082 (35.5) 36.6 1510 (39.7) 39.7 
40-59 1276 (41.8) 41.5 1536 (40.4) 40.3 
60+ 693  (22.7) 21.9 759 (19.9) 20.1 
Mean age 46.6 46.1 (39.2 to 49.4) 45.0 44.9 (39.2 to 48.8) 
     
Gender 
    
Male 1584 (51.9) 54.9 (43.5 to 69.2) 1932 (50.8) 51.5 (47.1 to 58.5) 
Female 1467 (48.1)  1873 (49.2)  
     
Townsend Score 
    
- 1.6 (least deprived) 430  (14.3)  943  (25.0)  
-1.599 to 0.497 451  (15.0)  892  (23.7)  
0.498 to 3.037 550  (18.3)  785  (20.8)  
3.038 to 5.098 752  (25.1)  610  (16.2)  
 (most deprived) 816  (27.2)  538  (14.3)  
Missing 52  37  
Mean Townsend 2.71 (3.39) 2.73 (-0.42 to 5.14) 1.05 (3.35) 1.43 (-1.24 to 5.49) 
     
Cigarettes/day 
    
<10 944 (30.9)  1382 (36.3)  
11-20 1357 (44.5)  1507 (39.6)  
21-30 422 (13.8)  545 (14.3)  
31-40 98 (3.2)  125 (3.3)  
41+ 33 (1.1)  26 (0.7)  
No response 197 (6.5)  220 (5.8)  
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Of the 6856 participants at baseline, 3512 provided follow up questionnaire data 
at six months. This proportion was similar in intervention and control practices, 
the mean response being 47.9% (range 28.8 to 55.6) and 53.7% (range 39.6 to 
63.3) respectively. Of those smokers who reported that they had quit smoking, 
the proportion consenting for further contact for validation was similar between 
intervention and control groups (58.3% and 56.2% respectively), but a higher 
proportion of these individuals in control practices (73.5%) than in the 
intervention group (56.7%) proved either to be not contactable or else 
subsequently refused to provide a sample.  
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4.3.2 Abstinence from smoking at 6 month follow up 
There was no significant difference in self-reported point abstinence from 
smoking at 6 months in intervention and control groups (8.6% and 7.4% 
respectively), either before or after adjusting for age, sex, Townsend score and 
amount smoked at baseline (Table 8). Of those who had quit by self-report, 
41.0% and 30.6% were respectively confirmed as non-smokers by salivary 
cotinine or exhaled carbon monoxide validation. The prevalence of validated 
point abstinence from smoking at 6 months was 3.5% and 2.5% in the 
intervention and control groups respectively, and the difference between them 
was not statistically significant different, either before or after adjustment for 
age, sex, Townsend Score and amount smoked (adjusted OR 1.64, 95% CI 0.92, 
2.89). There was no evidence of interaction between the effect of the 
intervention and Townsend score or cigarette consumption at baseline.   
 
Table 8: Effect of intervention versus control on main outcomes in all smokers 
responding at baseline 
 Intervention Control Unadjusted OR 
(95% CI) 
Adjusted OR* 
(95% CI) 
Of all smokers 
participating at 
baseline 
Mean % per 
practice 
(range) 
Mean % per 
practice 
(range) 
  
Self-reported 
smoking abstinence 
(last 7 days) at 6 
PRQWKV 
8.6 
(5 to 14.4) 
7.4 
(2.3 to 12.1) 
1.20 
(0.86 to 1.69) 
1.23 
(0.90 to 1.67) 
Validated smoking 
abstinence at 6 
PRQWKV 
3.5 
(1.9-6.4) 
2.5 
(0-5.4) 
1.60 
(0.89 to 2.87) 
1.64 
(0.92 to 2.89) 
WKRVHZKRGLGQRWUHVSRQGDWPRQWKVSUHVXPHGWREHFRQWLQXLQJWRVPRNH 
*adjusted for age, gender, quintiles of Townsend score and cigarette 
consumption at baseline   
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4.3.3 Receipt of smoking cessation advice and use of NHS stop smoking 
services 
A significantly higher percentage of participants in the intervention than in the 
control group reported that they had used the local stop smoking service during 
the period of the study (16.6% and 8.9% respectively), or had received advice 
on quitting from any source (29.3% and 21.8% respectively). Some respondents 
indicated that they had tried to see an advisor from the local NHS SSS but were 
unable to make an appointment (Table 9). An average of 17.9% of those in the 
intervention practices and 10.5% of those in the control practices either used, or 
tried to make an appointment with, the local NHS SSS during the course of the 
study.  
 
Table 9: Effect of intervention versus control on main outcomes in all responders 
at 6 months 
Of all those 
responding at 6 
months 
Intervention 
Mean % per 
practice (range) 
Control 
Mean % per 
practice (range) 
Unadjusted 
OR (95% CI) 
Adjusted OR* 
(95% CI) 
Overall 125  
(15 to 277) 
167  
(26 to 415) 
  
Used local 
smoking cessation 
service 
16.6 
(11.6 to 22.4) 
8.9 
(4.9 to 13.8) 
2.11 
(1.61 to 2.76) 
2.09 
(1.57 to 2.78) 
 
Given advice on 
quitting from any 
source 
29.3 
(13.3 to 38.6) 
21.8 
(15.3 to 38.5) 
1.72 
(1.38 to 2.16) 
1.68 
(1.36 to 2.07) 
*adjusted for age, gender, quintiles of Townsend score and cigarette 
consumption at baseline 
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4.3.4 Smoking and quitting behaviour amongst those continuing to 
smoke at 6 month follow up 
Among continuing smokers at follow-up, those in the intervention group were 
slightly more likely to have made a quit attempt during the course of the study 
(adjusted OR 1.23, 95% CI 1.01 to 1.51), although these attempts were no 
more likely to have lasted more than 24 hours than those in the control 
practices. Smokers in intervention practices were no more likely to have reduced 
their cigarette consumption over the 6 months, and were less likely to want to 
quit at follow up than their counterparts in the control practices (adjusted OR 
0.80, 95% CI 0.67 to 0.94) (Table 10).   
 
Table 10: Effect of intervention versus control on main outcomes in continuing 
smokers at 6 months 
 
Of current smokers 
responding at 6 
months 
Intervention 
N per practice 
Mean  102 
Range 12,210 
Control 
N per practice 
Mean  143 
Range 24,345 
 
Unadjusted 
OR (95% CI) 
 
Adjusted OR* 
(95% CI) 
Reduced cigarette 
consumption  
14.3 
(7.3 to 22.0) 
13.9 
(4.2 to 18.0) 
1.12 
(0.89 to 1.41) 
1.10** 
(0.86 to 1.40) 
Want to quit 62.7% 
(57.6 to 75.0) 
67.3% 
(59.7 to 75.0) 
0.83 
(0.70 to 0.98) 
0.80 
(0.67 to 0.94) 
Tried to quit in last 6 
months 
37.4% 
(26.8 to 47.5) 
33.3% 
(25.0 to 41.2) 
1.22 
(1.01 to 1.50) 
1.23 
(1.01 to 1.51) 
At least one attempt 
lasting 24hrs or more 
28.2% 
(19.0 to 39.0) 
27.4% 
(21.4 to 36.0) 
1.12 
(0.94 to 1.39) 
1.14 
(0.92 to 1.42) 
*adjusted for age, gender, quintiles of Townsend score and cigarette 
consumption at baseline   
** adjusted for age, gender, quintiles of Townsend score only (for model 
convergence). 
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4.3.5 Characteristics of NHS stop smoking service users 
More people attended the local NHS SSS during the period of the study than in 
the equivalent period of the previous year (Table 11). There was also a notable 
difference in the proportion of attendees who set a quit date, which at 66.4% in 
the study period was significantly lower than the 73.1% in the previous year 
(Table 11).  There was a significant increase in the proportion of non-white 
Caucasian clients attending the local NHS SSS in the year of the study as 
compared with the previous year, but no difference in socio-economic status.   
 
Table 11: Characteristics of service users during the study period, and for the 
preceding year 
 Year before study  
(2004) 
Year of study  
(2005) 
 
p value 
Number of users 
  
3468 4148   
Mean age (yrs) 
(n=7616) 
43.1 
(12 to 88) 
41.9 
(11 to 90) 
<0.001 
Mean Townsend score 
(n=7141) 
1.75 
(-5.770 to 9.070) 
1.69 
(-6.510 to 9.070) 
0.491 
Gender % Male  
(n=7616) 
41.2 43.0 0.122 
Ethnicity % White 
Caucasian (n=7423) 
93.4 91.7 0.007 
% Set quit date  
(n=7616) 
73.1 66.4 <0.001 
% Quit at 4 weeks 
(n=7616)* 
41.8 40.9 0.442 
Median (range) motivation 
to quit score (n=5976) 
9.0 
(1 to10) 
9.0 
(1 to 10) 
0.096 
*Clients lost to follow up assumed to be continuing to smoke at 4 weeks 
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4.3.6 Post-hoc analysis in the subgroup of smokers who wanted to 
speak to a smoking cessation advisor 
In those smokers who indicated at baseline that they would like to speak to a 
smoking cessation advisor (n = 1289 and 1551 in the intervention and control 
practices respectively), the response rate at 6 month follow-up was comparable 
with that for the complete study population. Validated quit rates were 
significantly higher in the intervention group than control (4.0% and 2.2% 
respectively), although the difference in self-reported abstinence was not 
statistically significant (Table 12). 
 
Table 12: Effect of intervention versus control on main outcomes in those 
smokers who indicated they would like speak to a smoking cessation advisor at 
baseline 
 Intervention Control Unadjusted OR 
(95% CI) 
Adjusted OR* 
(95% CI) 
Of all smokers who 
indicated they 
would like to speak 
to a smoking 
cessation advisor at 
baseline 
 
Mean % per 
practice 
(range) 
 
Mean % per 
practice 
(range) 
  
Self-reported 
smoking abstinence 
(last 7 days) at 6 
PRQWKV 
7.5 
(2.3-13.0) 
5.9 
(2.5-9.5) 
1.35  
(0.97 to 1.87) 
1.37  
(0.99 to 1.90) 
Validated smoking 
abstinence at 6 
PRQWKV 
4.0 
(0-10.0) 
2.2 
(0-4.0) 
1.96 
(1.08 to 3.58) 
2.05  
(1.11 to 3.76) 
*adjusted for age, gender, quintiles of Townsend score and cigarette 
consumption at baseline   
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4.4 DISCUSSION 
4.4.1 Main findings 
This study aimed to proactively identify smokers in Primary Care and offer help 
or advice about smoking cessation, which for those who requested it, included 
information about and referral to a range of evidence-based cessation support 
available through the UK NHS SSS.  The intervention increased the proportion of 
smokers reporting attendance at the local NHS SSS and had a modest effect on 
the number of quit attempts made, but at the population level had no significant 
impact on actual quit rates or reported cigarette consumption.    
 
Smokers in the intervention group were more likely to have received advice on 
smoking cessation from any source during the period of study. It is surprising 
that this proportion for the intervention group is only 29%, since advice was 
provided by phone or letter for the 40% who requested help or advice. This 
discrepancy is likely to be the result of poor recall of advice, or misunderstanding 
RI ZKDW ZH PHDQW E\ UHFHLYLQJ DGYLFH IURP µDQ\ VRXUFH¶ It is notable that 
smokers in the intervention group were less likely to want to quit at the end of 
the study than those in the control group, but this is most likely to be explained 
by their being more likely to have made a recent (unsuccessful) quit attempt.  
 
Smokers in the intervention group reported a significantly higher use of NHS SSS 
and there was an increase in service usage during the period of our study.  
Whilst we cannot be sure that this increase was due to this study rather than 
other initiatives, it would be consistent with the intervention being effective in 
increasing the number of smokers contacting the service. When comparing the 
characteristics of those attending the local SSS during the course of this study 
with a similar time period in the previous year, little evidence was found of a 
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difference in socio-demographic characteristics, but service users in the period of 
our study were less motivated to quit and less likely to set a quit date than those 
attending in the previous year. It is possible that by proactively offering smoking 
cessation support, we encouraged a group of smokers to access NHS SSS who 
were perhaps not as ready or motivated to quit as previous service users. 
Though this study was based in Nottinghamshire, a relatively deprived 
population, the local NHS SSS provides a standard range of evidence-based 
smoking cessation interventions with group or individual support at flexible times 
and locations which is typical of services available nationally93, and as such these 
results are likely to be generalisable to deprived populations and NHS cessation 
services across the country. 
 
The study was designed to detect a 1.5 percentage point difference in cessation 
between active and control groups based on recruiting 500 smokers per practice. 
This sample size was not achieved in a number of practices, and it remains 
possible that a true effect on cessation rates of this magnitude or smaller was 
missed.  The observed difference in quit rates attributable to the intervention 
was between 1 and 1.5% in all smokers, which though not statistically significant 
in this study, is potentially important in public health terms. 
 
The primary analysis compared smoking cessation at follow-up between all 
smokers in intervention and control practices, whether or not they asked for help 
or advice from a smoking cessation adviser. This approach was adopted to 
establish the public health impact of the intervention which encompassed a pro-
active approach to all smokers, but then targeted help to those who requested it. 
Although the study did not show a significant effect of the intervention on 
smoking cessation in the whole study population, there was post hoc evidence of 
a greater effect in the subgroup who requested help or advice from the smoking 
cessation advisor, with validated smoking abstinence increased two fold in the 
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intervention compared to the control group (adjusted OR 2.05 (95% CI 1.11, 
3.76)). This suggests that, whilst a pro-active approach to smokers in general 
may have no more than a small but limited impact on cessation rates in the 
smoking population, an intervention which successfully targets smokers who 
want help to quit, with pro-active provision of evidence-based smoking cessation 
support to these individuals, may be more effective.  
 
4.4.2 Comparison with previous research 
 
The previous UK study which has taken a proactive approach to offering smoking 
cessation128 which followed up 120 smokers recruited opportunistically by GPs 
following a discussion on smoking initiated by the GP and were given a 
prescription for NRT as an incentive to quit found that around a fifth had stopped 
smoking at three month follow up, with over twice as many having cut down 
their cigarette consumption. However, this study did not specifically refer 
smokers to NHS stop smoking services.  Whilst a US study found that smokers 
were much more likely to attend a smoking cessation programme if they had 
first received detailed information about the programme and strong 
encouragement to attend, the study did not report smoking cessation rates so 
the effect of contacting the service on cessation is unknown164. 
 
4.4.3 Strengths and limitations 
This study is the first to assess whether proactive contacting and referral into 
evidence-based cessation services57 165 would not only encourage more smokers 
to use the service but also lead to increased cessation. The findings suggest that 
a proactive approach is successful in smokers who want help to quit, but is not 
an effective means of increasing cessation in the population.   
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The response rate to the initial questionnaire was low at around 30% of the 
estimated number of current smokers in the practices, but importantly it was 
comparable between intervention and control practices so that this is unlikely to 
have introduced bias, but may limit the generalisability of our results. Both self-
reported and validated control group cessation rates were higher than 
anticipated spontaneous quit rates (approximately 2% annually)56 after 6 
months, and this is probably due to overrepresentation of motivated smokers 
among our participants. Whilst this response rate is not unusual for a community 
based study, smokers may also have been deterred by the two stage process 
imposed by ethical considerations of returning the questionnaire to the general 
practice and providing signed consent for these data to be seen by researchers. 
 
The response rate at follow-up was also relatively low and there was a small 
difference in response between intervention and control groups, with a poorer 
response from intervention group smokers, possibly as a result of response 
fatigue since some of this group would have been contacted in the interim. We 
have assumed that non-responders at follow-up were still smoking, as is 
standard practice in clinical trials, and to the extent that this may not have been 
true in some cases, smoking cessation rates in both groups would have been 
underestimated, and the marginally poorer response for intervention practices 
would have tended to reduce the apparent size of effect. This seems unlikely to 
have had more than a minimal impact on our results however.    
 
One of the potential limitations of this study was the chance differences at 
baseline between our intervention and control groups, those in intervention 
practices being on average more deprived and smoking more heavily, factors 
which predict lower cessation rates16. Adjusting for the variables measured had 
little impact on the results, but there may be residual confounding by 
unmeasured related factors, which would have tended to reduce the apparent 
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size of effect of the intervention. Nevertheless, we looked for interaction with 
socioeconomic status and cigarette consumption, and found no evidence to 
suggest a greater effect of the intervention in the less deprived or lighter 
smokers suggesting that these results are not simply due to the chance 
differences at baseline.  
 
Although self-reported smoking status ascertained by questionnaire has been 
shown to be accurate17, we were concerned that those in the intervention group 
may have been more likely to report success at quitting. Although we attempted 
to validate abstinence by collecting a saliva sample from participants who were 
abstinent by self report at 6 months and a relatively high proportion agreed to 
this in principal, it proved difficult to make face-to-face contact with many 
individuals, as is typical in this type of study166.  Control group smokers who had 
received less contact with the research team, and were also more likely to be 
working, were less likely to provide samples and, as those who did not provide 
saliva samples were assumed to be smoking, this misclassification would tend to 
increase the apparent cessation rate in the intervention compared with control. 
Nevertheless, the results were consistent for both validated and non-validated 
measures of smoking cessation, with neither showing a significant difference.  
 
Validated point abstinence from smoking at 6 months was selected rather than 
sustained abstinence over the 6 months, which might have been a better marker 
of lifetime abstinence, but point abstinence was the only feasible outcome in this 
community-based study.  The use of cigarette consumption as an indicator of 
dependence is also a limitation of this study, and would have been better 
presented as Heaviness of Smoking Index (HSI) or Fagerström.   The variables 
to calculate such values was not, however, available from the data collected. 
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Reporting bias may have contributed to the apparent increase in use of NHS stop 
smoking services in intervention compared to control groups, since those 
seeking help to quit in the intervention group were aware that we had booked 
them an appointment with the service. We do not know whether these 
individuals actually attended the appointment, since data collected by the NHS 
Stop Smoking Service is anonymised. There was an increase in service usage 
during the period of our study which would be consistent with our intervention 
being effective in increasing the number of smokers contacting the service, but 
we cannot be sure that the observed increase was due to our study.  The 
increase may have been the result of a number of other factors, such as other 
initiatives or advertisements being run at a local level or a reflection of increased 
service uptake at a national level. 
 
A high proportion (almost 22%) of those in control groups had received advice 
from any health professional, which is higher than would have been anticipated 
from data published elsewhere44, possibly reflecting a tendency for participating 
practices to have a special interest in promoting smoking cessation to patients. 
It is also possible that the control practices used the data we collected to provide 
smoking cessation advice to those who wanted it, which would have contributed 
to the null effect. However, practices were blinded to whether they were in the 
intervention or control groups, and were informed that patients in both 
treatment groups would receive intervention eventually, so that this is unlikely 
to have played a major role in our findings.   
 
4.4.4 Conclusions 
It appears that a proactive approach is successful in reaching smokers who want 
support to quit through primary care, and providing information about and 
referral to NHS SSS appears to increase smokers¶ receipt of smoking cessation 
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interventions, their propensity to start quit attempts and their chances of 
quitting, but this approach translates into at best only a modest and in this case 
non-significant increase in smoking cessation in the population.  However, there 
was evidence of a significant effect of the intervention in smokers who expressed 
an interest in receiving smoking cessation advice.      
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CHAPTER 5: UNPLANNED QUIT ATTEMPTS ± INCIDENCE, 
TRIGGERS AND USE OF SUPPORT 
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5.1 INTRODUCTION 
In the UK, smoking cessation services such as the one detailed in Chapter 4 
have been developed to provide all smokers wishing to attempt to quit smoking 
with behavioural and pharmacological support59 and are currently being used by 
more than 600,000 smokers each year6.  The use of behavioural support and 
pharmacotherapy substantially increases the likelihood of success in any attempt 
to quit smoking56 but their use in practice generally requires some degree of 
advance planning.   
 
Since there was an emerging evidence base suggesting that a large proportion of 
quit attempts appeared to be unplanned140 142, the study described in this 
chapter was designed to identify the characteristics of those who make 
unplanned attempts and the extent to which they use cessation support, to 
determine whether and how services need to adapt to meet their needs. This 
study was designed to investigate the occurrence and determinants of unplanned 
and planned quit attempts, and the sources of support used in these attempts, 
among a group of current and recent ex-smokers who reported making a quit 
attempt within the last six months. 
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5.2 METHODS 
In 2008, self-completion questionnaires (Appendix VI) were sent to 3512 
smokers and recent ex-smokers aged between 21 and 89, all of whom had been 
smokers in 2005 and, at that time, registered with 24 general practices in 
Nottinghamshire that participated in the cluster randomised controlled trial 
described in Chapter 4.  Although there was a potential risk of response fatigue 
from this group as they had already completed two questionnaires, the logistics 
of recruiting a new group of smokers in accordance with the methods previously 
described meant that this was not possible within the timeframe available.  
Questionnaires were accompanied by a standard letter (Appendix VII) explaining 
that the study was exploring attempts at quitting smoking and the factors which 
helped or hindered these.  We asked for responses from both current and ex-
smokers, and from current smokers whether or not they were currently 
attempting to quit.  Respondents were also asked whether they agreed to being 
contacted at a later date to discuss further their experiences of trying to quit 
smoking.  All were offered a £5 gift voucher for completion and return of the 
questionnaire.  A reminder letter was sent to non-responders after three weeks. 
 
The questionnaire asked about socio-demographic factors and smoking history 
and behaviour, including recent smoking cessation behaviour. The questionnaire 
DVNHG³Have you made a serious attempt to stop smoking in the last 12 months? 
By serious attempt we mean you decided that you would try to make sure you 
never smoked another cigarette.  Please include any attempt you are currently 
making´ 5HVSRQGHQWVZKRKDGPDGHDW OHDVWRQH µVHULRXV¶TXLWDWWHPSWZHUH
then asked for details about their last three quit attempts in accordance with 
:HVW¶V 6PRNLQJ 7RRONLW167 (or less depending on actual number), including: i) 
when the attempt occurred, ii) whether they planned the quit attempt, iii) factors 
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triggering  quit attempts and iv) the types of support used to help with 
cessation.  
 
5.2.1 Primary Outcomes 
Primary outcomes were proportion of attempts to quit smoking that were 
planned or unplanned, the most common triggers for planned and unplanned 
quit attempts and the common sources of support used in planned and the most  
unplanned quit attempts. 
 
5.2.2 Proportion of planned and unplanned quit attempts 
7KH IROORZLQJ TXHVWLRQ WDNHQ IURP :HVW¶V 6PRNLQJ 7RRONLW167) was used to 
FKDUDFWHULVH HDFK TXLW DWWHPSW DV SODQQHG RU XQSODQQHG ³Which of these 
statements best describes how your attempt to stop smoking started´
Respondents were given the following options: 
x I did not plan the quit attempt in advance; I just did it 
x I planned the quit attempt for later the same day 
x I planned the quit attempt the day beforehand 
x I planned the quit attempt a few days beforehand 
x I planned the quit attempt more than a week beforehand  
 
The most recent quit attempt was defined as unplanned if respondents selected 
WKHRSWLRQ³,GLGQRWSODQWKHTXLWDWWHPSWLQDGYDQFH,MXVWGLGLW´.  Any other 
response was considered to be a planned attempt, in line with previous 
research142 to allow comparability between studies.   
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5.2.3 Triggers for quit attempts 
Respondents were asked to select as many responses that applied to factors 
which had triggered their quit attempt from the list below: 
 
x Advice from a GP/health professional 
x TV advert for an NRT product 
x Government radio/tv/press advert 
x Hearing about a new stop smoking product 
x A decision that smoking was too expensive 
x Being faced with restrictions as a result of the smoking ban 
x I knew someone else that was stopping smoking 
x Seeing a health warning on a cigarette packet 
x Being contacted by my local NHS SSS 
x Health problems I had at the time 
x Preventing passive smoking to family/friends 
x Pressure from family/friends 
x Health problems from a family member/friend 
x Pregnancy  
x Something else (please state) 
x Nothing in particular 
x Cannot remember 
 
5.2.4 Support used in quit attempts 
Respondents were as asked to select as many responses that applied to support 
used in their quit attempt from the list below: 
 
x Nicotine replacement product (e.g. patches/gum/inhaler) without a 
prescription 
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x Nicotine replacement product on prescription or given to you by a health 
professional 
x Zyban (bupropion) 
x Champix (Varenicline) 
x Attended an NHS Stop Smoking Service group 
x Attended an NHS Stop Smoking Service one to one counselling session 
x Smoking helplines such as NHS smoking helpline or Quitline etc 
x Something else (please write in) 
x None of these 
x Cannot remember 
 
5.2.5 Data analysis 
Questionnaire data were entered into SPSS Version 16.  Townsend scores based 
RQ SDWLHQWVµ SRVWFRGHV ZHUH FDOFXODWHG IURP WKH  FHQVXV155 and were 
categorised into quintiles for analysis as previously described.  To minimise recall 
bias, whilst also ensuring sufficient numbers for analysis, only those recent quit 
attempts which were made in the last six months were analysed. In this group, 
those who reported making planned and unplanned attempts were compared in 
terms of age, sex, Townsend score, cigarette consumption reported at baseline 
(Chapter 3), triggers for the quit attempt and sources of support used using 
crosstabulation and chi-squared tests for univariate and logistic regression for 
multivariate analysis.  To explore the appropriateness of using only data on 
attempts reported within the previous six months, an identical analysis was 
conducted for data on quit attempts recalled within the previous three and 12 
months and compared findings with those using six months recall data.  The 
Leicestershire, Northamptonshire & Rutland Research Ethics Committee 
approved this study. 
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5.3 RESULTS 
5.3.1 Response to questionnaire 
1805 completed questionnaires were returned (51.4%).  A further 19 were 
returned as µDGGUHVVHH GHFHDVHG¶ DQG  UHWXUQHG DV QR ORQJHU DW WKH
registered address.  Those who responded to the questionnaire were slightly less 
likely to be male but were otherwise similar to those who did not respond (Table 
13). 
 
Table 13: Socio-demographic characteristics of those individuals sent and 
responding to the questionnaire 
 Questionnaires 
sent (n=3512) 
Respondents 
(n=1805) 
Made quit attempt in 
last 6 months 
(n=394) 
% male 51.4 45.7 50.9 
Median age (IQR) 47 (36 - 58) 51 (40.75 - 61) 52 (40.5 - 62) 
Median Townsend score 
(IQR) 
1.33 (-1.30 ± 4.62) 1.32 (-1.45 ± 4.54) 1.29 (-1.34 ± 4.34) 
Cigarette consumption    
>10 35.8% 36.8% 32.5% 
11-20 41.5% 40.7% 43.9% 
21-30 14.6% 13.8% 17.5% 
31+ 4.3% 4.3% 5.3% 
Missing  3.8% 4.5% 0.8% 
 
Of respondents, 327 (18.1%) had been abstinent from smoking for more than 
12 months and 639 (35.4%) had made a serious quit attempt in the last year.  
Of these 639 people, 394 had made their most recent quit attempt in the last six 
months. The characteristics of this group are shown in Table 13, and did not 
differ substantially from those of all respondents. At the time of the survey, 
26.1% (n=103) of this group reported that they were abstinent from smoking, 
and 36.6% of current smokers at the time of completing the questionnaire 
reported having made a quit attempt in the last year.  
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5.3.2 Quit attempts made in the last six months 
Of the 394 quit attempts made in the last six months, 147 (37%) were 
unplanned.  Fifteen individuals did not answer the question relating to planning 
their quit attempt, and were excluded from further analyses.  Females were 
significantly less likely to make unplanned quit attempts than males (adjusted 
OR 0.63, 95% CI 0.41-0.97) (Table 14).  There were less marked effects of 
other socio-demographic characteristics. Recent quit attempts made by smokers 
in the oldest age category were more likely to be unplanned that those in other 
categories (50.9% of recent attempts in those aged over 64 being made with no 
pre-planning), though there was no statistically significant trend with increasing 
age.   
 
Unplanned quit attempts were least common in quintile 1 of Townsend score 
(least disadvantaged) (30.3%) and highest in quintile 4 (48.7%), but there was 
no significant trend across quintiles of deprivation.  Although unplanned quit 
attempts were reported more frequently by heavier smokers, this finding was 
not statistically significant.  A similar pattern was seen if recent quit attempts in 
the last three or 12 months were analysed, though the tendency for unplanned 
attempts to be lowest in the least deprived and highest in 4th quartile of 
Townsend score was more apparent for attempts made more recently (Table 15 
and Table 16 respectively).  
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Table 14: Characteristics of those making quit attempts in the last 6 months 
 
 
*Adjusted for gender, age, Townsend index and cigarette consumption 
**Townsend scores and cigarette consumption information for 3 individuals were 
not available, and included as a separate missing value category for analysis.  
 Total      
n   
UNPLANNED ADJUSTED OR 
(95% CI) 
P 
VALUE 
  N %   
GENDER      
MALE 172 77 44.8 1 0.03 
FEMALE 207 70 33.8 0.63 (0.41 ± 0.97)  
AGE      
<38 80 29 36.2 1 0.27 
39-48 92 36 39.1 1.04 (0.54 ± 1.99)  
49-57 74 29 39.2 1.09 (0.55 ± 2.17)  
58-64 76 24 31.6 0.81 (0.40 ± 1.61)  
>64 57 29 50.9 1.85 (0.90 ± 3.78)  
TOWNSEND      
<= -1.808 (least deprived) 76 23 30.3 1 0.28 
-1.808 ± 0.164 68 27 39.7 1.63 (0.80 ± 3.32)  
0.164 ± 2.542 77 30 39 1.45 (0.73 ± 2.89)  
2.542 ± 4.900 76 37 48.7 2.17 (1.09 ± 4.32)  
4.900+ (most deprived) 79 30 38 1.39 (0.70 ± 2.75)  
CIGS SMOKED      
0-10 124 50 40.3 1 0.84 
11-20 168 59 35.1 0.82 (0.50 ± 1.35)  
21-30 64 26 40.6 1.02 (0.54 ± 1.94)  
31+ 20 9 45 1.02 (0.37 ± 2.82)  
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Table 15: Characteristics of those making quit attempts in the last 3 months 
 
 
*Adjusted for gender, age, Townsend index and cigarette consumption 
**Townsend scores and cigarette consumption information for 2 and 3 
individuals respectively were not available, and included as a separate missing 
value category for analysis.  
 Total      
n   
UNPLANNED ADJUSTED OR 
(95% CI) 
P 
VALUE 
  N %   
GENDER      
MALE 118 55 46.6 1 0.10 
FEMALE 151 53 35.1 0.64 (0.38 ± 1.08)  
AGE      
<38 57 20 35.1 1 0.11 
39-48 64 24 37.5 0.94 (0.43 ± 2.06)  
49-57 55 23 41.8 1.22 (0.54 ± 2.74)  
58-64 48 16 33.3 0.96 (0.41 ± 2.22)  
>64 45 25 55.6 2.60 (1.12 ± 6.03)  
TOWNSEND      
<= -1.808 (least deprived) 53 16 30.2 1 0.22 
-1.808 ± 0.164 47 19 40.4 1.66 (0.70 -3.93)  
0.164 ± 2.542 59 24 40.7 1.56 (0.69 ± 3.52)  
2.542 ± 4.900 51 27 52.9 2.78 (1.19 ± 6.51)  
4.900+ (least deprived) 57 22 38.6 1.45 (0.64 ± 3.31)  
CIGS SMOKED      
0-10 87 34 39.1 1 0.58 
11-20 123 45 36.6 1.00 (0.55 ± 1.81)  
21-30 41 17 41.5 1.24 (0.56 ± 2.75)  
31+ 15 9 60.0 2.18 (0.65 ± 7.30)  
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Table 16: Characteristics of those making quit attempts in the last 12 months 
 
 
*Adjusted for gender, age, Townsend index and cigarette consumption 
**Townsend scores and cigarette consumption information for 5 individuals were 
not available, and included as a separate missing value category for analysis. 
 
 Total      
n   
UNPLANNED ADJUSTED OR 
(95% CI) 
P 
VALUE 
  N %   
GENDER      
MALE 281 130 46.3 1 <0.01 
FEMALE 321 108 33.6 0.60 (0.42 ± 0.84)  
AGE      
<38 137 52 38.0 1 0.50 
39-48 140 54 38.6 0.96 (0.58 ± 1.58)  
49-57 112 38 33.9 0.79 (0.46 ± 1.36)  
58-64 115 48 41.7 1.05 (0.62 ± 1.78)  
>64 98 46 46.9 1.35 (0.78 ± 2.33)  
TOWNSEND      
<= -1.808 (least deprived) 114 44 38.6 1 0.69 
-1.808 ± 0.164 119 46 38.7 1.15 (0.67 ± 1.99)  
0.164 ± 2.542 118 44 37.3 0.98 (0.57 ± 1.70)  
2.542 ± 4.900 118 53 44.9 1.41 (0.82 ± 2.43)  
4.900+ (most deprived) 128 51 39.8 1.11 (0.65 ± 1.89)  
CIGS SMOKED      
0-10 197 89 45.2 1 0.12 
11-20 276 93 33.7 0.63 (0.43 - 0.92)  
21-30 98 40 40.8 0.82 (0.49 ± 1.36)  
31+ 26 11 42.3 0.87 (0.37 ± 2.07)  
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5.3.3 Triggers for quit attempts 
Respondents indicated which one or more of a prompted list of possible triggers 
had led to their recent quit attempt. In unplanned quit attempts, the most 
commoQWULJJHUUHSRUWHGZDV³advice from a GP/health professional´RFFXUULQJ
LQRIDOOXQSODQQHGUHFHQWTXLWDWWHPSWVIROORZHGE\³health problems I 
had at the time´³a decision that smoking was too expensive´
³nothing in particular´  DQG ³pressure from family/friends                       
(Figure 3).  A similar pattern was evident for unplanned quit attempts made 
within the last three months and 12 months (Figure 4 and Figure 5 respectively), 
although the proportion reporting receiving advice from a GP/health professional 
is lower in the 12 month data.  The pattern of specific triggers was somewhat 
different to that seen for planned quit attempts, in which the most common 
WULJJHU UHSRUWHG ZDV ³a decision that smoking was too expensive´ 
IROORZHG E\ ³KHDOWK SUREOHPV , KDG DW WKH WLPH´  ³advice from a 
GP/health professional´  ³pressure from family/friends´  DQG
³preventing passive smoking to family/friends´  (Figure 6).  Again, a 
similar pattern was evident for planned quit attempts made within the last three 
months and 12 months (Figure 7 and Figure 8 respectively).  Over twice as 
PDQ\ UHVSRQGHQWV LQGLFDWHG WKDW ³nothing in particular´ WULJJHUHG WKHLU TXLW
attempt in the 6 month unplanned group as compared to the planned group 
(17% and 8.2% respectively).  Differences in triggers for planned and unplanned 
quit attempts were only significantly in the factors of ³a decision that smoking 
was too expensive´(ȱ2 = 7.88, p=<0.01) and ³QRWKLQJLQSDUWLFXODU´ (ȱ2 = 6.82, 
p=0.01). 
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Figure 3: Triggers for unplanned quit attempts made within the last six months   
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Figure 4: Triggers for unplanned quit attempts made within the last three months 
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Figure 5: Triggers for unplanned quit attempts made within the last 12 months 
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Figure 6: Triggers for planned quit attempts made within the last six months 
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Figure 7: Triggers for planned quit attempts made within the last three months 
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Figure 8: Triggers for planned quit attempts made within the last 12 months
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5.3.4 Sources of support for quit attempts 
Respondents indicated which one or more of a prompted list of possible sources 
of support they had used on their most recent quit attempt.  Most reported that 
unplanned quit attempts were made without the use of any support (51.7%).  
The most common source of support reported to be used in unplanned quit 
attempts was NRT obtained without prescription (25.9%), followed by NRT 
obtained on prescription (16.3%), use of an NHS SSS one to one counselling 
VHVVLRQ µVRPHWKLQJHOVH¶DQGXVH of an NHS SSS group (4.1%) 
(Figure 9).  A similar pattern was evident for unplanned quit attempts made 
within the last 3 months and 12 months (Figure 10 and Figure 11 respectively).  
In contrast, amongst those reporting planned quit attempts, only 25.9% were 
reported to be unsupported. Planned quit attempts were supported by NRT 
obtained without prescription (38.4%), NRT obtained on prescription (19.8%), 
use of an NHS stop smoking service 1-1 (12.5%) and an NHS stop smoking 
service group (9.1%) (Figure 12).  Again, a similar pattern was evident for 
planned quit attempts made within the last three months and 12 months  
(Figure 13 and Figure 14 respectively).
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Figure 9: Sources of support used in unplanned quit attempts made within the last six months 
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Figure 10: Sources of support used in unplanned quit attempts made within the last three months 
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Figure 11: Sources of support used in unplanned quit attempts made within the last 12 months 
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Figure 12: Sources of support used in planned quit attempts made within the last six months 
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Figure 13: Sources of support used in planned quit attempts made within the last three months 
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Figure 14: Sources of support used in planned quit attempts made within the last 12 months 
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5.3.5 Success of quit attempts made within the last six months 
Of all respondents who reported making quit attempts in the previous six 
months, 34% of those who had not planned these reported still being abstinent 
at the time of responding to the questionnaire,  compared to 22.4% of those 
who reported planning their quit attempt.  The higher reported abstinence in 
those who did not plan their quit attempts was independent of gender, age, 
Townsend score and cigarette consumption (adjusted OR 2.01, 95% CI 1.23 to 
3.27 p<0.01). There was little difference in the success of planned and 
unplanned quit attempts according to how long ago the attempt had been made 
(Table 17). The association between absence of planning and successful 
abstinence was most marked among those whose most recent quit attempt was 
made three to six months ago. 
 
Table 17: Current abstinence in those making a planned or unplanned quit 
attempt in the last 6 months, overall, and stratified by how long ago the attempt 
was made.  
 Total  Currently abstinent Adjusted OR (95% 
CI) 
 N %  
Quit attempt in 
the last 6 months 
Planned 232 52 22 1 
Unplanned 147 50 34 2.01 (1.23 to 3.27) 
How long ago quit 
attempt was made 
     
Up to 1 month 
Planned 66 15 22.7 1 
Unplanned 41 11 26.8 1.37 (0.49 to 3.84) 
1-3 months 
Planned 95 19 20 1 
Unplanned 67 18 26.9 1.46 (0.64 to 3.31) 
3-6 months 
Planned 71 18 25.4 1 
Unplanned 39 21 53.8 4.63 (1.80 to 11.94) 
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5.4 DISCUSSION 
5.4.1 Main findings 
This study demonstrates that smokers who make unplanned attempts to stop 
smoking make less use of evidence-based cessation support than those who do 
plan, that the main trigger for the unplanned quit attempt is advice from a 
doctor or health professional, and that unplanned attempts appear more likely to 
succeed than those that are planned. Unplanned attempts were more common 
among men but were not significantly related to socioeconomic status or amount 
smoked.   
 
5.4.2 Strengths and limitations 
This is the first study to investigate the triggers for and use of support in 
unplanned attempts to quit smoking. 
 
This study has several limitations.  As smokers are recalling events which may 
have been made up to six months previously, there is the possibility that recall 
bias may be playing a role in the reports of planning, support and triggers for 
their quit attempts.  A study by Gilpin and Pierce168 found that recall of quit 
attempts deteriorates over time with participants often forgetting the occurrence 
of attempts of a short duration. The authors concluded that recall of quit 
attempts lasting less than one week is probably reliable up to three to four 
months before an interview but not beyond this point.  This suggestion was later 
supported by Shiffman and colleagues169, who reported that participants in a 
study comparing real time versus retrospective smoking lapses were unable to 
accurately recall details of a potentially meaningful event after a period of a few 
months.  Since it is possible that our study findings are distorted by biased recall 
of events associated with quit attempts which may have been made up to six 
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months previously, we repeated our analyses including quit attempts made 
within the last three or 12 months and found that the key findings remained the 
same, with the exception of the proportion of unplanned quit attempts reportedly 
being triggered by advice from a GP/health professional. 
 
It is clear that there is a likelihood that quit attempts which reported the use of 
prescription medications or behavioural support required some element of 
planning, even though respondents reported that their quit attempt was 
unplanned.  This is a limitation of the current study as the categorisation of 
planned or unplanned relies on self-report but raises an interesting question for 
future research as to what respondents mean when they define a quit attempt as 
µXQSODQQHG¶7KHXVHRIFLJDUHWWHFRQVXPSWLRQGDWDIURPLVDOLPLWDWLRQRI
the current study as consumption patterns may have changed in the following 
time period.  This was the only means by which a comparison between all 
respondents could be made, however, as more recent cigarette consumption 
data was not available for those who had successfully quit smoking in 2008. 
   
Despite the large initial sample size, only 394 smokers reported making a quit 
attempt in the last six months so it is possible that we failed to detect an effect 
of individual socio-demographic characteristics on making unplanned quit 
attempts as a result of the relatively small sample size.  The participants in our 
study were originally part of a randomised intervention trial of a pro-active 
approach to provide smoking cessation support, but this is unlikely to have 
affected our findings since the intervention was completed in all practices prior 
to data collection for this study.   
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5.4.3 Comparison with previous research 
The finding that 36.6% of current smokers reported having made a quit attempt 
in the last year is comparable with national data44.  The proportion of quit 
attempts reported to be unplanned in our study population is lower than 
reported previously140 142, but consistent in finding higher reported success rates 
than in planned attempts. Although we attempted to determine whether 
unplanned attempts were more common among disadvantaged smokers, or 
those with lower levels of smoking, we found only that unplanned attempts were 
significantly more likely in men. This observation has not been previously 
reported, but may reflect differences in the way in which men and women go 
about quitting smoking170, and complements the observation that women are 
more likely than men to use NHS stop smoking services in England6.  Although 
limited research exists as to the degree to which men and women plan behaviour 
change, one study indicated that women have a greater potential for planning171  
but this finding was not replicated in a later study170.  Additionally, a number of 
psychological and social factors have been identified which may affect smoking 
cessation in females, including a fear of weight gain, a need for social support 
and self-efficacy about quitting172.  It is possible that these factors may lend 
themselves to more females planning their quit attempt to accommodate and 
attempt to overcome these issues.    Our finding that unplanned quit attempts 
ZHUH PRUH OLNHO\ LQ WKH RYHU V ZDV FRQVLVWHQW ZLWK  :HVW DQG 6RKDOV¶
observation among older smokers142. Although research suggests that the least 
dependent smokers are the most likely to quit successfully34, the results from 
this study do not indicate that lighter smokers are any more likely to make 
unplanned quit attempts than heavier smokers.  
 
Collectively the three most common triggers and sources of support were the 
same for planned and unplanned quit attempts but the most common trigger, 
and source of support used, differed between planned and unplanned quit 
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attempts. As may be expected, advice from a GP or health professional was a 
key trigger for both planned and unplanned quit attempts and supports the 
guidelines recommending that health professionals provide brief opportunistic 
advice to smokers during routine consultations whether or not they are seeking 
help to stop56.  Previous research has indicated that a large proportion of 
smokers are interested in receiving smoking cessation advice and support if it is 
offered to them162, and the fact that this was the most common trigger in 
unplanned quit attempts suggests that such advice may potentially initiate a quit 
attempt in individuals who were not necessarily planning on trying to quit above 
any other factor.  A decision that smoking was too expensive was the primary 
trigger for planned quit attempts and was a factor in nearly twice as many 
planned than unplanned attempts.  It perhaps is to be expected that an 
increasing cost of smoking is likely to lead to smokers thinking about and 
planning to make a quit attempt.  Health problems of respondents were the 
second most common trigger for both planned and unplanned quit attempts, 
which is in line with previous research reporting that health is a major motivation 
for wanting to quit173.  Of interest LV WKH ILQGLQJ WKDW µQRWKLQJ LQ SDUWLFXODU¶
WULJJHUHGWKHTXLWDWWHPSWIRUPRUHWKDQWZLFHDVPDQ\RIWKRVHZKRGLGQ¶WSODQ
as those who did.  This may support the suggestion of West and Sohal, that an 
alternative model to the stages of change approach baVHG RQ ³FDWDVWURSKH
WKHRU\´143 may be applicable to smoking cessation142.  This model proposes that 
beliefs, past experiences and the current situation create varying levels of 
motivational tension which can lead to an attempt to quit smoking with small 
triggers and it is possible that such small triggers have been forgotten by 
respondents to this survey.   
 
We found that over half of all unplanned quit attempts were made without any 
form of support, twice as many as those which had been planned.  Given the 
evidence from randomised studies that support increases the success rate of quit 
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attempts by up to four fold56, that this is a missed opportunity even though 
unplanned quit attempts appear to have a greater likelihood of success. It is also 
noteworthy that over a quarter of those who made planned attempts did not use 
any support. The most common form of support used by both groups was NRT 
obtained without prescription, which indicates that the majority of smokers are 
not making use of NHS services and support available to help them to quit 
despite considerable government investment in these services.  It is possible 
that this finding reflects a lack of awareness of NHS support available to help 
smokers to quit, and if this is the case then further emphasis needs to be placed 
on publicising and promoting these services to smokers. Two studies 
investigating reasons why smokers may not access stop smoking services have 
suggested that barriers may include factors such as fear of being judged, fear of 
failure and lack of knowledge, particularly in the case of smokers from lower 
socio-economic groups109 110. It is also possible that other factors influenced the 
low reported use of prescription medications, such as a difficulty in obtaining an 
appointment with a GP to gain a prescription or the expense of prescription 
charges and these factors cannot be ruled out as explanations for our findings.  
However, our study provides further evidence that the prevailing model of 
smoking cessation services offered by health systems may not apply for a large 
propoUWLRQRIVPRNHUV¶TXLWDWWHPSWV)RUH[DPSOH1+6 SSS advise individuals 
to set a quit date and plan ahead.  On the assumption that the success rate of 
spontaneous quit attempts could be increased still further if supported by 
behavioural and pharmacological interventions, our findings suggest that these 
services need to be more flexible and adaptable to smokers who make 
unplanned quit attempts.  
 
A number of studies have been conducted looking at ways access to stop 
smoking services could be improved, and many of these findings may be 
applicable to those smokers who make unplanned attempts to quit smoking.  
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These include providing drop in sessions so that smokers do not have to book in 
advance118 119 and providing pharmacy based support that may be more 
immediately accessible to his group of potential quitters111 113 174  Also, as doctors 
and health professionals can themselves trigger such unplanned quit attempts, 
systems should be in place to offer immediate support and/or referral to services 
when these are made.  Few quit attempts involved the use of support from 
helplines and since these could be an immediate avenue of support and advice 
for those smokers making unplanned quit attempts, investigating why helplines 
are not used more frequently in such quit attempts could be useful.  If lack of 
awareness about helplines explained their under-use, then raising awareness 
about their availability should, possibly, be a priority in tobacco control strategy. 
Similar issues may explain why few quitters reported use of internet-based 
cessation-support systems, though this could also have occurred because 
respondents had to record use of these as an open, free-text response and there 
was no dedicated category to record use of internet support on the study 
questionnaire.    
 
5.4.4 Conclusions 
It is clear that unplanned quit attempts are common amongst all socio-
demographic groups and the majority of unplanned attempts are unsupported.  
It is widely accepted that a quit attempt which uses evidence-based cessation 
support is more likely to be successful, so it is important to find ways of offering 
DQG SURYLGLQJ VXFK VXSSRUW WR VPRNHUV ZKR GRQ¶W SODQ FHVVDWLRQ DWWHPSWV LQ
advance.  Further research is needed in order to determine the best ways of 
doing this but our findings suggest that, as health professionals trigger many 
unplanned quit attempts, specific advice of how to obtain cessation support 
should be mandatory whenever a smoker who is receptive to the notion of 
attempting cessation, but has made no plans for this, is encountered.   
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CHAPTER 6: A QUALITATIVE EXPLORATION OF THE USE OF 
AND ATTITUDES TOWARDS SUPPORT IN A GROUP OF 
SMOKERS AND EX-SMOKERS 
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6.1 INTRODUCTION 
Recent evidence from Canada140, the UK142 and the US141 indicates that a 
substantial proportion of quit attempts are made without pre-planning, and this 
finding was replicated in chapter 5.  Survey data reveal that smokers making 
unplanned quit attempts are less likely to use any form of evidence-based 
support to help them to stop141 175 but there has been no detailed exploration of 
how this group engage in quit attempts, why they may or may not choose to use 
support and their attitudes to the support currently available.   Gaining a greater 
insight into these factors may result in the discovery of better ways to support 
those who make unplanned quit attempts, which ultimately could lead to higher 
numbers of these smokers using evidence-based cessation support, potentially 
increasing their likelihood of achieving abstinence. Consequently, this study was 
designed to learn more about and gain a greater understanding of unplanned 
attempts to quit smoking.  
 
6.2 METHODS 
6.2.1 Study design and participants 
This was a qualitative study using semi-structured interviews.  The study was 
approved by the Leicestershire, Northamptonshire and Rutland ethics committee.    
Potential interviewees were selected from smokers who had participated in a 
Nottingham general practice-based, cluster-randomised controlled trial (as 
described in Chapter 2), with all reporting themselves to be smokers at the end 
of this study in 2006.  Potential interviewees responded to a questionnaire, sent 
in 2008, asking them about their smoking status and quitting behaviour, and 
whether they would be willing to discuss their quit attempts (as described in 
Chapter 5).  We were interested to interview a selection of those who reported 
that their most recent quit attempt had been unplanned.  In order to determine 
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whether a quit attempt was unplanned, we used the following question taken 
from the Smoking Toolkit Survey167³Which of these statements best describes 
KRZ\RXUDWWHPSWWRVWRSVPRNLQJVWDUWHG"´.  Potential responses were: 
 I did not plan the quit attempt in advance; I just did it 
 I planned the quit attempt for later the same day 
 I planned the quit attempt the day beforehand 
 I planned the quit attempt a few days beforehand 
 I planned the quit attempt more than a week beforehand  
Unplanned quit attempts were considered to be those for which the first option 
above was chosen ³, GLGQRWSODQ WKHTXLW DWWHPSW LQDGYDQFH , MXVWGLG LW´
Any other response was considered to be a planned attempt.  Where 
respondents agreed to discuss their quit attempt, purposive sampling was used 
to identify  interviewees with varied ages, gender, socio-economic status and 
smoking status, and these people were invited for interview (socio-demographic 
data was collected at the time of completing the questionnaire).  Of 297 
individuals who gave consent to be contacted to discuss their experiences of 
quitting smoking, 180 smokers and ex-smokers were selected and sent a letter 
over a three month period inviting them to participate in an interview (Appendix 
VIII) and an accompanying information sheet providing further details on the 
study (Appendix IX) 7KH WHUP µRQH-to-one discXVVLRQ¶ZDVXVHG LQSDUWLFLSDQW
contact so as not to make potential participants feel intimidated at the thought 
of an interview. 
 
6.2.2 Primary outcomes 
The overall aim of the interviews was to gain a greater knowledge and 
understanding of the use of support, attitudes to support, reasons for success 
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and opinions on ways of better supporting smokers who make unplanned 
attempts to quit smoking. 
 
6.2.3 Interviews 
A semi-structured interview was used as it allowed the interviewer to ensure that 
essential topics were covered and to ensure continuity between interviews176.  A 
semi-structured interview guide (Appendix X) was developed from responses to 
the questionnaire detailed in Chapter 5 and previous literature on quitting 
smoking, with careful reference to that dealing with unplanned/spontaneous 
cessation.  7KHJXLGHFRYHUHGLQWHUYLHZHHV¶YLHZVRQWKHIROORZLQJWRSLFV 
 
x Background to smoking behaviour 
x Experiences of the quit attempt 
x Support used 
x Attitudes to support available 
x Factors contributing to ease of quitting 
x Ways in which attempts may be better supported 
 
One idea that the interviewer specifically sought to explore with interviewees 
was the potential for a new way of providing a comprehensive package of 
pharmacological, behavioural and self-help support options and information to 
smokers who may try to quit, which for the purposes of the interview was 
referred to as a µTXLW SDFN¶.  Such a resource is not currently available to 
smokers but may present a feasible means of giving smokers the opportunity to 
make an informed decision about the use of support.  When asking interviewees 
their views on how they could have been better supported in quit attempts and 
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after they had finished stating their spontaneous thoughts on this topic, the 
interviewer specifically sought their views on the provision of such a resource. 
 
Written informed consent to take part in the study was obtained from all 
participants who were informed that the interviews were confidential and that 
they could withdraw from the study at any point without penalty.  Interviews 
were conducted in a quiet room at Nottingham City Hospital by the lead 
researcher (RM), either face to face or by telephone where this was not possible.  
Interviews lasted for approximately 30 minutes and were tape recorded for 
transcription.   
 
6.2.4 Data analysis 
Interviews were transcribed verbatim during the course of the interview process.  
The completeness of transcripts was checked and any missing data were 
checked against the original audio file and the transcripts amended where 
possible.  The interviewer familiarised herself with the raw data by listening to 
interview tapes and reading transcripts in an iterative process to identify themes 
and subthemes and then indexed the data accordingly.  Subsequent data 
analysis strategies are illustrated in Box 1.  To facilitate a systematic inspection 
of text coded under each category, all transcripts were coded using the 
definitions agreed during early analysis (Appendix XI) and imported into NVivo 8, 
a qualitative data analysis package (QSR International Ltd, Melbourne, 
Australia).  After coding all data, text relating to themes and categories relating 
to the study aims were collated and findings summarised.  To assist 
interpretation of data, text relating to several issues of potential importance 
ZHUH µFKDUWHG¶ DV SHU WKH )UDPHZRUN DSSURDFK177, to enable relationships 
between views held and interviewees with different characteristics to be 
explored. In line with the aims of this research, specific factors charted were 
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triggers, the nature of the quit attempt, self-reported nicotine dependence, the 
use of support, attitudes to support available, perceived reasons for success of 
quit attempts and ways of better supporting smokers who try and quit (Appendix 
XII).  Trustworthiness was established through constant comparison.  Findings 
are illustrated with appropriate, anonymised quotations in the subsequent results 
section, with identification by gender, success or failure of quit attempt and the 
nature of any  
support used.
 
Box 1: Data analysis strategies 
 
 
 
 
 
 
 
 
 
 
 
A sub-sample of five transcripts were randomly selected and repetitively read by 
RM to identify the most important themes and categories arising from the 
interviews.  Concepts and themes for this analysis were based on concepts 
emerging from the data with minimal imposition from RM.  RM met with TC, SL 
and AM to discuss emergent themes, develop provisional definitions of these 
themes and identify areas for charting.  RM then developed a coding framework 
and returned to the transcripts to develop definitions of each theme and 
category. 
 
RM read the remaining transcripts to further develop sub-themes and categories, 
then met with TC, SL and AM to finalise definitions of themes and categories.  All 
data relevant to each category were identified and coded by RM using constant 
comparison.  RM completed a draft of the major findings, which was shared with 
TC, SL and AM.  Areas of interest for charting were identified to allow the 
relationship between views held and interviewee characteristics to be compared.  
RM charted the data for further analysis and met with TC, AL and AM to discuss 
findings.  RM then completed a second draft of the major findings, which was 
read by TC, AL and AM.  Each transcript was then read by TC, SL or AM to 
increase reliability of observations. 
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6.3 RESULTS 
6.3.1 Response and characteristics of interviewees 
Of the 180 smokers and ex-smokers contacted and invited for interview, 59 
(33%) responded and 32 (18%) agreed to participate, with 20 being interviewed 
and of these, 15 had been abstinent from smoking at the time of completing the 
questionnaire and were also abstinent at the time of interview.  55% of 
interviews were conducted face to face, 45% over the telephone.  Of 
interviewees, 55% were male, the median age was 46.5 years (range 27-67 
years) and median Townsend score 1.41, indicating a slightly greater level of 
material deprivation than average (IQR=7.49). 
 
6.3.2 Triggers for quit attempts 
A number of factors were reported as being important in triggering quit 
attempts.  Commonly reported triggers included health concerns for themselves 
or a family member, a change in home or work situations, the introduction of 
smoke free legislation and knowing someone else who had quit.  Less commonly 
UHSRUWHG WULJJHUV LQFOXGHG VRPH GHJUHH RI µDYHUVLYH VPRNLQJ¶ where smokers 
KDG VPRNHG VR PXFK WKH\ GLGQ¶W ZDQW WR VPRNH DQ\ PRUH, financial 
considerations, a lack of enjoyment of smoking, pregnancy, 
advertisements/seeing NHS stop smoking services and running out of cigarettes. 
 
I think you certainly appreciate your health much more as you get older, 
and obviously you hear far more stories about people with problems like 
cancer, lung cancer, emphysema, and I was hearing more stories about 
that about people around my age group, so I thought  it really is time to 
let go now, and I think that played quite a bit part of it to be honest. 
Female, 59, successful, unsupported, spontaneous 
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I had a heart attack in February that prompted me to try again 
Male, 38, unsuccessful, supported, delayed 
 
 
I think I just sort of woke up, and it was the beginning of the 6 weeks 
KROLGD\ DQG , GLGQ¶W XVHG WR VPRNH PXFK LQ WKH KROLGD\V DQ\ZD\
becDXVH , SUREDEO\ ZDVQ¶W VR VWUHVVHGDQG , WKLQN , MXVW GHFLGHG
SUREDEO\ DERXW WKH ILUVW RU VHFRQG GD\ RI WKH KROLGD\V , WKRXJKW µZHOO
WKHUH¶V QR SRLQW LQ WKLQNLQJ ,¶OO KDYH D EUHDN DQG VWDUW DJDLQ EHFDXVH ,
ZRQ¶WEHJRLQJEDFNWRWKDWMRE¶HYHQWKRXJh I was going back to work at 
WKHHQGRIWKHZHHNVKROLGD\VRGLGQ¶W,MXVWVWRSSHG 
 
Female, 59, successful, unsupported, spontaneous 
 
 
 
7KHUHZDVWKHVPRNLQJEDQDQG,WKRXJKWZKDW¶VWKHSRLQWRIJRLQJRXW
DQG\RXFDQ¶WKDYHDFLJ\RXFDQ¶WJRLQrestaurants and have a cig, so I 
thought, pack it in. 
 
Female, 41, successful, supported, delayed 
 
 
I think what did influence me as well, my ex-husband, he packed in, and 
I thought, if he can do it, and my other friend, she packed in, I think just 
before ,GLGDIHZPRQWKVVKH¶GEHHQSDFNHGLQDQG,WKRXJKWLI&ODUH
FDQGRLWDQGVKH¶V\RXQJHU,WKLQNVKH¶VDERXW\HDUV\RXQJHUWKDQ
PHWKHQ,WKRXJKWLIWKH\FDQGRLWWKHQ,¶PJRLQJWRGRLW 
 
Female, 60, successful, supported, delayed 
 
6.3.3 The nature of quit attempts: spontaneous vs delayed 
Although all interviewees had reported that their quit attempt had been 
unplanned, there was a great deal of heterogeneity in what this meant in 
practice. One notable difference was that the amount of time which passed 
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between making the decision to quit and putting the decision into action varied 
between individuals.  There were two distinct groups of interviewees who 
reported unplanned quit attempts who could be categorised by the amount of 
delay made; µVSRQWDQHRXV¶LHWKRVHZKRGHFLGHGWRTXLWDQGGLGVRLPPHGLDWHO\
DQG µGHOD\HG¶ LH WKRVH ZKR GLGQ¶W VWRS LPPHGLDWHO\ after deciding to quit.  
7KRVH LQ WKH VSRQWDQHRXV JURXS RIWHQ UHSRUWHG VWRSSLQJ µILUVW WKLQJ LQ WKH
PRUQLQJ¶ RQ WKH GD\ WKDW WKH\ KDG PDGe their decision whereas the delayed 
group would often postpone initiating the attempt for up to a few days. One 
apparent difference between these two groups was the self-reported level of 
nicotine dependence of the interviewee whilst they were a smoker.  All 
interviewees who reported that they were less or non-dependent on smoking 
had made a spontaneous quit attempt whereas more of those who were 
dependent on smoking delayed initiating their attempt after having made their 
decision to quit.  A number of interviewees reported having cut down in the time 
leading up to the initiation of their quit attempt suggesting that the quit attempt 
when it happened was the end point of a long process, but this did not appear to 
differ between spontaneous and delayed attempts. 
 
I ZHQW WR VRPHERG\¶V ELUWKGD\ GR LQ -DQXDU\ DQG ZRNH XS ZLWK D
KDQJRYHUWKHQH[WGD\DQG,MXVWGLGQRWIDQF\DFLJRQHELWDQG,GRQ¶W
NQRZZKDWLWZDV,MXVWKDGWKLVIHHOLQJWKDWFDPHRYHUPHWKDWVDLG,¶P
never going to have one again 
Male, 41, successful, supported, spontaneous 
 
,WZDVRQHDIWHUQRRQDWZRUN , WKRXJKW µGR\RXNQRZZKDW , FDQ¶WEH
GRLQJZLWKWKLVDQ\PRUH,¶PJHWWLQJUHDOO\IHGXSZLWKLW 
So when you made that decision then at that point, did you smoke after 
that, when you tKRXJKW\RXFRXOGQ¶WEHERWKHUHGZLWKLW" 
Yeah 
For about how long? 
About five days 
Female, 46, unsuccessful, supported, delayed 
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 About how long did you spend cutting down? 
Um, 1 timed myself on hours. I did every three hours or sometimes I 
went over cos I forgot others I went before cos I was absolutely dying for 
a fag you know 
Female, 43, unsuccessful, supported, delayed 
 
 
I was a bit of an erratic smoker I suppose, but mainly a social smoker if I 
went to the pub with my friends you know, go out with about 20 and 
FRPHEDFNZLWKDERXWVR,¶PWKLQNLQJRILQWKHSXEQRWWKDWI used to 
go very often you understand. 
Female, 38, successful, unsupported, spontaneous 
 
 
In the time immediately before you quit, how dependent would you say 
you were? 
Oh very, very.....oh dear, it was the hardest time of my life 
Female, 60, successful, supported, delayed 
 
6.3.4 6XSSRUW XVHG LQ µWUXH VSRQWDQHRXV¶ DQG µGHOD\HG¶ XQSODQQHG
quitters 
Charting, as per the Framework method, was used to investigate differences in 
the reported use of support between interviewees making spontaneous and 
delayed quit attempts and revealed substantial differences.  Support could be 
pharmacotherapy, behavioural support or alternative therapy.   A minority 
(3/10) of spontaneous quit attempts were made with the use of support, 
whereas in contrast, the majority (9/10) of delayed quit attempts involved some 
form of support being accessed by the smoker.  In some instances, it appeared 
that the time taken to seek support to quit may have been the reason for the 
time delay in implementing the decision to make a quit attempt.   
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,FDQ¶WUHPHPEHUWKHH[DFWWLPHVFDOHDOWKRXJKZHGLGJRWR1HZ/HDI
together at the doctors......it must have been a couple of days 
Male, 27, successful, supported, delayed 
 
Okay, so when you quit in August, can you remember did you plan it, did 
you set a date for it? 
No, I was at a party with some friends who were heavy smokers, and I 
VXGGHQO\WZLJJHGDWWKLVSDUW\WKDWWKH\ZHUHQ¶WVPRNLQJ,ZDVVR
astonished I asked them why not DQGKRZDQGWKH\VDLGWKH\¶GEHHQ
hypnotized.... I think I got in within a matter of days if I recall 
(hypnotist). 
Female, 41, successful, supported, delayed 
 
6.3.5 Reasons for not using support 
Some of the respondents indicated why they may choose not to use any support 
in their quit attempt and opinions on this were offered regardless of whether 
attempts were successful or unsuccessful, supported or unsupported and 
spontaneous or delayed.  The main reasons expressed for this decision were a 
lack of time to access support, a dislike of taking medications, a thought that 
they could do it themselves, not approaching the GP as they were perceived to 
EH WRR EXV\ 157 LV WRR H[SHQVLYH WR EX\ WKH\ GLGQ¶W ZDQW WR DWWHQG JURXS
counselling sessions and were not able to access traditional services. 
 
VXSSRVH,¶GQHHGHGVRPHWKLQJ,SUREDEO\ZRXOGQ¶WKDYHJRWLW0H
EHLQJPH,¶PEXV\DOOWKHWLPHDQGLWZRXOGKDYHEHHQHDVLHUWRMXVW
have a cigarette than go to the GP or try and get an inhalator or go to 
New LHDIZKHQ,¶YHJRWQRWLPHWRJRWRWKHWKLQJV 
Female, 59, successful, unsupported, spontaneous 
 
,GRQ¶WSDUWLFXODUO\OLNHWDONLQJSLOOVRUSRWLRQVVRQR,GLGQ¶WWDNH
anything 
Male, 58, successful, unsupported, spontaneous 
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To be honest, I knew I could get these things, and that, but it never 
bothered me, I just thought I could do it on my own. 
Male, 44, successful, unsupported, delayed 
 
 
Ok, and have you ever consulted your GP about giving up smoking, or 
New Leaf? 
No, not at all.  You just associate them with being incredibly busy people 
and the last thing you want to do is go and chat in their surgery, god 
NQRZVLWLVTXLWHGLIILFXOWWRJHWDQHPHUJHQF\DSSRLQWPHQWZKHQ\RX¶UH
G\LQJVR\RX¶UHQRWUHDOO\JRLQJWRJRDQGYLVLWWKHPGR\RXVHHZKDW,
meaQ"7KDW¶VWKHIHHOLQJ,¶YHDOZD\VNLQGRIKDGVRWKH\DUHWKHODVW
person I would go to to be honest. 
Female, 38, successful, unsupported, spontaneous 
 
6.3.6 Support for smokers who want to quit 
The majority of participants thought that there was enough support and 
encouragement available to smokers who may try to quit smoking, regardless of 
whether their unplanned quit attempt was successful or unsuccessful, 
spontaneous or delayed or whether they used support or not.  However, it 
sometimes appeared that although interviewees were aware of services 
available, they were not entirely sure of what that support entailed. 
 
 7KH\¶YHGRQHTXLWHDORWDOUHDG\KDYHQ¶WWKH\WKH\DUHGRLQJDOOWKH
advertising they can, you see hundreds of adverts, if you want to quit 
ULQJWKLVQXPEHUVRQRLWLVWKHUHLI\RXZDQWLW\RX¶YHRQO\JRWWRSLFN
up the phone, and you are sort of like in the system 
Male, 38, unsuccessful, supported, delayed 
 
I think there is a lot to offer, I see leaflets and poster all over my surgery 
DERXW1HZ/HDIDQGLQWKHFKHPLVWV7KHUH¶VDOVRORWVRISURGXFWVDQG
,¶YHVHHQWKHPRQFKHFN-RXWLQVKRSVLQ:LONLQVRQ¶VGLGDOOWKHELWVDQG
pieces, I think there is plenty there 
Female, 38, successful, unsupported, spontaneous 
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:HOO,PHDQZH¶YHJRWLWDOODWZRUNFRV,ZRUNIRUWKHFRXQFLOVRZH¶YH
JRW1HZ/HDIDQGHYHU\WKLQJWKHUHVRLWZDVDOOWKHUHLI,¶GZDQWHGLWLW¶V
MXVWQHYHUUHDOO\,GRQ¶WNQRZZKHWKHULW¶VMXVWJRWWREHWKHULJKWWLPH
to pack up and that was it  
Male, 39, successful, unsupported, spontaneous 
 
New Leaf? [local NHS SSS]. I remember seeing a stall there saying we 
could go and see a counsellor, have I got that wrong? That you could go 
and make an appointment or something, but I always thought it was a bit 
unclear about it all. 
Female, 54, successful, unsupported, spontaneous 
 
6.3.7 Perceptions of why quit attempts are successful  
No differences were observed in opinions about the factors which might influence 
the success of quit attempts between smokers making spontaneous and delayed 
quit attempts.  For both, a common emergent theme was that it needed to be 
WKHµULJKWWLPH¶IRUWKHVPRNHUWRTXLWDQGVmokers needed to want to stop and 
make this decision for themselves, and this was irrespective of the amount of 
support available or any other factors which may have influenced the quit 
attempt.  Once a quit attempt had been initiated, almost all interviewees 
identified having the right frame of mind and desire to quit as being a key factor 
for a quit attempt being successful.  A number of interviewees reported that a 
change in situational factors had contributed to their quit attempt being 
successful and a minority of interviewees EHOLHYHGWKDW µVLJQLILFDQWRWKHUV¶ (e.g. 
children or dependent partners) were particularly important external factors in 
influencing success at quitting smoking.  
 
,WKLQNHDFKLQGLYLGXDOKDVJRWWR\RXFDQ¶WSXVKWKHPLQWRGRLQJLW
\RXFDQ¶WPDNHWKHP,WKLQNLWLVDQLQGLYLGXDOFKRLFHLQWKHHQGEXW,
think the help is there if anybody needed it 
Female, 46, successful, supported, delayed 
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\RXKDYHJRWWRZDQWWRVWRSLW¶VQRJRRGVD\LQJRRKZHOO,¶OOWU\LWLILQ
\RXURZQPLQG\RX¶UHQRWUHDG\,PHDQLW¶VOLNH\RXFDQWDNHDKRUVH
WRZDWHUEXW\RXFDQ¶WPDNHLWGULQN 
Female, 67, unsuccessful, supported, spontaneous 
 
,WKLQN\RX¶YHJRWWRJHW\RXUPLQGULJKW\RX¶YHJRWWRJHWLWLQ\RXU
PLQGWKDW\RX¶UHQRWJRLQJWRGRLWDQGWKHUHSODFHPHQWWKLQJVKHOSWKH
FUDYLQJV,I\RXKDYHQ¶WJRWLWLQ\RXUKHDGWKDW\RX¶UHQRWJRLQJWRVWRp, 
WKHQ\RX¶UHQRWJRLQJWRVWRS 
Male, 59, successful, supported, spontaneous 
 
,I\RXGRQ¶WZDQWWRVWRS\RXGRQ¶WDQGLWGRHVQ¶WPDWWHUZKDWSHRSOHVD\
or do to you, or no matter what the government, what campaign they 
start, you know, I think it is all totally irrelevant, and it is all down to the 
individuals mind.   
Male, 41, successful, supported, spontaneous 
 
I just made that decision, the decision was made, I knew I was going to 
GRLWDQG,GLGLW,GRQ¶WNQRZOLNH,VDLG,¶GMXVWJRWLWILUPO\ fixed, in 
my brain, I wanted to stop....there was just something in my mind that 
said now is the time, and that time was right for me. 
Female, 60, successful, supported, delayed 
 
,WKLQNLW¶VPDLQO\EHFDXVHHYHU\WKLQJKDVFKDQJHGDERXWWKH
HQYLURQPHQW,¶PLQWKHVLWXDWLRQ\RXNQRZWKHIDPLO\VLWXDWLRQWKDW,¶P
LQVRZHPRYHGWRVRPHZKHUHZHGLGQ¶WNQRZDQ\RQHXPJRWSUHJQDQW
DQGWKHQJRWSUHJQDQWDJDLQDQGXPZH¶YHGHYHORSHGQHZIULHQGV:H
GRQ¶WJRWRWKHSXEDQ\PRUHZHKDUGO\GULQNEHFDXVHZH¶YHgot kids 
DQG\RXNQRZZH¶UHMXVWWRRWLUHGWRJRRXW>ODXJKV@KDYHQ¶WJRWDQ\
money to sort of go and live it up so um, i would say that that was 
instrumental really  
Female, 35, successful, supported, delayed 
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I think it was probably because of my son, I PHDQLW¶VMXVWWKHRQHWKLQJ
WKDW\RXORRNDWDQGWKLQNQR,¶PQRWKDYLQJKLPQRRQFH\RXWKLQN
DERXWLWLW¶VOLNH\RXSXWWRWKHEDFNRI\RXUPLQGZKDWGDPDJH\RXFDQ
do to yourself.....But when you think about what damage it can do to him 
LW¶VLt just puts you off completely 
Male, 39, successful, unsupported, spontaneous 
 
 
6.3.8 Better supporting smokers 
 
A small number of interviewees felt that whilst there was plenty of support 
available, there should be more emphasis on educating and raising the 
awareness of smokers as to what was available to help them quit.  Some 
reported that they ZHUHQ¶W UHDOO\ VXUH DERXW ZKDW VXSSRUW ZDV DYDLODEOH.  A 
number of interviewees reported that whilst there was enough support available, 
they thought the provision of support may be better provided if things were done 
somewhat differently.  A broad spectrum of suggestions were made as to how to 
improve or change existing support provision, including differences in the way in 
which NRT was offered, more targeting of younger smokers, constant 
reinforcement of information to smokers and a different focus in media 
campaigns to better emphasise the day-to-day effects of smoking rather than 
MXVWSUHVHQWLQJDµZRUVWFDVHVFHQDULR¶  
 
I think if they [patches] were sold alongside cigarettes, they would 
seriously make people think, and if they were sold individually alongside 
cigarettes, it would be much better 
Male, 59, successful, supported, spontaneous 
 
I think they do enough with like the physical things, you know the sprays 
and patches and promoting and things like that......But I think for 
younger ones they need something different. 
Female, 59, successful, unsupported, spontaneous 
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But it is that reinforcement of information, you know, reminding them, 
and it has got to be fairly constant, because people will take it a different 
SRLQWVLQWKHLUOLYHVVRLW¶VJRWWREHIDLUO\UHJXODUO\WDUJHWHG,JXHVV
UDWKHUWKDQRQHRIIVKHUHDQGWKHUHLW¶VDOZD\VJRWWREHDURXQGVRUWRI
thing.  You might think, oh that was then, but PD\EHWKH\¶UHQRWGRLQJLW
QRZEHFDXVH,¶YHQRWKHDUGDERXWLWIRUDZKLOH 
Female, 54, successful, unsupported, spontaneous 
 
.....because I mean I know they do all the advertising on the cigarette 
packs and all that but they always go for the worst case scenario like 
WKHVHFDQFDXVHKHDUWGLVHDVHDQGDOOWKLVORWEXWWKH\GRQ¶WIRFXVRQWKH
things well it just stinks and all that.  If you tell somebody that they smell 
EHFDXVHWKH\VPRNH,WKLQNWKDW¶VPRUHOLNHO\WKDQVD\LQJRRK\RXPLJKW
get cancer-well I might not.....But whatever, you will smell you will have 
EDGWHHWKDQG\RX\RXUKRXVHZDQWVGHFRUDWLQJHYHU\\HDURUVRµFRV\RX
mess it up with nicotine and all that lot and that, I think that sort of thing 
gets to people more than saying ooh you might die because, well we all 
PLJKWGLHDQG,WKLQNWKDW¶VWKHEOD]HDWWLWXGHSHRSOHKDYH 
Male, 39, successful, unsupported, spontaneous 
 
Several interviewees suggested ways in which access to and provision of existing 
services could be improved.  Most commonly reported was the need for service 
provision to fit in better with their existing lifestyle, for example providing 
telephone support if they were not able to access traditional services 
(interviewees were not aware this was possible in some cases), a means of 
having access to NRT if they are not able to attend weekly meetings or having 
support available on a longer-term basis.  When asked if smokers, including 
themselves, could be better supported in quit attempts, the majority of 
participants responded favourably to the specific suggestion of an alternative 
means of providing and accessing support, and these opinions did not differ 
between those making spontaneous and delayed quit attempts.  Many of the 
participants were also supportive of the idea of stop smoking services being 
available in alternative, arguably more accessible, locations than currently 
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offered.  One participant had made his quit attempt as a result of seeing a SSS 
stall in Nottingham city centre, whilst others felt that having stop smoking 
VHUYLFHV LQ µDOWHUQDWLYH¶ ORFDWLRQV ZRXOG LQFUHDVH WKH QXPEHU RI VPRNHUV ZKR
were aware of and had access to such support and would break down barriers to 
smokers making an initial contact with stop smoking services. 
 
<HDK,FRXOGQ¶WHUGR>JRWR1+6666Peeting] 
Yeah ok. So if it was possible for you to have got support by telephone 
would that have appealed to you at all or is that not something for you? 
8PEHFDXVH,¶YHQHYHUKHDUGRILW,GRQ¶WNQRZEXWPD\EHSHUKDSVLW
would have done yeah 
 Would you be willing to try it possibly in the future if it.... 
 Oh yes definitely 
Female, 58, unsuccessful, supported, delayed 
 
,ZHQWDZHHNZKHUH,FRXOGQ¶WJHWDQ\OR]HQJHVRQSUHVFULSWLRQZKHUH,
ZDVORFNHGLQPHHWLQJVDQG,FRXOGQ¶WJHWRXW,¶YHDFWXDOO\UXQ out, so I 
have started smoking again.  If  people are willing to help you and give 
you, say, a week up front of advice and whether you need to help you 
VWRSVPRNLQJWKHQLI\RX¶YHJRWDZHHNZKHUH\RXFDQ¶WJHWRXWDQGJHW
ZKDW\RXQHHG\RX¶YHDOUHDG\JRWLWWKHUHVR\RX¶UHQRWJRLQJWRVOLS
back to your old ways. 
 
Female, 43, unsuccessful, supported, delayed 
 
I MXVWXP,MXVWWKLQNSHUVRQDOO\P\VHOIOLNH,VDLGEHIRUHWKH\GRQ¶WJLYH
you long enough um and you know I think maybe 3 or 4 weeks my 
experienFHDQG\RXNQRZRUPD\EHDELWORQJHUWKDQWKDW,FDQ¶WTXLWH
remember and then they expect you to finish you know 
Female, 58, unsuccessful, supported, delayed 
 
I was walking through the market square and there was a marquee set 
up about stopping smoking, and so I went there and signed on there and 
then as I walked through the market square..... it was just 
FRQYHQLHQWWKDWWKH\ZHUHWKHUH,GLGQ¶WNQRZWKH\ZHUHWKHUH,MXVW
KDSSHQHGWREHSDVVLQJDQG,KDGDELWRIVSDUHWLPHDQG,WKRXJKWµ2K
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yeaK¶EHFDXVHXSWRWKHQ,KDGEHHQWKLQNLQJDERXWLWDQGNHSW
postponing it sort of thing, I must make an appointment to go to the 
doctors, and the new leaf counsellor 
Male, 59, successful, supported, spontaneous 
 
6.3.9 Quit packs 
When the suggestion of that VRPH NLQG RI µTXLW SDFN¶ RIIHULQJ D UDQJH RI
pharmacological and behavioural support ideas was suggested to interviewees 
almost all participants were supportive of this, with the main reasons for support 
EHLQJ WKDW LWZRXOGPDNH WKH µILUVWPRYH¶ WRZDUGV quitting for the smoker and 
provide an opportunity to try different forms of NRT without the associated cost.   
 
I think it is a good idea, because I believe human beings are quite lazy 
SHRSOHEDVLFDOO\ , WKLQN LI \RX¶YHJRW WRJRRXW DQG ILQG LW IRU \RXUself, 
unless they really, really want to do it, they are not going to look, 
ZKHUHDVLIVRPHRQHLVWR\LQJZLWKWKHLGHDEXWUHDOO\FDQ¶WEHERWKHUHGLI
it is given to them I think they will be more likely to consider it, because 
WKH\KDYHQ¶WJRt to do all the leg work themselves. 
Female, 38, successful, unsupported, spontaneous 
 
I think that would be a good thing because someone else is taking the 
ILUVWPRYH UDWKHU WKDQ MXVW OHDYLQJ LWXS WR WKHP <RX¶UHJLYLQJ WKHPD
FKRLFH DUHQ¶W \RX LQ D ZD\LI WKH\ had in their hands, it would have 
EHHQOLNHPHZLWKWKHLQKDODWRUZRXOGQ¶WLWLI,¶GKDGLW,PHDQVXSSRVH
,¶G QHHGHG LW VXSSRVH ,¶G QHHGHG VRPHWKLQJ , SUREDEO\ ZRXOGQ¶W KDYH
JRWLWPHEHLQJPH,¶PEXV\DOOWKHWLPHDQGLWZRXOGKDYHEHHQHDVLHU
to just have a cigarette than to go to the GP or try and get an inhalator or 
JRWRQHZOHDIZKHQ,¶YHJRWQRWLPHWRJRWRWKHWKLQJV 
Female, 59, successful, unsupported, spontaneous 
 
 
Yes, it would be a reasonable idea, because that way you avoid having to 
IRUNRXW IRUHDFKRI WKH WKLQJVRQO\ WR ILQG WKDW\RXFDQ¶W VWDQG
the taste or smell or whatever. 
Male, 58, successful, unsupported, spontaneous 
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6.4 DISCUSSION  
6.4.1 Main findings 
This study demonstrates that many quit attempts which are reported in surveys 
DV µXQSODQQHG¶ PD\ DFWXDOO\ LQYROYH VXEVWDQWLDO SODQQLQJ  6PRNHUV PDNLQJ
FHVVDWLRQ DWWHPSWV ZKLFK WKH\ EHOLHYH DUH µXQSODQQHG¶ RIWHQ GHOD\ LQLWLDWLQJ
these and in some cases this delay is used to obtain available support to 
LQFUHDVH VPRNHUV¶ chances of achieving abstinence.  However, most quit 
DWWHPSWVZKLFKZHUHWUXO\µVSRQWDQHRXV¶DQGLQYROYHGQRGHOD\LQLQLWLDWLRQ, were 
made without support.  Attitudes to the provision of support to assist quit 
attempts were generally positive, though, and most interviewees, whether 
making spontaneous or delayed cessation attempts reported that they would 
have been receptive to using support if it had been easily accessible and 
available.   
 
6.4.2 Strengths and limitations 
This is the first detailed qualitative research to investigate, with smokers and ex-
smokers, triggers for unplanned quit attempts and the use of, and attitudes 
towards, support in these attempts.  Purposive selection of interviewees as 
detailed earlier was made to ensure that individuals from both genders and a 
range of age and socio-economic groups were included in the study.  The sample 
size was small, despite a large number of people being contacted to take part 
and it is possible that those who did not agree to participate in interviews may 
have held different views to those who volunteered.  It is also possible that if a 
larger number of unsuccessful unplanned quit attempters were interviewed then 
stronger differences may have been found in opinions between these and 
successful quitters.  A thorough description of the views of interviewees, 
however, has been reported from a range of age and socio-economic groups and 
a number of common themes identified. 
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Steps to ensure both the trustworthiness and generalisability of these results 
were taken at all stages of the research.  The semi-structured interview allowed 
respondents the opportunity to express their views freely on topics covered and 
so allowed themes to emerge without constraint by the views of the interviewer, 
whilst the one-to-one nature of the interviews ensured that participants did not 
feel intimidated by the presence of others and thus would feel freer to express 
their own views.  Given the factors just described it is, therefore, of minimal 
likelihood that these interviewees misrepresented their opinions.  The emergence 
of a number of common themes increases the likelihood that as complete a 
picture as possible was gained from this group of interviewees on the principal 
issues covered in the interviews.  Data analysis was conducted in as objective, 
rigorous and systematic approach as possible, both in the development of 
themes and categories used and their application to interview transcripts. 
 
6.4.3 Comparison with previous research 
This study has illustrated that when smokers WDONDERXWPDNLQJµXQSODQQHG¶TXLW
attempts these can often include substantial preparation.  The decision to quit 
may be unplanned but a delay is often incurred before the attempt is 
implemented and this delay may or may not be a result of the time taken to 
seek support.  No studies to date have looked specifically at how a smoker 
GHILQHV DQ µXQSODQQHG¶ TXLW DWWHPSW our finding that unplanned quit attempts 
may be spontaneous or delayed is a novel one.  Four previous studies have 
reported that unplanned quit attempts are common and more likely to be 
successful than planned attempts140-142 175.  Although one of these studies had a 
FOHDUGHILQLWLRQRIDQµXQSODQQHG¶TXLWDWWHPSW (defined as a sudden decision not 
to smoke any more cigarettes, including those that might be remaining in the 
current pack)140, the other three studies asked the same question and defined an 
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µXQSODQQHG¶ TXLW DWWHPSWDV RQHZKLFKKDV WKH UHVSRQVH RI µ, GLG not plan the 
quit attempt in advaQFH , MXVW GLG LW¶141 142 175.  This study has illustrated the 
need for a clearer, agreed definition of what constitutes an µXQSODQQHG¶ quit 
attempt so that comparisons can be made between studies on this topic.  
RHVHDUFKLQWRKRZWRSURYLGHVXSSRUWWRµXQSODQQHG¶TXLWWHUVDOVRUHOLHVRQEHLQJ
able to accurately identify this group with any new definition. 
 
The finding that unplanned (spontaneous) quit attempts appeared to have been 
more common in less dependent smokers is in line with the quantitative data 
presented by Ferguson and colleagues on this topic141.  No research to date 
appears to have examined whether unplanned quit attempters have cut down 
their cigarette consumption in the time period leading up to the unplanned 
attempt, although the findings from this study do not suggest any difference 
between spontaneous and delayed quitters.  
 
Differences were apparent in the support which interviewees reported using in 
WUXH µVSRQWDQHRXV¶ DQG µGHOD\HG¶ TXLW DWWHPSWV  7KH PDMRULW\ RI VSRQWDQHRXV
quit attempts were made without the use of support, whereas in contrast, the 
majority of delayed quit attempts were made with support which suggests that 
some people may have delayed or postponed their quit attempt in order to seek 
this out0XFKUHVHDUFKKDVIRFXVHGRQVPRNHUV¶XVHRIFHVVDWLRQVXSSRUWbut 
until this study no research had investigated how this differs between those who 
perceive that they plan their quit attempts and those who do not.  Factors such 
as a perceived failure of NRT to control cravings and to help with the behavioural 
and psychological aspects of smoking, concern about the safety of NRT, a fear of 
becoming addicted to NRT, NRT use being a sign of being weak-willed and the 
cost of NRT have all been identified as reasons for smokers choosing not to use 
NRT in a quit attempt in the wider context of smoking cessation110 178-183.  
Despite being available on prescription, many smokers perceive NRT to be 
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relatively inaccessible and this may in part explain the finding that NRT was not 
widely used reported in this study.  Previous research has reported that some 
smokers chose not to get a prescription for NRT as they feared the time delay 
involved in making an appointment with their GP will delay their quit attempt178 
and this may in part explain why spontaneous quitters for the most part used no 
support in their quit attempt whereas the majority of quit attempts using support 
were delayed.  Whilst this study examines whether unplanned quit attempts 
were made with or without the use of support, the reasons for smokers making 
this decision have not been fully explored.  Although some insight was gained 
into possible reasons why smokers may not use support in their quit attempt, 
further research is warranted to see whether there are further underlying factors 
ZKLFK VKRXOG EH DGGUHVVHG WR LQFUHDVH VPRNHUV¶ XVH RI HIIHFWLYH FHVVDWLRQ
support.   
 
Whilst it has been shown that pharmacological support may help to quit 
smoking, willpower has been reported to be the key factor which determines 
long term abstinence103 and willpower is unaffected  by medications178.  Another 
study has reported that some smokers may perceive a greater sense of 
achievement gained by quitting through willpower alone and this is the only way 
to achieve effective cessation183, potentially limiting the utility of smoking 
cessation medications for a number of smokers unless beliefs and attitudes can 
be changed.  It has been suggested that those smokers who choose to use stop 
smoking medications are likely to have a lower self-efficacy to stop smoking178 
184, and thus potentially are less likely to quit successfully from the outset.  
Willpower was identified by a majority of interviewees as being important for a 
quit attempt to be successful, regardless of whether their quit attempt had been 
successful or not.  Whilst this suggestion potentially offers a partial explanation 
IRUWKHILQGLQJWKDWPRUHRIWKHWUXHµVSRQWDQHRXV¶TXLWWHUVZHUHVXFFHVVIXODQG
chose to not use support, further research is certainly required in this area to 
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determine if there are any other factors related to a smokers choice to use or not 
use support, and if this is related to the success of the quit attempt. 
 
In particular, it would be of interest and importance to further explore the issues 
already discussed in relation to PRIME theory50.  PRIME theory (plans, responses, 
impulses/inhibitory forces, motives and evaluations) proposes that higher 
elements influence each other, i.e. plans influence evaluations which 
subsequently influence motives which act through impulses or inhibitory forces 
to directly influence behaviour.  The human motivational system is suggested to 
be highly influenced by the moment, thus explaining why µVSRQWDQHRXV¶DWWHPSWV
to quit smoking may be initiated.  According to PRIME theory, the one factor 
which provides the motivational system with some stability is the concept of 
µLGHQWLW\¶DQGWKHODEHOVZHJLYHRXUVHOYHV)RUH[DPSOH:HVWVXJJHVWVWKDWan 
LPDJHRIEHLQJDQµH[-VPRNHU¶LVDQLPSRUWDQWIDFWRULQUHVLVWLQJDWHPSWDWLRQWR
smoke after a quit attempt has been initiated.  Whilst the current study did find 
a suggestion that the smoker had to be in the right frame of mind for the 
attempt to be successful, it did not specifically examine how smokers identified 
themselves once the quit attempt had been initiated and this is an interesting 
avenue for future research. 
 
Although the majority of smokers reported that they thought there was enough 
support available to smokers who wanted to quit, it is possible that smokers are 
not fully aware of the full range of support that is available to them and thus are 
basing their opinions on the level and suitability of support available on their own 
knowledge rather than actual fact.  There is a lack of published research 
investigating smokers knowledge and views of smoking cessation support 
available and whilst we did not explore this possibility in any depth in these 
interviews, it remains an interesting avenue for future research to address this 
issue more fully.  Smokers who have made unplanned quit attempts were 
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generally receptive to the idea of support being provided in a more accessible 
and rapid way and these opinions did not differ between those making 
spontaneous and delayed quit attempts or those who had used or not used 
support.  Very few participants in this study had made a conscious decision to 
not use any support in their quit attempt.  A number of previous studies have 
been conducted looking at ways access to stop smoking services could be 
improved, and many of these findings may be applicable to smokers who make 
unplanned attempts to quit smoking.  These include providing a service which 
utilizes a drop in system so that smokers do not need to pre-book 
appointments118 119 and providing community based support, e.g. in pharmacies 
that may be more immediately accessible to this group of potential quitters111 113 
174.  As previously discussed, a delay in the access to NRT and/or behavioural 
support may well be a factor which discourages smokers from using support and 
so overcoming this potential barrier may increase the use of NRT and/or 
behavioural support.  Expense is another factor which has previously been 
suggested as a reason for not using NRT178, and this would become a more 
pertinent issue for those more disadvantaged smokers who choose not to obtain 
prescription NRT.  Indeed, cost was acknowledged by some interviewees in this 
study as a reason for not using NRT.  Engaging smokers in using support at an 
appropriate time, without the need to delay their quit attempt in order to achieve 
this, may be a potential means of increaVLQJ VPRNHUV¶ XSWDNH RI HIIHFWLYH
cessation support and subsequently quit rates.   
 
Previous research suggested that the most immediate forms of support 
available, i.e. telephone and internet support, were not largely used by potential 
quitters175, although this may have been due to a lack of awareness of the 
availability of such services.  In addition to promoting immediately accessible 
telephone and internet support, it seems likely that providing pharmacological 
and/or behavioural support in a quick and acceptable manner to those making 
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unplanned quit attempts would increase uptake and potentially increase quit 
rates.  Further research is needed to determine why potential quitters may not 
choose to access these particular forms of support.  It is possible that publicity 
and education about these services may be an important area for future 
development in order to better support unplanned quitters who would have a 
greater need for immediate support.   
 
 
6.4.4 Conclusions 
This is the first research WR VKRZ WKDW VPRNHUV¶ UHSRUWV RI µXQSODQQHG¶ TXLW
attempts may indeed involve elements of planning and delay, often in order to 
gain access to cessation support.  Further research is needed to delineate what 
VPRNHUVPHDQ E\ DQ µXQSODQQHG¶ TXLW DWWHPSW EHIRUH LQIHUHQFHV FDQ EH PDGH
about their occurrence and success relatLYHWRµSODQQHG¶DWWHPSWVThe fact that 
¶XQSODQQHG¶ TXLWWHUV PD\ DFWXDOO\ GHOD\ WKH LQLWLDWLRQ RI WKHLU TXLW DWWHPSW
provides an opportunity for health services to offer cessation support to a group 
RI TXLWWHUV ZKR PD\ EH FRQVLGHUHG µXQUHDFKDEOH¶ GXH WR the perceived way in 
which they make their quit attempt, i.e. generally in a very short space of time 
and without an interest in using support services.  The majority of smokers and 
ex-smokers interviewed were receptive to the idea of support being immediately 
available whether or not their quit attempt involved support or not, thus these 
findings have clear implications for future research and policy implementation.   
In order to specifically support those smokers who make their quit attempt 
spontaneously, investigation is needed into ways in which smoking cessation 
support can be made available to potential quitters within a much shorter 
timescale, and the type of support they would be most likely to use.  However, 
future research should also address the question of why unplanned, and often 
unsupported quit attempts appear more likely to be successful than those which 
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DUHSODQQHG)XUWKHULQYHVWLJDWLRQRIIDFWRUVLQIOXHQFLQJVPRNHUV¶FKRLFHWRXVH
or not use evidence-based cessation support and their knowledge of the range of 
support available is important to determine how to better support all smokers, 
regardless of whether their quit attempt is planned or not.   
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CHAPTER 7: SUMMARY CONCLUSIONS AND                          
FUTURE DIRECTIONS 
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The ovHUDOO DLP RI WKLV WKHVLV ZDV WR LQYHVWLJDWH VPRNHUV¶ XVH RI HIIHFWLYH
smoking cessation support, and explore novel approaches to providing support. 
This thesis has shown clearly that opportunities to support smokers who want to 
quit smoking are being missed.   
 
The main trial detailed in this thesis was to investigate whether a proactive 
approach to identifying smokers and offering evidence-based support to help 
them quit smoking was a feasible approach, which would not only increase 
smoking quit rates but also increase access to NHS stop smoking services.  
Smokers were identified from their electronic primary care medical record and 
contacted by the GP who offered smoking cessation support and thus the first 
step to testing this approach was to assess whether primary care records were 
sufficiently complete and accurate to allow identification of smokers in this way. 
 
Well established clinical guidelines recommend that systematic ascertainment of 
smoking status and intervention to promote cessation in all smokers should be a 
fundamental component of all health care provision. Being able to identify 
smokers from primary records is clearly a vital first step in providing any primary 
care based intervention aimed at targeting and supporting smokers.  The 
findings presented in chapter 3, however, indicate that systematic failure to 
ascertain smoking behaviour in primary care continued after the introduction of 
the 2004 GP contract with over 20% of recorded data being inaccurate.  
Consequently, major opportunities to promote smoking cessation were probably 
still being missed DV *3V FDQ¶W LQWHUYHQH DJDLQVW VPRNLQJ XQOHVV WKH SDWLHQWV
smoking status is actually recorded.  It was also found that over 1 in 10 (13%) 
of smokers in primary care are interested in talking to smoking cessation 
advisors about receiving support to help them quit smoking when questioned.  
This emphasises the importance of being able to accurately identify smokers 
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from medical records in order to facilitate cessation support being offered to 
primary care patients who are likely to accept it. 
 
Since chapter 3 found that there was clearly a demand for smoking cessation 
support if offered to smokers and, although not perfect, primary care records 
offered a tool for identifying the large majority of smokers within a general 
practice, the study proposed in chapter 4 appeared to offer a feasible and 
promising method of increasing smokers use of effective cessation support and 
quit rates.  This found a proactive approach was effective in increasing the 
number of smokers attending the local NHS SSS and the number of smokers 
reporting making quit attempts.  At a population level, however, the intervention 
had no significant impact on quit rates although validated quit rates were 
significantly higher in the intervention group when post-hoc analyses were 
restricted to those smokers who had initially requested contact with a stop 
smoking advisor for advice on quitting, and thus a proactive approach may be 
more effective in smokers who are more motivated to want to try and quit.   
 
Whilst this intervention had a limited effect at a population level, even a small 
effect has the potential to make a significant impact on national smoking 
prevalence.  A replication of the study in a larger population would be justified 
given the positive findings among those wanting help.  It is possible that the 
follow up period was too short and more time would be needed for smokers to 
achieve cessation and so future research should be conducted over a longer time 
period to see if this has any effect on outcomes.  The significant effect among 
those originally requesting advice from a stop smoking advisor indicates that the 
approach is successful if smokers motivated to help are able to be identified 
easily. Given the method employed to identify smokers in this study was time 
and resource intensive, future research should look at alternative means of 
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identifying this group of smokers in a more cost effective manner, for example 
via a promotion at a community event or location.   
 
The finding that a significant effect was seen in smokers who were more 
motivated to quit adds to the importance of maintaining up-to-date smoking 
records within primary care and the recommendation that GPs should offer brief 
smoking cessation advice and establish a smoker¶s desire to receive smoking 
cessation support in primary care consultations. The challenge for the UK NHS is 
to find ways of engaging these smokers¶, capitalise on their interest in receiving 
cessation advice and potentially translate this interest into higher quit rates.  As 
WKH VWXG\ ZDV HIIHFWLYH LQ LQFUHDVLQJ VPRNHUV¶ DFFHVV WR 1+6 VWRS VPRNLQJ
services, another possibility is that the service, for whatever reason, did not 
effectively respond to the needs of the individual smokers attending 
appointments.  Further research with smokers who have used services but not 
achieved abstinence, particularly of a qualitative nature, may be useful in 
delineating reasons for the findings of this study and identifying areas in which 
services may need to adjust their working practice to better meet the needs of 
clients. 
 
Whilst proving to have some effectiveness, the intervention detailed in chapter 4 
required a large amount of advance planning; from contacting smokers and 
establishing their interest in attending stop smoking clinics to booking their 
appointments which in some cases may have been days or even weeks after the 
initial telephone contact was made.  Alternative ways of proactively identifying 
smokers should be explored.  
 
As recent evidence suggests that not all quit attempts are planned140 142, the 
study in chapter 5 was designed to investigate the occurrence and determinants 
of both planned and unplanned attempts, and the sources of support that may or 
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may not be used in these attempts among a group of current and ex-smokers.  
It also aimed to determine whether existing NHS stop smoking services need to 
DGDSW WR PHHW WKH QHHGV RI µXQSODQQHG¶ TXLWWHUV  7KH UHVXOWV RI WKLV VWXG\
showed that over a third of all quit attempts analysed were made without any 
pre-planning, were  most commonly initiated by advice to quit from a GP or 
health professional and that these attempts were less likely to involve the use of 
any evidence-based support to help them quit.  Although more common in men 
than women, unplanned quit attempts were equally employed across both socio-
economic and age groups.   
 
The finding that advice from a GP or health professional was the most commonly 
reported trigger for a smoker making an unplanned quit attempt in chapter 5 is 
yet another illustration of the importance of accurate and complete recording of 
smoking status in primary care medical records and the potential benefits which 
may be gained from GPs offering brief smoking cessation advice in all 
consultations with smokers.  Further research should focus on ways of 
encouraging and improving the delivery of smoking cessation advice in primary 
care and referral to support systems that are accessible to smokers. 
 
Those who chose to make their quit attempt without any pre-planning may be 
FRQVLGHUHG µXQUHDFKDEOH¶ RU µXQVXLWDEOH¶ IRU WKH W\SH RI SURDFWLYH LQWHUYHQWLRQ
detailed previously.  This group of smokers are likely to be keen to initiate their 
quit attempt as soon as the decision in made and thus may not be willing to 
experience the inevitable time delay involved from the point of making the initial 
contact with the smoker to the booking of and ultimate attendance at an NHS 
SSS.  However, as evidence from randomised studies suggests that support 
increases the success rate of quit attempts by up to four fold56, it is important to 
find ways of offering and providing such support to smokerV ZKR GRQ¶W SODQ
cessation attempts in advance immediately and effectively, as they appear to 
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represent a significant minority of smokers who make a quit attempt. In order to 
successfully do this, it is necessary to gain a greater understanding of how and 
why smokers go about unplanned quit attempts. The qualitative research in 
Chapter 6 enabled an exploration of unplanned attempts to quit smoking in a 
group of current and ex-smokers. 
 
Perhaps the most interesting and important finding reported in chapter 6 was 
that PDQ\ TXLW DWWHPSWV ZKLFK DUH UHSRUWHG LQ VXUYH\V DV µXQSODQQHG¶ PD\
actually involve substantial planning.  Smokers making cessation attempts which 
WKH\EHOLHYHDUH µXQSODQQHG¶RIWHQGHOD\LQLWLDWLQJWKHVHDQGLQVRPHFDVHVWKLV
delay is used to REWDLQ DYDLODEOH VXSSRUW WR LQFUHDVH VPRNHUV¶ FKDQFHV RI
achieving abstinence.  Further research should build on these findings to attempt 
to find alternative terminology to describe better the substantial number of 
VPRNHUV ZKR UHSRUW PDNLQJ µXQSODQQHG¶ TXit attempts so that they can be 
appropriately categorised and supported.  Although not all chose to use support 
in their quit attempt, the majority of smokers and ex-smokers interviewed were 
receptive to the idea of using support if it had been accessible and readily 
available.  Further exploration of ZK\ VPRNHUV¶ FKRRVH WR XVH RU QRW XVH
evidence-based cessation support would be helpful.  Further research to explore 
ways of ensuring that smokers are fully aware of all the various types of support 
available to them would also appear helpful as this appeared to be a potential 
issue for some interviewees.  
   
The finding that interviewees were generally receptive to the idea of using 
VXSSRUWFRPELQHGZLWKWKHILQGLQJWKDWPDQ\µXQSODQQHG¶TXLWWHUVDFWXDOO\GHlay 
making their quit attempts, suggests that this group of smokers may not be as 
µXQUHDFKDEOH¶ LQ WHUPV RI VXSSRUW SURYLVLRQ DV PD\ KDYH EHHQ SUHYLRXVO\
assumed and  has clear implications for future research and policy 
implementation. In order to specifically support those smokers who make their 
 159 
 
 
quit attempt spontaneously, investigation is needed into ways in which smoking 
cessation support can be made available to potential quitters within a much 
VKRUWHUWLPHVFDOH  ,I WKH LGHDRIVRPHNLQGRI µTXLWSDFN¶Zas to be developed 
further, exploration of both the content and the ways in which such a product 
should be marketed and made available to smokers to ensure optimum uptake 
and effectiveness are also an important avenue for future research and should 
be a priority in the tobacco control field. 
 
Whilst this thesis has highlighted that recording of smoking status and provision 
of brief cessation advice in primary care may provide an avenue to cessation, it 
is important to continue exploring the processes of attempts to quit smoking 
with potential quitters.  It is very clear that there are many different ways in 
which smokers make their quit attempts which may have varying requirements 
for support.  Further research is needed in order to determine the best ways of 
supporting different groups of smokers who want to, or are trying to quit, rather 
WKDQDVVXPLQJD µRQHVL]HILWVDOO¶PRGHOZLOOEHDQHIIHFWLYHVWUDWHJ\WRUHGXFH
smoking prevalence and smoking related mortality and morbidity in the UK or 
worldwide. 
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APPENDIX II: Initial letter 
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Dear Patient, 
 
We are currently checking the information that we have on our practice records 
on whether or not you smoke. To update our records we would like you to 
complete and return the enclosed questionnaire. 
 
In addition, with your agreement, we would like to share this information with 
researchers from the University of Nottingham who are carrying out a research 
study to try out a new way of providing help and advice to smokers who want to 
stop.  This research is funded by the British Heart Foundation. 
 
If you agree to share this information with the researchers please sign the 
consent form on the questionnaire. The research team may ask you to fill in 
another short questionnaire at a later date. If you smoke, and would like support 
to stop smoking please tick the relevant box on the questionnaire and the 
research team can arrange for someone to contact you. Your answers will be 
totally confidential and seen only by researchers at the University of Nottingham. 
You are under no obligation to take part and can withdraw at any time without 
this affecting your care from the practice in any way. 
 
For further information about the research study you may contact Rachael 
Murray at the Division of Respiratory Medicine, Clinical Sciences Building, 
Nottingham City Hospital, Nottingham NG5 1PB. Tel 0115 840 4759. 
 
Many thanks for your help, 
 
 
 
Rachael Murray 
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APPENDIX III: Telephone script 
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Hello, my name is Rachael and I am calling from the University of Nottingham.  
You recently returned a form to your GP at the ...................practice to say that 
you would like advice on stopping smoking? 
 
The fact that you are considering giving up is excellent and we would like to 
provide you with any help and assistance that you may need. 
 
Have you tried giving up before? 
 
How are you feeling about giving up now? 
 
Have you heard about or used the New Leaf (or Fresh Start) service before? 
If no:  Free weekly support service for 6-8 weeks (less or more if you need) 
 Run district wide sessions and you have a choice of where to attend 
If you are entitled to free prescriptions you can receive up to 8 weeks of 
NRT vouchers and upto 4 weeks from your GP after that.  If not, you can 
receive NRT and/or zyban cheaper on prescription from your doctor.  
If yes: how would you feel about going again? 
 
Do you know anything about NRT or zyban? 
They can be used to help manage your withdrawal symptoms.  NRT is available 
in several forms and zyban is a tablet that reduces your desire to smoke, 
although it is not suitable for everyone.  The New Leaf advisor can tell you more 
about these and discuss which is best for you. 
 
We can make an appointment for you to see a New Leaf advisor who can 
prepare a smoking cessation plan based on your individual needs if you would 
like? 
 
If no: would you like me to send you some information in the post so you can 
think about it in your own time? 
 
If yes: where would be the best place for you to attend a session with New Leaf? 
I can book that for you and call back to confirm.  
 
Potential questions: 
 
Will I have to pay? 
The New Leaf service is free.  The medications will be charged at prescription 
prices unless you are  
exempt from payment in which case they are free. 
 
How long do I have to see an advisor for? 
This is entirely up to you but we would suggest 8 weekly sessions as this has 
been shown to provide the best chance of quitting.  Whilst we would encourage 
you to attend you are under no obligation.  The service is there to support you in 
your quit attempt but not put you under any pressure. 
 
Can I choose whether to use NRT products or zyban? 
Zyban is not suitable for everyone but once you have received advice on the 
various products available the advisor will support you in your decision of 
whichever options are available to you.  Research has shown that using the right 
medication in combination with advice and support from cessation advisors can 
significantly increase your chances of quitting. 
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APPENDIX V: Follow up letter
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Dear  
 
 
You may remember completing a questionnaire about 6 months ago asking 
whether you smoke. Thank you very much! This was part of a research study to 
identify smokers in general practices in Nottingham, and to try a new way of 
providing advice and support to people who want to stop smoking. This research 
is funded by the British Heart Foundation.  
 
In this second and final questionnaire we want to ask you a few further 
questions about your smoking, and would be grateful if you could return the 
questionnaire to us in the FREEPOST envelope provided. 
 
When you answered the first questionnaire you may have requested support to 
help you stop smoking. If you have not yet been contacted and would like help 
to stop smoking you will be contacted very soon.   
 
 
 
 
Many thanks for your help,  
Best wishes, 
 
 
 
Rachael Murray 
Division of Respiratory Medicine,  
University of Nottingham,  
Clinical Sciences Building,  
Nottingham,  
NG5 1PB.  
Tel 0115 8231932 
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Date 
ID 
 
 
Dear  
 
A questionnaire survey into spontaneous smoking cessation 
 
In 2005, you provided information on smoking to your GP.  You kindly gave 
consent for that information to be passed on to researchers from the University 
of Nottingham and responded to a follow-up questionnaire from us in 2006.  
Thank you very much for your contribution to this point.   
 
This information was extremely useful in helping us to understand the sources of 
advice and support many smokers use to help them quit.  We would now like to 
ask you some further questions to find out more about your smoking, and 
especially about any attempts you have made to stop smoking and the things 
that have helped or hindered you in trying to quit.  
 
We would be very grateful if you would complete this questionnaire whether or 
not you are currently smoking, and whether or not you are trying to quit.  
Completion of the questionnaire is entirely voluntary, and should take no more 
than 10 minutes of your time. 
 
Please return the questionnaire to us in the FREEPOST envelope provided.  As a 
thank you for your time, we will be sending a £5 gift voucher to all those people 
who return their completed questionnaire to us.   
 
Also, if you would be willing to be contacted at a later date to further discuss 
your experiences of trying to quit smoking, please indicate this in the box 
provided. 
 
If you have any questions about the study please contact Rachael Murray 
(details below). 
 
Yours sincerely,  
 
 
Rachael Murray  
Cancer Research UK Graduate Training Fellow  
Division of Epidemiology and Public Health,  
Clinical Science Building,  
Nottingham City Hospital,  
FREEPOST NG4809, 
Nottingham NG5 1BR.      
Phone 0115 823 1932  
Email: rachael.murray@nottingham.ac.uk 
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Dear  
 
A study to explore spontaneous smoking cessation 
 
You recently completed a questionnaire on your smoking habits and attempts to 
quit smoking.  Thank you very much.  This is part of a research study funded by 
Cancer Research UK to try and find ways to help smokers who want to stop 
smoking.  You indicated on the questionnaire that you would be willing to further 
discuss your experiences of attempting to quit smoking and we would like to 
invite you to participate in a one-to-one discussion, at your convenience, to 
share your experiences with us.  We would like to collect as much information as 
SRVVLEOHDERXWSHRSOH¶VH[SHULHQFHVRITXLWWLQJVPRNLQJDQG\RXULQYROYHPHQWLV
very important to us. 
 
 
If you would be willing to participate in a discussion, then please complete the 
enclosed contact details sheet and return it in the freepost envelope provided.  
We will then be in touch with you shortly to arrange a convenient time and 
location for the discussion.  If you do not wish to participate in a discussion then 
please indicate this and we will not bother you again. 
 
 
An information sheet telling you more about the study and what would be 
involved is enclosed.  Please do not hesitate to contact me if you have any 
further questions, my details can be found at the end of the information sheet. 
 
Best wishes, 
 
 
 
Rachael Murray 
Cancer Research UK Graduate Training Fellow 
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A study to explore spontaneous smoking cessation: an invitation to 
participate in a one-to-one discussion about your experiences of trying 
to quit smoking 
 
You are being invited to take part in a one-to-one discussion of your experiences 
of quitting smoking.  Before you decide to take part it is important for you to 
understand why the research is being done and what it involves.  Please take 
time to read the following information and ask us if you have any questions.   
 
What is the purpose of the study? 
Many people who quit smoking do so spontaneously (without planning in 
advance).  This study aims to explore spontaneous smoking cessation, identify 
factors which may help or hinder such quit attempts and to try and find ways of 
supporting smokers who make spontaneous quit attempts.   
 
Why have I been chosen? 
You indicated on a questionnaire concerning your attempts to quit smoking 
which you recently completed and returned to us that you would be willing to 
participate in further research to discuss your experiences of trying to quit.  We 
DUHLQWHUHVWHGLQSHRSOH¶VH[SHULHQFHVRITXLWWLQJVPRNLQJDQGZRXOGWKHUHIRUH
like to ask you some further questions to help us find the best way of supporting 
people who try to quit. 
 
Do I have to take part?  
It is up to you whether or not to participate in the one-to-one discussion.  If you 
decide to take part you are still free to withdraw at any time without giving a 
reason without this affecting your legal rights. 
 
What will I have to do? 
If you decide to take part in a one-to-one discussion then please complete the 
enclosed contact details sheet and consent form and post this back to us in the 
freepost envelope provided.  We will then contact you to arrange a convenient 
time for the one-to-one discussion.  The one-to-one discussion will either be 
conducted over the telephone, or at the Clinical Sciences Building at Nottingham 
City Hospital.  If you decide not to take part, please could you let us know by 
crossing the relevant box on the contact details sheet?  This will stop us from 
asking you again.  Your contact details will be kept confidential and will be 
destroyed at the end of the study, which will be in approximately 2 years unless 
you have indicated that you would be happy for us to contact you at a later date 
for further research. 
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What will we do? 
1. If you agree to participate in a one-to-one discussion, we will discuss 
your experiences of trying to quit smoking, what you found helpful or not 
in your attempt, and what you think may have been useful to you at this 
WLPH:HZLOOXVHWKHLQIRUPDWLRQ\RXSURYLGHWRLQYHVWLJDWHSHRSOH¶V
experiences of stopping smoking and aim to find a new way of supporting 
smokers who want to quit. 
 
 
What are the possible benefits or disadvantages of taking part in this 
part of the study? There are no direct benefits to you from participating in a 
discussion. However, the results are important for the study to gain as much 
information as possible to help people stop smoking.  A disadvantage is that 
participation in a discussion may take between 30 and 60 minutes. 
  
Will my participation in the study be kept confidential? 
Yes.  The discussion will be conducted in confidentiality between you and the 
researcher.  To allow us to analyse the information you provide, the discussion 
will be tape recorded and typed up.  The typed up comments will not include 
your name, and only the researcher you have spoken to will know the code used 
to anonymise your comments.  The transcripts may be analysed by up to three 
researchers.  All data and tapes will be kept in a secure location at the University 
of Nottingham and only the researcher and her academic supervisors will have 
access to it.   
 
Who is organising and funding the research? 
This research is sponsored by the University of Nottingham and funded by 
Cancer Research UK.  
 
What if something goes wrong? 
Please remember that you are not required to participate in this part of the 
research project. You can withdraw your participation at any time by contacting 
the principal investigator, Rachael Murray.  If you wish to complain, or have any 
concerns about any aspect of the way you have been approached or treated 
during the course of this study, please initially contact the principal investigator, 
Rachael Murray.  If you feel your complaint was not handled adequately than 
please contact the University of Nottingham, University Park, Nottingham, NG7 
2RD. 
 
What will happen to the results of the research study? 
The results of the research will be integrated into the thesis of the researcher 
who is conducting the study in pursuit of a doctoral degree.  The results will also 
be published in a medical journal.  You will not be identified in any report or 
other publication; all information will be kept anonymous.  All data which are 
collected will be stored for a period of at least 7 years as required by University 
of Nottingham Research Code of Conduct   
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Who has reviewed the study? 
The Nottinghamshire Research Ethics Committee is a group of people who read 
and check research projects.  A Local Research Ethics Committee is made up of 
people chosen by a Strategic Health Authority.  Some work in health care and 
some have other jobs.  It is the job of the Local Research Ethics Committee to 
allow research projects to happen.  They only do this when they believe that the 
research will do more good than harm. If there are concerns about the research 
project, they are considered very carefully before making a decision.  Research 
cannot happen unless the Local Research Ethics Committee has said it can.   
 
Contact for further information 
Rachael Murray 
Cancer Research UK Graduate Training Fellow 
Division of Epidemiology and Public Health,  
Clinical Science Building,  
Nottingham City Hospital  
Phone 0115 823 1932  
Email: rachael.murray@nottingham.ac.uk 
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INTRODUCTIONS 
x Thanks for agreeing to take part 
x Background to the purpose of the interview 
x Confidentiality, right to withdraw and recording of the interview 
 
BACKGROUND/OVERVIEW (confirm details provided on questionnaire) 
 
x How much did you/do you smoke 
x How long did you/have you smoked for 
x How dependent do you think you are/were (time to first cig, feelings in 
non-smoking areas etc) 
x Is there much smoking around them-family, friends, work colleagues etc 
x How many times have they seriously tried to quit smoking?  In last 12 
months? 
 
EXPERIENCES OF THE SPONTANEOUS QUIT ATTEMPT 
 
x How long did you manage to quit for?  
x Did you set a date/plan in advance to quit smoking?  
x Did you cut down before trying to quit?  
x What factors influenced your desire to try and quit smoking? What was 
the most important factor? 
x What time of day did you make the decision to quit/initiate the quit 
attempt? 
x Can you remember anything about the situation you were in at the time? 
(environmental factors, any life changing events etc) 
x IF THE ATTEMPT WAS UNSUCCESSFUL:  Thinking about unsuccessful 
attempts-why do you think it was unsuccessful? Was there a trigger back 
to smoking? Is there anything you can think of that would have been 
beneficial during the attempt? 
x IF THE ATTEMPT WAS SUCCESSFUL: Thinking about the successful 
attempt-why do you think it was successful? Did it feel different to other 
attempts? If so, how/why?  Does anything stand out in your mind as 
being particularly helpful in the attempt? 
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SUPPORT THEY USED 
x What did you use to help them stop smoking? (Nothing/NRT/behavioural 
therapy/alternative therapy) 
x How did you hear about this type of help? 
x ,I\RXGLGQ¶WXVH157ZRXOG\RXKDYHXVHGLWLILWZDVDYDLODEOH" 
x If not, why not? 
x Did they consult their GP/New Leaf? Were they helpful? Why? 
 
INTRODUCE POSSIBILITY OF QUIT PACK 
x Introduce idea of a quit pack containing NRT samples, contact info etc. 
x What do they think it should include? 
x Do they think they would have found it helpful? 
x Who should deliver it-GP/pharmacy/city centre etc 
x Would an associated quit line/drop in session be helpful? 
 
 
AVAILABLE SUPPORT  
x Did you have support from family/friends when you tried to quit? 
x Do you think the NHS offer sufficient support to help people quit 
smoking? 
x Is there anything not offered that you think would be beneficial? 
x Would having New Leaf/other support stalls in city centre, supermarket 
etc be helpful? 
 
OTHER 
x Why do you think some smokers apparently find it so easy to quit? 
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APPENDIX XI: Coding table
  
 
 
  
 
 
1
9
3
 
 
 
THEMES CATEGORIES DEFINITIONS 
TRIGGERS  
Internal factors 
External factors 
Factors which triggered the paUWLFLSDQWV¶TXLWDWWHPSW 
Internal factors triggered the quit attempt 
External factors triggered the quit attempt 
NATURE OF THE QUIT 
ATTEMPT 
 
Spontaneous  
Delayed 
Cut down 
No cut down 
Dependent 
Less/non-dependent 
How the quit attempt was made 
The attempt was initiated as soon as the decision to quit was made 
The attempt was initiated some time after the decision to quit was made 
The individual reduced their smoking prior to the quit attempt  
The individual did not reduce their smoking prior to the quit attempt 
The individual was dependent on smoking (by self report) 
The individual was less or non-dependent on smoking (by self report) 
SUPPORT USED  
Pharmacological 
Behavioural 
Alternative 
Nothing 
Support participants used in the quit attempt 
Pharmacological support was used in the quit attempt 
Behavioural support was used in the quit attempt 
Alternative therapy was used in the quit attempt  
No support was used in the quit attempt  
REASONS FOR NOT USING 
SUPPORT 
 
Access 
Importance of the 
individual 
Personal preference 
Factors which meant participants may not use support in their quit 
attempt 
Access to NRT products/services was a reason for not using support 
Individuals thought they could successfully quit without support 
Individuals would prefer not to use existing support and medications  
  
 
 
 
1
9
4
 
SUPPORT AVAILABLE  
Individual 
Enough 
Education and 
awareness 
Different 
Participants views on the support available to help smokers quit 
The importance of the individual in successful quitting 
Enough support is available to help smokers quit 
More education/awareness of the support available is needed 
Support should be offered in a different way 
FACTORS INFLUENCING 
SUCCESS 
 
Right time 
Mindset  
Significant others 
Factors participants feel are important for an attempt to be successful  
It has to be the right time for the individual to make the quit attempt 
The mindset of the individual is an important factor for success 
Significant others are an important factor for success 
BETTER SUPPORTING 
SMOKERS 
 
Provision 
Location 
Ways in which participants feel smokers could be better supported in 
quit attempts  
Provision of smoking cessation support as a way of better supporting smokers 
Location of smoking cessation support as a way of better supporting smokers 
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APPENDIX XII: Coding framework
  
 
 
  
 
 
1
9
6
 
PERSON SUCCESS? 
REASONS 
FOR 
SUCCESS 
REASONS 
FOR 
FAILURE 
USE OF 
SUPPORT 
ATTITUDE 
TO 
AVAILABLE 
SUPPORT 
ATTEMPTS 
BETTER 
SUPPORTING 
SMOKERS 
SPONTANEOUS DELAYED 
CUT 
DOWN? 
DEPENDENT? 
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APPENDIX XIII: Publications and presentations arising 
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PUBLICATIONS ARISING 
 
Murray RL, Lewis, S.A., Coleman, T., Britton, J., McNeill, A.  Unplanned 
attempts to quit smoking: missed opportunities for health promotion? 
Addiction 2009; In Press. 
 
Murray RL, Coleman T, Antoniak M, Stocks J, Fergus A, Britton J, et al. The 
effect of proactively identifying smokers and offering smoking cessation 
support in primary care populations: a cluster-randomized trial. Addiction 
2008;103(6):998-1006; discussion 1007-8. 
 
 Murray RL, Coleman T, Antoniak M, Fergus A, Britton J, Lewis SA. The potential 
to improve ascertainment and intervention to reduce smoking in Primary 
Care: a cross sectional survey. BMC Health Services Research 
2008;8(1):6. 
 
 
PRESENTATIONS/ABSTRACTS 
 
Murray RL, (2009).  Spontaneous smoking cessation.  Invited plenary speaker, 
UKNSCC June 2009 
 
Murray RL, McNeill, A, Coleman, T, Britton, J, Lewis SA.  Unplanned quit 
attempts: incidence and use of support.  SRNT Europe, October 2008.  Oral 
Presentation 
 
Murray RL, Coleman T, Britton J, Antoniak M, Fergus A, Lewis S.  Cluster-
randomised controlled trial of pro-actively identifying smokers & offering support 
from NHS stop smoking services.  UKNSCC, Birmingham, July 2008.  Oral 
Presentation 
 
Murray, RL, Coleman, T, Antoniak, M, Fergus, A, Britton, J, Lewis SA. (2007). 
Promoting Smoking Cessation in Primary Care: A Cluster-Randomized Controlled 
Intervention Trial of a Pro-Actively Identifying Smokers and offering Evidence-
Based Support to Stop Smoking.  American Thoracic Society, April 2007.  Poster-
discussion
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APPENDIX XIV: Postgraduate training courses attended 
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COURSE TITLE       CREDIT VALUE 
 
How to prepare an effective poster presentation    2 
Getting going on your thesis and getting your work published  2 
MS Excel functionality b       1 
Exploiting the power of MS Word (a & b)     2 
Introduction to library skills (advanced)     1 
Using Nvivo® to analyse qualitative data     2 
Interview workshop        1 
Preparing your first year report and writing scientific abstracts  1 
Advanced statistics 3        1 
Building a bibliography (an online learning course)   1 
Analysing interview transcripts      2 
Critical analysis of scientific literature     1 
Faculty postgraduate Research Forum     3 
 
TOTAL          20  
 225 
 
 
 
 
 
 
 
 
 
 
REFERENCES 
 226 
 
 
 
 
1. Murray CJL, Lopez AD. Alternative projections of mortality and disability by 
cause 1990-2020: Global burden of disease study. Lancet 
1997;349(9064):1498-1504. 
2. Fagerstrom K. The epidemiology of smoking - Health consequences and 
benefits of cessation. Drugs 2002;62:1-9. 
3. Beyond Smoking Kills: Protecting children, reducing inequalities: ASH, 2008. 
4. Parrott S, Godfrey C. ABC of smoking cessation - Economics of smoking 
cessation. British Medical Journal 2004;328(7445):947-949. 
5. Parrott S, Godfrey C, Raw M. Costs of employee smoking in the workplace in 
Scotland. Tobacco Control 2000;9(2):187-192. 
6. Statistics on Smoking: England, 2008: The Information Centre, 2008. 
7. Family Spending 2007 edition: National Statistics, 2006. 
8. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 
years' observations on male British doctors. British Medical Journal 
2004;328(7455):1519. 
9. Wald NJ, Hackshaw AK. Cigarette smoking: an epidemiological overview. 
British Medical Bulletin 1996;52(1):3-11. 
10. Hanrahan JP, Sherman CB, Bresnitz EA, Emmons KM, Mannino DM. Cigarette 
smoking and health. American Journal of Respiratory and Critical Care 
Medicine 1996;153(2):861-865. 
11. Nicotine Addiction in Britain A report of the Tobacco Advisory Group of the 
Royal College of Physicians  London: Royal College of Physicians, 2000. 
12. Quinn M, Babb P, Brock A, Kirby L, Jones J. Cancer Trends in England and 
Wales 1950-1999. London: Office for National Statistics, 2001. 
13. Peto R, Lopez A, Boreham J, Thun M. Mortality from smoking in developed 
countries. Oxford  Oxford University Press, 2006. 
14. Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in Relation to 
Smoking - 40 Years Observations on Male British Doctors. British Medical 
Journal 1994;309(6959):901-911. 
15. Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R. Smoking, smoking 
cessation, and lung cancer in the UK since 1950: combination of national 
statistics with two case-control studies. British Medical Journal 
2000;321(7257):323-329. 
16. Kerstjens HAM, Rijcken B, Schouten JP, Postma DS. Decline of FEV1 by age 
and smoking status: facts, figures, and fallacies. Thorax 1997;52(9):820-
827. 
17. Beck GJ, Doyle CA, Schachter EN. Smoking and Lung-Function. American 
Review of Respiratory Disease 1981;123(2):149-155. 
18. Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, et al. 
Effects of Smoking Intervention and the Use of An Inhaled Anticholinergic 
Bronchodilator on the Rate of Decline of Fev(1) - the Lung Health Study. 
Jama-Journal of the American Medical Association 1994;272(19):1497-
1505. 
19. Marsh S, Aldington S, Shirtcliffe P, Weatherall M, Beasley R. Smoking and 
COPD: what really are the risks? European Respiratory Journal 
2006;28(4):883-884. 
20. Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive 
pulmonary disease (COPD). Lancet 2004;364(9434):613-620. 
21. Twigg L, Moon G, Walker S. The smoking epidemic in England. London: 
Health Development Agency, 2004. 
22. Mahonen MS, McElduff P, Dobson AJ, Kuulasmaa KA, Evans AE. Current 
smoking and the risk of non-fatal myocardial infarction in the WHO 
MONICA Project populations. Tobacco Control 2004;13(3):244-250. 
23. Negri E, Lavecchia C, Nobili A, Davanzo B, Bechi S. Cigarette-Smoking and 
Acute Myocardial-Infarction - A Case-Control Study from the Gissi-2 Trial. 
European Journal of Epidemiology 1994;10(4):361-366. 
 227 
 
 
 
24. McElduff P, Dobson A, Beaglehole R, Jackson R. Rapid reduction in coronary 
risk for those who quit cigarette smoking. Australian and New Zealand 
Journal of Public Health 1998;22(7):787-791. 
25. Howard G, Wagenknecht LE, Burke GL, Diez-Roux A, Evans GW, McGovern P, 
et al. Cigarette smoking and progression of atherosclerosis - The 
atherosclerosis risk in communities (ARIC) study. Jama-Journal of the 
American Medical Association 1998;279(2):119-124. 
26. Hankey GJ. Smoking and risk of stroke. Journal of Cardiovascular Risk 
1999;6(4):207-211. 
27. Curtis KM, Savitz DA, Arbuckle TE. Effects of cigarette smoking, caffeine 
consumption, and alcohol intake on fecundability. American Journal of 
Epidemiology 1997;146(1):32-41. 
28. Sofikitis N, Takenaka M, Kanakas N, Papadopoulos H, Yamamoto Y, Drakakis 
P, et al. Effects of cotinine on sperm motility, membrane function, and 
fertilizing capacity in vitro. Urological Research 2000;28(6):370-375. 
29. Kyrklund-Blomberg NB, Granath F, Cnattingius S. Maternal smoking and 
causes of very preterm birth. Acta Obstetricia et Gynecologica 
Scandinavica 2005;84(6):572-577. 
30. Larsen LG, Clausen HV, Jonsson L. Stereologic examination of placentas from 
mothers who smoke during pregnancy. American Journal of Obstetrics 
and Gynecology 2002;186(3):531-537. 
31. Cliver SP, Goldenberg RL, Cutter GR, Hoffman HJ, Davis RO, Nelson KG. The 
Effect of Cigarette-Smoking on Neonatal Anthropometric Measurements. 
Obstetrics and Gynecology 1995;85(4):625-630. 
32. Acheson D. Independent Inquiry into Inequalitites in Health Report: The 
Stationary Office  1998. 
33. Chesterman J, Judge K, Bauld L, Ferguson J. How effective are the English 
smoking treatment services in reaching disadvantaged smokers? 
Addiction 2005;100:36-45. 
34. Chandola T, Head J, Bartley M. Socio-demographic predictors of quitting 
smoking: how important are household factors? Addiction 
2004;99(6):770-777. 
35. Romeri E, Baker A, Griffiths C. Mortality by deprivation and cause of death in 
England and Wales, 1999-2003. Health Stat Q 2006(32):19-34. 
36. Jha P, Peto R, Zatonski W, Boreham J, Jarvis MJ, Lopez AD. Social 
inequalities in male mortality, and in male mortality from smoking: 
indirect estimation from national death rates in England and Wales, 
Poland, and North America. Lancet 2006;368(9533):367-370. 
37. Robinson SG, E. Smoking and drinking among adults, 2007. General 
Household Survey, 2007. London: Office for National Statistics, 2009. 
38. Graham H, Der G. Patterns and predictors of smoking cessation among 
British women. Health Promotion International 1999;14(3):231-239. 
39. Jarvis MJ. ABC of smoking cessation - Why people smoke. British Medical 
Journal 2004;328(7434):277-279. 
40. McNeill AD, Jarvis MJ, Stapleton JA, West RJ, Bryant A. Nicotine Intake in 
Young Smokers - Longitudinal-Study of Saliva Cotinine Concentrations. 
American Journal of Public Health 1989;79(2):172-175. 
41. Wetter DW, Kenford SL, Smith SS, Fiore MC, Jorenby DE, Baker TB. Gender 
differences in smoking cessation. J Consult Clin Psychol 1999;67(4):555-
62. 
42. Bohadana A, Nilsson F, Rasmussen T, Martinet Y. Gender differences in quit 
rates following smoking cessation with combination nicotine therapy: 
influence of baseline smoking behavior. Nicotine Tob Res 2003;5(1):111-
6. 
43. Jarvis MJ. Gender differences in smoking cessation: real or myth? Tobacco 
Control 1994;3  324-328. 
 228 
 
 
 
44. Lader D. Smoking-related Behaviour and Attitudes, 2007. London: Office for 
National Statistics, 2008. 
45. Jefferis BJMH, Power C, Graham H, Manor O. Changing social gradients in 
cigarette smoking and cessation over two decades of adult follow-up in a 
British birth cohort. Journal of Public Health 2004;26(1):13-18. 
46. Infant Feeding Survey 2005: Early Results: The Information Centre   2006. 
47. Coulthard M, Farrell M, Singleton N, Meltzer H. Tobacco, alcohol and drug 
use and mental health. London   Office for National Statistics   2002. 
48. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. 
Smoking and mental illness - A population-based prevalence study. Jama-
Journal of the American Medical Association 2000;284(20):2606-2610. 
49. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text 
Revision. Washington, DC: American Psychiatric Association, 2000:191-
296. 
50. West R. Theory of Addiction. London: Blackwell publishing, 2006. 
51. West R. The PRIME Theory of motivation as a possible foundation for 
addiction treatment. In: Henningfield J, Santora, P. and Bickel, W.  , 
editor. Drug Addiction Treatment in the 21st Century: Science and Policy 
Issues. Baltimore: John's Hopkins University Press, 2007. 
52. Godfrey C, Parrott S, Coleman T, Pound E. The cost-effectiveness of the 
English smoking treatment services: evidence from practice. Addiction 
2005;100(s2):70-83. 
53. Lichtenstein E, Hollis JF, Severson HH, Stevens VJ, Vogt TM, Glasgow RE, et 
al. Tobacco cessation interventions in health care settings: Rationale, 
model, outcomes. Addictive Behaviors 1996;21(6):709-720. 
54. Tengs TO, Adams ME, Pliskin JS, Safran DG, Siegel JE, Weinstein MC, et al. 
500 Lifesaving Interventions and Their Cost-Effectiveness. Risk Analysis 
1995;15(3):369-390. 
55. Raw M, Anderson P, Batra A, Dubois G, Harrington P, Hirsch A, et al. WHO 
Europe evidence based recommendations on the treatment of tobacco 
dependence. Tobacco Control 2002;11(1):44-46. 
56. West R, McNeill A, Raw M. Smoking cessation guidelines for health 
professionals: an update. Thorax 2000;55(12):987-999. 
57. Judge K, Bauld L, Chesterman J, Ferguson J. The English smoking treatment 
services: short-term outcomes. Addiction 2005;100(s2):46-58. 
58. McNeill A, Foulds J, Bates C. Regulation of nicotine replacement therapies 
(NRT): a critique of current practice. Addiction 2001;96(12):1757-1768. 
59. Smoking cessation services in primary care, pharmacies, local authorities 
and workplaces, particularly for manual working groups, pregnant women 
and hard to reach communitites. London  National Institute for Clinical 
Excellence  2008. 
60. Molyneux AN. ABC of smoking cessation - Nicotine replacement therapy. 
British Medical Journal 2004;328(7437):454-456. 
61. 'Medicines, ethics and practice guide' amendments (June 2008). The 
Pharmaceutical Journal 2008;280:702. 
62. Fagerstrom KO, Schneider NG, Lunell E. Effectiveness of Nicotine Patch and 
Nicotine Gum As Individual Versus Combined Treatments for Tobacco 
Withdrawal Symptoms. Psychopharmacology 1993;111(3):271-277. 
63. Stead LF, Perera R, Bullen C, Mant D, Lancaster T. Nicotine replacement 
therapy for smoking cessation. Cochrane Database of Systematic Reviews 
2008(3):CD000146. 
64. Haggstram FM, Chatkin JM, Sussenbach-Vaz E, Cesari DH, Fam CF, Fritscher 
CC. A controlled trial of nortriptyline, sustained-release bupropion and 
placebo for smoking cessation: preliminary results. Pulmonary 
Pharmacology & Therapeutics 2006;19(3):205-209. 
65. Roddy E. ABC of smoking cessation - Bupropion and other non-nicotine 
pharmacotherapies. British Medical Journal 2004;328(7438):509-511. 
 229 
 
 
 
66. Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, et al. 
Efficacy of varenicline, an alpha 4 beta 2 nicotinic acetylcholine receptor 
partial agonist, vs placebo or sustained-release bupropion for smoking 
cessation - A randomized controlled trial. Jama-Journal of the American 
Medical Association 2006;296(1):56-63. 
67. Hughes J, Stead L, Lancaster T. Antidepressants for smoking cessation. 
Cochrane Database Syst.Rev. 2006(3):CD000031. 
68. McRobbie H, Lee M, Juniper Z. Non-nicotine pharmacotherapies for smoking 
cessation. Respiratory Medicine 2005;99(10):1203-1212. 
69. Foulds J, Steinberg MB, Williams JM, Ziedonis DM. Developments in 
pharmacotherapy for tobacco dependence: past, present and future. Drug 
and Alcohol Review 2006;25(1):59-71. 
70. Tonstad S, Tonnesen P, Hajek P, Williams KE, Billing CB, Reeves KR. Effect of 
maintenance therapy with varenicline on smoking cessation - A 
randomized controlled trial. Jama-Journal of the American Medical 
Association 2006;296(1):64-71. 
71. Tapper AR, McKinney SL, Nashmi R, Schwarz J, Deshpande P, Labarca C, et 
al. Nicotine activation of alpha 4*receptors: Sufficient for reward, 
tolerance, and sensitization. Science 2004;306(5698):1029-1032. 
72. Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, et al. 
Varenicline, an alpha 4 beta 2 nicotinic acetylcholine receptor partial 
agonist, vs sustained-release bupropion and placebo for smoking 
cessation - A randomized controlled trial. Jama-Journal of the American 
Medical Association 2006;296(1):47-55. 
73. Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking 
cessation. Cochrane Database of Systematic Reviews 2009(3). 
74. Coleman T. ABC of smoking cessation - Use of simple advice and behavioural 
support. British Medical Journal 2004;328(7436):397-399. 
75. Brief interventions and referral for smoking cessation in primary care and 
other settings. London: National Institute for Clinical Excellence, 2006. 
76. Parrott S, Godfrey C, Raw M, West R, McNeill A. Guidance for commissioners 
on the cost effectiveness of smoking cessation interventions. Thorax 
1998;53 Supp 5 Pt 1:AS1-AS38. 
77. Coleman T. ABC of smoking cessation - Cessation interventions in routine 
health care. British Medical Journal 2004;328(7440):631-633. 
78. West R. ABC of smoking cessation - Assessment of dependence and 
motivation to stop smoking. British Medical Journal 2004;328(7435):338-
339. 
79. Jarvis MJ, Wardle J, Marmot M, Wilkinson RG. Social patterning of individual 
health behaviours: the case of cigarette smoking. Social Determinants of 
Health (2nd Edition). Oxford: Oxford University Press, 2005. 
80. Coleman T. Smoking cessation: integrating recent advances into clinical 
practice. Thorax 2001;56(7):579-582. 
81. McEwen A, Akotia N, West R. General Practitioners' views on the English 
national smoking cessation guidelines. Addiction 2001;96(7):997-1000. 
82. Senore C, Battista RN, Shapiro SH, Segnan N, Ponti A, Rosso S, et al. 
Predictors of smoking cessation following physicians' counseling. 
Preventive Medicine 1998;27(3):412-421. 
83. Coleman T, Murphy E, Cheater F. Factors influencing discussion of smoking 
between general practitioners and patients who smoke: a qualitative 
study. British Journal of General Practice 2000;50(452):207-210. 
84. Zwar NA, Richmond RL. Role of the general practitioner in smoking 
cessation. Drug and Alcohol Review 2006;25(1):21-26. 
85. Lancaster T, Stead L. Physician advice for smoking cessation. Cochrane 
Database of Systematic Reviews 2004(4):CD000165. 
86. Solomon LJ, Marcy TW, Howe KD, Skelly JM, Reinier K, Flynn BS. Does 
extended proactive telephone support increase smoking cessation among 
 230 
 
 
 
low-income women using nicotine patches? Preventive Medicine 
2005;40(3):306-313. 
87. Borland R, Segan CJ. The potential of quitlines to increase smoking 
cessation. Drug and Alcohol Review 2006;25(1):73-78. 
88. Stead L, Perera R, Lancaster T. Telephone counselling for smoking cessation. 
Cochrane Database of Systematic Reviews 
2006;%19;3:CD002850.:CD002850. 
89. Swartz LH, Noell JW, Schroeder SW, Ary DV. A randomised control study of a 
fully automated internet based smoking cessation programme. Tob 
Control 2006;15(1):7-12. 
90. Graham AL, Cobb NK, Raymond L, Sill S, Young J. Effectiveness of an 
internet-based worksite smoking cessation intervention at 12 months. J 
Occup Environ Med 2007;49(8):821-8. 
91. Strecher VJ, Shiffman S, West R. Randomized controlled trial of a web-based 
computer-tailored smoking cessation program as a supplement to 
nicotine patch therapy. Addiction 2005;100(5):682-8. 
92. Raw M, McNeill A, West R. Smoking cessation: evidence based 
recommendations for the healthcare system. British Medical Journal 
1999;318(7177):182-185. 
93. McNeill A, Raw M, Whybrow J, Bailey P. A national strategy for smoking 
cessation treatment in England. Addiction 2005;100(s2):1-11. 
94. Lancaster T, Stead LF. Individual behavioural counselling for smoking 
cessation. Cochrane Database of Systematic Reviews 2005(2):CD001292. 
95. Stead LF, Lancaster T. Group behaviour therapy programmes for smoking 
cessation. Cochrane Database of Systematic Reviews 2005(2):CD001007. 
96. Smoking Kills. A White Paper on Tobacco. London  Department of Health, 
1998. 
97. The NHS Cancer plan: a plan for investment, a plan for reform. London: 
Department of Health, 2000. 
98. Bauld L, Chesterman J, Judge K, Pound E, Coleman T. Impact of UK National 
Health Service smoking cessation services: variations in outcomes in 
England. Tobacco Control 2003;12(3):296-301. 
99. NHS Stop Smoking Services: Service and monitoring guidance-2007/08. 
London: Department of Health, 2007. 
100. Pound E, Coleman T, Adams C, Bauld L, Ferguson J. Targeting smokers in 
priority groups: the influence of government targets and policy 
statements. Addiction 2005;100(s2):28-35. 
101. Bauld L, Coleman T, Adams C, Pound E, Ferguson J. Delivering the English 
smoking treatment services. Addiction 2005;100(s2):19-27. 
102. Hart JT. Inverse Care Law. Lancet 1971;1(7696):405-&. 
103. Wiltshire S, Bancroft A, Amos A, Parry O. "They're doing people a service" - 
qualitative study of smoking, smuggling, and social deprivation. British 
Medical Journal 2001;323(7306):203-207. 
104. Statistics on NHS Stop Smoking Services: England, April 2007 to March 
2008: The Information Centre, 2008. 
105. Investing in General Practice: The New General Medical Services Contract. 
London, 2004. 
106. Quality and Outcomes Framework: Guidance. London: Department of 
Health, 2004. 
107. Raw M, McNeill A, West R. Smoking cessation guidelines for health 
professionals - A guide to effective smoking cessation interventions for 
the health care system. Thorax 1998;53:S1-S19. 
108. Murray RL, Bauld L, Hackshaw LE, McNeill A. Improving access to smoking 
cessation services for disadvantaged groups: a systematic review. J Public 
Health (Oxf) 2009. 
109. Roddy E, Antoniak M, Britton J, Molyneux A, Lewis S. Barriers and 
motivators to gaining access to smoking cessation services amongst 
 231 
 
 
 
deprived smokers - a qualitative study. BMC Health Services Research 
2006;6:147. 
110. Wiltshire S, Bancroft A, Parry O, Amos A. 'I came back here and started 
smoking again': perceptions and experiences of quitting among 
disadvantaged smokers. Health Educ Res 2003;18(3):292-303. 
111. Blenkinsopp A, Anderson C, Armstrong M. Systematic review of the 
effectiveness of community pharmacy-based interventions to reduce risk 
behaviours and risk factors for coronary heart disease. J Public Health 
Med 2003;25(2):144-53. 
112. Bauld L, Ferguson, J, Lawson, L, Chesterman, J and Judge, K. Tackling 
Smoking in Glasgow: Final Report, Glasgow Centre for Population Health, 
Glasgow, 2006. 
113. Doescher MP, Whinston MA, Goo A, Cummings D, Huntington J, Saver BG. 
Pilot study of enhanced tobacco-cessation services coverage for low-
income smokers. Nicotine Tob Res 2002;4 Suppl 1:S19-24. 
114. Needleman I, Warnakulasuriya S, Sutherland G, Bornstein MM, Casals E, 
Dietrich T, et al. Evaluation of tobacco use cessation (TUC) counselling in 
the dental office. Oral Health Prev Dent 2006;4(1):27-47. 
115. Carr AB, Ebbert JO. Interventions for tobacco cessation in the dental 
setting. Cochrane Database Syst Rev 2006(1):CD005084. 
116. Gordon JS, Lichtenstein E, Severson HH, Andrews JA. Tobacco cessation in 
dental settings: research findings and future directions. Drug Alcohol Rev 
2006;25(1):27-37. 
117. Barbeau EM, Li Y, Calderon P, Hartman C, Quinn M, Markkanen P, et al. 
Results of a union-based smoking cessation intervention for apprentice 
iron workers (United States). Cancer Causes Control 2006;17(1):53-61. 
118. Owens C, Springett J. The Roy Castle Fag Ends Stop Smoking Service: A 
Successful Client-led approach to Smoking Cessation. Journal of Smoking 
Cessation 2006;1(1):13-18. 
119. Springett J. The challenge of combining lay knowledge with evidence-based 
practice in health promotion: Fag Ends smoking cessation service. Critical 
Public Health 2007;17(3):243-256. 
120. Ritchie D, Schulz S, Bryce A. One size fits all? A process evaluation--the 
turn of the 'story' in smoking cessation. Public Health 2007;121(5):341-
8. 
121. Cahill K, Perera R. Competitions and incentives for smoking cessation. 
Cochrane Database Syst Rev 2008(3):CD004307. 
122. Coleman T, Lewis S, Hubbard R, Smith C. Impact of contractual financial 
incentives on the ascertainment and management of smoking in primary 
care. Addiction 2007;102(5):803. 
123. Bentz CJ, Bayley KB, Bonin KE, Fleming L, Hollis JF, McAfee T. The 
feasibility of connecting physician offices to a state-level tobacco quit line. 
American journal of preventive medicine 2006;30(1):31-7. 
124. Perry RJ, Keller PA, Fraser D, Fiore MC. Fax to quit: a model for delivery of 
tobacco cessation services to Wisconsin residents. WMJ 2005;104(4):37-
40, 44. 
125. Milch CE, Edmunson JM, Beshansky JR, Griffith JL, Selker HP. Smoking 
cessation in primary care: a clinical effectiveness trial of two simple 
interventions. Preventative Medicine 2004;38(3):284-94. 
126. Prochaska JO, Velicer WF, Fava JL, Rossi JS, Tsoh JY. Evaluating a 
population-based recruitment approach and a stage-based expert system 
intervention for smoking cessation. Addictive Behaviours 
2001;26(4):583-602. 
127. Tillgren P, Eriksson L, Guldbrandsson K, Spiik M. Impact of direct mail as a 
method to recruit smoking mothers into a "quit and win" contest. Journal 
of Health Communication 2000;5(4):293-303. 
 232 
 
 
 
128. Copeland L, Robertson R, Elton R. What happens when GPs proactively 
prescribe NRT patches in a disadvantaged community. Scott Med J 
2005;50(2):64-8. 
129. Borland R, Balmford J, Hunt D. The effectiveness of personally tailored 
computer-generated advice letters for smoking cessation. Addiction 
2004;99(3):369-377. 
130. Velicer WF, Prochaska JO, Redding CA. Tailored communications for 
smoking cessation: past successes and future directions. Drug and 
Alcohol Review 2006;25(1):49-57. 
131. Prochaska JO, Diclemente CC. Stages and Processes of Self-Change of 
Smoking - Toward An Integrative Model of Change. Journal of Consulting 
and Clinical Psychology 1983;51(3):390-395. 
132. Prochaska JO, Diclemente CC, Norcross JC. In Search of How People 
Change - Applications to Addictive Behaviors. American Psychologist 
1992;47(9):1102-1114. 
133. Riemsma RP, Pattenden J, Bridle C, Sowden AJ, Mather L, Watt IS, et al. 
Systematic review of the effectiveness of stage based interventions to 
promote smoking cessation. BMJ 2003;326(7400):1175-7. 
134. Herzog TA. Are the stages of change for smokers qualitatively distinct? An 
analysis using an adolescent sample. Psychology of addictive behaviors 
2007;21(1):120-5. 
135. Sutton S. Back to the drawing board? A review of applications of the 
transtheoretical model to substance use. Addiction 2001;96(1):175-86. 
136. West R. Time for a change: putting the Transtheoretical (Stages of Change) 
Model to rest. Addiction 2005;100(8):1036-9. 
137. Herzog TA. Analyzing the transtheoretical model using the framework of 
Weinstein, Rothman, and Sutton (1998): the example of smoking 
cessation. Health Psychology 2008;27(5):548-56. 
138. Herzog TA, Blagg CO. Are most precontemplators contemplating smoking 
cessation? Assessing the validity of the stages of change. Health 
Psychology 2007;26(2):222-31. 
139. Etter JF, Perneger TV. A comparison of two measures of stage of change for 
smoking cessation. Addiction 1999;94(12):1881-9. 
140. Larabie LC. To what extent do smokers plan quit attempts? Tobacco Control 
2005;14(6):425-428. 
141. Ferguson SG, Shiffman S, Gitchell JG, Sembower MA, West R. Unplanned 
quit attempts--Results from a U.S. sample of smokers and ex-smokers. 
Nicotine Tob Res 2009. 
142. West R, Sohal T. "Catastrophic" pathways to smoking cessation: findings 
from national survey. British Medical Journal 2006;332(7539):458-460. 
143. Brown C. Chaos and Catastrophe theories: Quantitative applications in the 
social sciences. London: Sage Publications Inc, 1995. 
144. Bland JM, Kerry SM. Statistics notes. Trials randomised in clusters. BMJ 
1997;315(7108):600. 
145. Kerry SM, Bland JM. Analysis of a trial randomised in clusters. BMJ 
1998;316(7124):54. 
146. Kerry SM, Bland JM. Sample size in cluster randomisation. BMJ 
1998;316(7130):549. 
147. Adams G, Gulliford MC, Ukoumunne OC, Eldridge S, Chinn S, Campbell MJ. 
Patterns of intra-cluster correlation from primary care research to inform 
study design and analysis. Journal of Clinical Epidemiology 
2004;57(8):785-794. 
148. Wilson A, Manku-Scott T, Shepherd D, Jones B. A comparison of individual 
and population smoking data from a postal survey and general practice 
records. British Journal of General Practice 2000;50(455):465-468. 
149. McEwen A, West R. Smoking cessation activities by general practitioners 
and practice nurses. Tobacco Control 2001;10(1):27-32. 
 233 
 
 
 
150. West R, Hajek P, Stead L, Stapleton J. Outcome criteria in smoking 
cessation trials: proposal for a common standard. Addiction 
2005;100(3):299-303. 
151. Binnie V, McHugh S, Macpherson L, Borland B, Moir K, Malik K. The 
validation of self-reported smoking status by analysing cotinine levels in 
stimulated and unstimulated saliva, serum and urine. Oral Diseases 
2004;10(5):287-293. 
152. Verification SfRiNaTSSoB. Biochemical verification of tobacco use and 
cessation. Nicotine and Tobacco Research 2002;4(2):149-159. 
153. Jarvis MJ, Tunstallpedoe H, Feyerabend C, Vesey C, Saloojee Y. Comparison 
of Tests Used to Distinguish Smokers from Nonsmokers. American Journal 
of Public Health 1987;77(11):1435-1438. 
154. Townsend P, Phillmore, P., Beattie, A. Health and Deprivation: inequality 
and the North. London: Croon-Helm, 1988. 
155. 2001 Census, UK National Statistics website:  
http://www.statistics.gov.uk/census/     Office for National Statistics, 
2004. 
156. Morris R, Carstairs V. Which Deprivation - A Comparison of Selected 
Deprivation Indexes. Journal of Public Health Medicine 1991;13(4):318-
326. 
157. Fiore MC, Bailey WC, Cohen SJ, Dorfman SF, Fox BJ, Goldstein MG, et al. A 
clinical practice guideline for treating tobacco use and dependence - A US 
Public Health Service report. Jama-Journal of the American Medical 
Association 2000;283(24):3244-3254. 
158. Mant J, Murphy M, Rose P, Vessey M. The accuracy of general practitioner 
records of smoking and alcohol use: comparison with patient 
questionnaires. Journal of Public Health Medicine 2000;22(2):198-201. 
159. Petitti DB, Friedman GD, Kahn W. Accuracy of Information on Smoking-
Habits Provided on Self-Administered Research Questionnaires. American 
Journal of Public Health 1981;71(3):308-311. 
160. Pierce JP, Gilpin E, Burns DM, Whalen E, Rosbrook B, Shopland D, et al. 
Does tobacco advertising target young people to start smoking? Evidence 
from California. JAMA 1991;266(22):3154-8. 
161. McCormick A, Fleming D, Charlton J. Morbidity Statistics from General 
Practice. Fourth national study 1991-1992. London   HMSO, 1995. 
162. Murray RL, Coleman T, Antoniak M, Fergus A, Britton J, Lewis SA. The 
potential to improve ascertainment and intervention to reduce smoking in 
Primary Care: a cross sectional survey. BMC Health Services Research 
2008;8(1):6. 
163. Rabash J, Steele F, Browne WJ, Prosser B. A user's guide to MLWin 2.0: 
University of Bristol, 2005. 
164. Lichtenstein E, Hollis J. Patient Referral to A Smoking Cessation Program - 
Who Follows Through. Journal of Family Practice 1992;34(6):739-744. 
165. Ferguson J, Bauld L, Chesterman J, Judge K. The English smoking 
treatment services: one-year outcomes. Addiction 2005;100(s2):59-69. 
166. Lennox AS, Osman LM, Reiter E, Robertson R, Friend J, McCann I, et al. 
Cost effectiveness of computer tailored and non-tailored smoking 
cessation letters in general practice: randomised controlled trial. British 
Medical Journal 2001;322(7299):1396-1400. 
167. West R. Smoking toolkit study: protocol and methods, 2006. 
168. Gilpin E, Pierce JP. Measuring smoking cessation: problems with recall in 
the 1990 California Tobacco Survey. Cancer Epidemiol Biomarkers Prev 
1994;3(7):613-7. 
169. Shiffman S, Hufford M, Hickcox M, Paty JA, Gnys M, Kassel JD. Remember 
that? A comparison of real-time versus retrospective recall of smoking 
lapses. J Consult Clin Psychol 1997;65(2):292-300. 
 234 
 
 
 
170. O'Connor EA, Carbonari JP, DiClemente CC. Gender and smoking cessation: 
a factor structure comparison of processes of change. Journal of 
consulting and clinical psychology 1996;64(1):130-8. 
171. Gender differences and smoking cessation: Processes of change. 94th 
Annual Convention of the American Psychological Association; August, 
1986; Washington, DC. 
172. Gritz ER, Nielsen IR, Brooks LA. Smoking cessation and gender: the 
influence of physiological, psychological, and behavioral factors. Journal 
of the American Medical Women's Association 1996;51(1-2):35-42. 
173. McCaul KD, Hockemeyer JR, Johnson RJ, Zetocha K, Quinlan K, Glasgow 
RE. Motivation to quit using cigarettes: a review. Addictive Behaviours 
2006;31(1):42-56. 
174. Bauld L, Chesterman J, Ferguson J, Judge K. A comparison of the 
effectiveness of group-based and pharmacy-led smoking cessation 
treatment in Glasgow. Addiction 2009;104(2):308-16. 
175. Murray RL, Lewis, S.A., Coleman, T., Britton, J., McNeill, A Unplanned 
attempts to quit smoking: missed opportunities for health promotion? 
Addiction 2009;In Press. 
176. Mathie A, Carnozzi, A. Qualitative Research for Tobacco Control: A How-to 
Introductory Manual for Researchers and Development Practitioners. 
Ottowa, Canada: IRTC, 2005. 
177. Ritchie J, Spencer, L. Qualitative data analysis for applied policy research. 
In: Bryan A, Burgess, R., editor. Analyzing qualitative data. London: 
Routledge, 1994:173-194. 
178. Vogt F, Hall S, Marteau TM. Understanding why smokers do not want to use 
nicotine dependence medications to stop smoking: qualitative and 
quantitative studies. Nicotine Tob Res 2008;10(8):1405-13. 
179. Copeland L. An exploration of the problems faced by young women living in 
disadvantaged circumstances if they want to give up smoking: can more 
be done at general practice level? Fam Pract 2003;20(4):393-400. 
180. Etter JF, Perneger TV. Attitudes toward nicotine replacement therapy in 
smokers and ex-smokers in the general public. Clin Pharmacol Ther 
2001;69(3):175-83. 
181. Hammond D, McDonald PW, Fong GT, Borland R. Do smokers know how to 
quit? Knowledge and perceived effectiveness of cessation assistance as 
predictors of cessation behaviour. Addiction 2004;99(8):1042-8. 
182. Shiffman S, Ferguson SG, Rohay J, Gitchell JG. Perceived safety and 
efficacy of nicotine replacement therapies among US smokers and ex-
smokers: relationship with use and compliance. Addiction 
2008;103(8):1371-8. 
183. Kishchuk N, Tremblay M, Lapierre J, Heneman B, O'Loughlin J. Qualitative 
investigation of young smokers' and ex-smokers' views on smoking 
cessation methods. Nicotine Tob Res 2004;6(3):491-500. 
184. Van Der Rijt GA, Westerik H. Social and cognitive factors contributing to the 
intention to undergo a smoking cessation treatment. Addict Behav 
2004;29(1):191-8. 
 
 
